0001060955-23-000033.txt : 20231027 0001060955-23-000033.hdr.sgml : 20231027 20231027082101 ACCESSION NUMBER: 0001060955-23-000033 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 88 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231027 DATE AS OF CHANGE: 20231027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ICON PLC CENTRAL INDEX KEY: 0001060955 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 981067160 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-08704 FILM NUMBER: 231352219 BUSINESS ADDRESS: STREET 1: SOUTH COUNTY BUSINESS PARK STREET 2: LEOPARDSTOWN CITY: DUBLIN 18 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00 353 1 291 2000 MAIL ADDRESS: STREET 1: SOUTH COUNTY BUSINESS PARK STREET 2: LEOPARDSTOWN CITY: DUBLIN 18 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ICON PLC /ADR/ DATE OF NAME CHANGE: 20010213 6-K 1 iclr-20230930.htm 6-K iclr-20230930
falseQ3000106095512/319/30/2023http://fasb.org/us-gaap/2023#OtherLiabilitieshttp://fasb.org/us-gaap/2023#OtherLiabilitieshttp://fasb.org/us-gaap/2023#NontradeReceivablesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent00010609552023-01-012023-09-3000010609552023-09-30iso4217:USD00010609552022-12-310001060955us-gaap:FairValueInputsLevel1Member2023-09-300001060955us-gaap:FairValueInputsLevel1Member2022-12-31iso4217:EURxbrli:sharesxbrli:shares00010609552023-07-012023-09-3000010609552022-07-012022-09-3000010609552022-01-012022-09-30iso4217:USDxbrli:shares0001060955us-gaap:CommonStockMember2022-12-310001060955us-gaap:AdditionalPaidInCapitalMember2022-12-310001060955iclr:OtherUndenominatedCapitalMember2022-12-310001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001060955us-gaap:RetainedEarningsMember2022-12-310001060955us-gaap:RetainedEarningsMember2023-01-012023-03-3100010609552023-01-012023-03-310001060955us-gaap:CommonStockMember2023-01-012023-03-310001060955us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001060955us-gaap:CommonStockMember2023-03-310001060955us-gaap:AdditionalPaidInCapitalMember2023-03-310001060955iclr:OtherUndenominatedCapitalMember2023-03-310001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001060955us-gaap:RetainedEarningsMember2023-03-3100010609552023-03-310001060955us-gaap:RetainedEarningsMember2023-04-012023-06-3000010609552023-04-012023-06-300001060955us-gaap:CommonStockMember2023-04-012023-06-300001060955us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001060955us-gaap:CommonStockMember2023-06-300001060955us-gaap:AdditionalPaidInCapitalMember2023-06-300001060955iclr:OtherUndenominatedCapitalMember2023-06-300001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001060955us-gaap:RetainedEarningsMember2023-06-3000010609552023-06-300001060955us-gaap:RetainedEarningsMember2023-07-012023-09-300001060955us-gaap:CommonStockMember2023-07-012023-09-300001060955us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001060955us-gaap:CommonStockMember2023-09-300001060955us-gaap:AdditionalPaidInCapitalMember2023-09-300001060955iclr:OtherUndenominatedCapitalMember2023-09-300001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001060955us-gaap:RetainedEarningsMember2023-09-300001060955us-gaap:CommonStockMember2021-12-310001060955us-gaap:AdditionalPaidInCapitalMember2021-12-310001060955iclr:OtherUndenominatedCapitalMember2021-12-310001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001060955us-gaap:RetainedEarningsMember2021-12-3100010609552021-12-310001060955us-gaap:RetainedEarningsMember2022-01-012022-03-3100010609552022-01-012022-03-310001060955us-gaap:CommonStockMember2022-01-012022-03-310001060955us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001060955iclr:OtherUndenominatedCapitalMember2022-01-012022-03-310001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001060955us-gaap:CommonStockMember2022-03-310001060955us-gaap:AdditionalPaidInCapitalMember2022-03-310001060955iclr:OtherUndenominatedCapitalMember2022-03-310001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001060955us-gaap:RetainedEarningsMember2022-03-3100010609552022-03-310001060955us-gaap:RetainedEarningsMember2022-04-012022-06-3000010609552022-04-012022-06-300001060955us-gaap:CommonStockMember2022-04-012022-06-300001060955us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001060955us-gaap:CommonStockMember2022-06-300001060955us-gaap:AdditionalPaidInCapitalMember2022-06-300001060955iclr:OtherUndenominatedCapitalMember2022-06-300001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001060955us-gaap:RetainedEarningsMember2022-06-3000010609552022-06-300001060955us-gaap:RetainedEarningsMember2022-07-012022-09-300001060955us-gaap:CommonStockMember2022-07-012022-09-300001060955us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001060955us-gaap:CommonStockMember2022-09-300001060955us-gaap:AdditionalPaidInCapitalMember2022-09-300001060955iclr:OtherUndenominatedCapitalMember2022-09-300001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001060955us-gaap:RetainedEarningsMember2022-09-3000010609552022-09-300001060955us-gaap:CustomerRelationshipsMember2023-09-300001060955us-gaap:OrderOrProductionBacklogMember2023-09-300001060955us-gaap:TradeNamesMember2023-09-300001060955us-gaap:DatabasesMember2023-09-300001060955us-gaap:TechnologyBasedIntangibleAssetsMember2023-09-300001060955iclr:Clients15Member2023-07-012023-09-300001060955iclr:Clients15Member2022-07-012022-09-300001060955iclr:Clients15Member2023-01-012023-09-300001060955iclr:Clients15Member2022-01-012022-09-300001060955iclr:Clients610Member2023-07-012023-09-300001060955iclr:Clients610Member2022-07-012022-09-300001060955iclr:Clients610Member2023-01-012023-09-300001060955iclr:Clients610Member2022-01-012022-09-300001060955iclr:Clients1125Member2023-07-012023-09-300001060955iclr:Clients1125Member2022-07-012022-09-300001060955iclr:Clients1125Member2023-01-012023-09-300001060955iclr:Clients1125Member2022-01-012022-09-300001060955iclr:OtherCustomersMember2023-07-012023-09-300001060955iclr:OtherCustomersMember2022-07-012022-09-300001060955iclr:OtherCustomersMember2023-01-012023-09-300001060955iclr:OtherCustomersMember2022-01-012022-09-30xbrli:pure00010609552023-10-012023-09-3000010609552022-01-012022-12-310001060955iclr:OncacareMember2023-04-200001060955iclr:OncacareMember2023-01-012023-09-300001060955us-gaap:CustomerRelationshipsMember2022-12-310001060955us-gaap:OrderOrProductionBacklogMember2022-12-310001060955us-gaap:TradeNamesMember2022-12-310001060955us-gaap:DatabasesMember2022-12-310001060955us-gaap:TechnologyBasedIntangibleAssetsMember2022-12-310001060955us-gaap:FairValueInputsLevel2Member2023-09-300001060955us-gaap:FairValueInputsLevel3Member2023-09-300001060955us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2023-09-300001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel1Membericlr:InterestRateCapAndInterestRateSwapMember2023-09-300001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Membericlr:InterestRateCapAndInterestRateSwapMember2023-09-300001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel3Membericlr:InterestRateCapAndInterestRateSwapMember2023-09-300001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembericlr:InterestRateCapAndInterestRateSwapMember2023-09-300001060955us-gaap:DesignatedAsHedgingInstrumentMembericlr:InterestRateCapAndInterestRateSwapMember2023-09-300001060955us-gaap:FairValueInputsLevel2Member2022-12-310001060955us-gaap:FairValueInputsLevel3Member2022-12-310001060955us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel1Membericlr:InterestRateCapAndInterestRateSwapMember2022-12-310001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Membericlr:InterestRateCapAndInterestRateSwapMember2022-12-310001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel3Membericlr:InterestRateCapAndInterestRateSwapMember2022-12-310001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembericlr:InterestRateCapAndInterestRateSwapMember2022-12-310001060955us-gaap:DesignatedAsHedgingInstrumentMembericlr:InterestRateCapAndInterestRateSwapMember2022-12-310001060955us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2023-09-300001060955iclr:A2021RestructuringPlanMember2023-01-012023-09-300001060955iclr:PersonnelRelatedLiabilitiesMember2023-09-300001060955iclr:FacilityLiabilityMember2023-09-300001060955iclr:OtherLiabilityMemberus-gaap:OtherCurrentLiabilitiesMember2023-09-300001060955iclr:OtherLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMember2023-09-300001060955us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-09-300001060955us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-09-300001060955us-gaap:CostOfSalesMember2023-01-012023-09-300001060955us-gaap:CostOfSalesMember2022-01-012022-09-300001060955us-gaap:OtherCurrentLiabilitiesMember2023-09-300001060955us-gaap:OtherCurrentLiabilitiesMember2022-09-300001060955us-gaap:SecuredDebtMembericlr:TermLoanFacilityMember2023-09-300001060955us-gaap:SecuredDebtMembericlr:TermLoanFacilityMember2022-12-310001060955iclr:SeniorSecuredNotesMemberus-gaap:SeniorSubordinatedNotesMember2023-09-300001060955iclr:SeniorSecuredNotesMemberus-gaap:SeniorSubordinatedNotesMember2022-12-310001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-09-300001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2022-12-310001060955us-gaap:SecuredDebtMembericlr:TermLoanFacilityMember2021-07-010001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2021-07-010001060955us-gaap:SecuredDebtMembericlr:SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember2021-07-010001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-05-020001060955us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembericlr:TermLoanFacilityMember2023-06-302023-06-300001060955srt:MinimumMembericlr:TermLoanFacilityMember2023-06-302023-06-300001060955srt:MaximumMembericlr:SeniorSecuredRevolvingLoanFacilityMemberus-gaap:BaseRateMembericlr:VariableRateComponentOneMember2023-01-012023-09-300001060955iclr:SeniorSecuredRevolvingLoanFacilityMemberus-gaap:BaseRateMembericlr:VariableRateComponentOneMember2023-01-012023-09-300001060955srt:MinimumMembericlr:SeniorSecuredRevolvingLoanFacilityMemberus-gaap:BaseRateMembericlr:VariableRateComponentOneMember2023-01-012023-09-300001060955srt:MaximumMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembericlr:SeniorSecuredRevolvingLoanFacilityMembericlr:VariableRateComponentTwoMember2023-01-012023-09-300001060955us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembericlr:SeniorSecuredRevolvingLoanFacilityMembericlr:VariableRateComponentTwoMember2023-01-012023-09-300001060955srt:MinimumMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembericlr:SeniorSecuredRevolvingLoanFacilityMembericlr:VariableRateComponentTwoMember2023-01-012023-09-300001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-01-012023-01-310001060955srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-01-310001060955us-gaap:RevolvingCreditFacilityMembersrt:MinimumMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-01-130001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-01-012023-01-310001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-03-312023-03-310001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-03-310001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-03-312023-03-310001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-04-012023-04-300001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-04-300001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-04-012023-04-300001060955us-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-06-302023-06-300001060955us-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-08-172023-08-170001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-09-292023-09-290001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-09-290001060955us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:LineOfCreditMembericlr:SeniorSecuredRevolvingLoanFacilityMember2023-09-292023-09-290001060955us-gaap:SecuredDebtMembericlr:TermLoanFacilityMember2023-03-312023-03-310001060955us-gaap:SecuredDebtMembericlr:TermLoanFacilityMember2023-06-302023-06-300001060955us-gaap:SecuredDebtMembericlr:TermLoanFacilityMember2023-09-292023-09-290001060955iclr:SeniorSecuredNotesMemberus-gaap:SeniorSubordinatedNotesMember2021-07-010001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateCapMember2022-11-29iclr:instrument0001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:InterestRateCapMember2022-11-290001060955us-gaap:InterestRateSwapMember2022-11-290001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateCapMember2023-09-300001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateCapMember2022-12-310001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-09-300001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2022-12-310001060955us-gaap:DesignatedAsHedgingInstrumentMembericlr:OtherReceivablesMemberus-gaap:FairValueInputsLevel2Membericlr:InterestRateCapAndInterestRateSwapMember2023-09-300001060955us-gaap:EmployeeStockOptionMember2022-12-310001060955us-gaap:EmployeeStockOptionMember2022-12-312022-12-310001060955us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001060955us-gaap:EmployeeStockOptionMember2023-09-300001060955us-gaap:EmployeeStockOptionMember2023-09-302023-09-300001060955us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001060955iclr:RestrictedStockUnitsTwentyThirteenMember2015-05-112015-05-110001060955iclr:RestrictedStockUnitsTwentyThirteenMember2015-05-110001060955iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember2019-05-160001060955iclr:NonExecutiveDirectorMembericlr:ConsultantsRestrictedStockUnitsTwentyNineteenMember2019-05-162023-09-300001060955iclr:PerformanceShareUnitMember2022-12-310001060955us-gaap:RestrictedStockUnitsRSUMember2022-12-310001060955iclr:PerformanceShareUnitMember2023-01-012023-09-300001060955us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001060955iclr:PerformanceShareUnitMember2023-09-300001060955us-gaap:RestrictedStockUnitsRSUMember2023-09-300001060955iclr:PerformanceShareUnitMember2022-01-012022-12-310001060955us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001060955srt:MaximumMembericlr:PerformanceBasedGrantsMember2023-09-300001060955us-gaap:CostOfSalesMember2023-07-012023-09-300001060955us-gaap:CostOfSalesMember2022-07-012022-09-300001060955us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300001060955us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012022-09-300001060955srt:MaximumMembericlr:BuybackProgramMember2023-01-012023-09-300001060955iclr:BuybackProgramMember2022-02-182022-03-31iclr:segment0001060955country:IE2023-07-012023-09-300001060955country:IE2022-07-012022-09-300001060955country:IE2023-01-012023-09-300001060955country:IE2022-01-012022-09-300001060955iclr:RestOfEuropeMember2023-07-012023-09-300001060955iclr:RestOfEuropeMember2022-07-012022-09-300001060955iclr:RestOfEuropeMember2023-01-012023-09-300001060955iclr:RestOfEuropeMember2022-01-012022-09-300001060955country:US2023-07-012023-09-300001060955country:US2022-07-012022-09-300001060955country:US2023-01-012023-09-300001060955country:US2022-01-012022-09-300001060955iclr:RestOfWorldMember2023-07-012023-09-300001060955iclr:RestOfWorldMember2022-07-012022-09-300001060955iclr:RestOfWorldMember2023-01-012023-09-300001060955iclr:RestOfWorldMember2022-01-012022-09-300001060955country:IE2023-09-300001060955country:IE2022-12-310001060955iclr:RestOfEuropeMember2023-09-300001060955iclr:RestOfEuropeMember2022-12-310001060955country:US2023-09-300001060955country:US2022-12-310001060955iclr:RestOfWorldMember2023-09-300001060955iclr:RestOfWorldMember2022-12-310001060955iclr:PhilipsPharmaSolutionsFormerlyBioTelResearchLLCMemberus-gaap:SubsequentEventMember2023-10-020001060955iclr:PhilipsPharmaSolutionsFormerlyBioTelResearchLLCMemberus-gaap:SubsequentEventMember2023-10-022023-10-02


FORM 6-K
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 under
the Securities Exchange Act of 1934


For
the month of October, 2023

ICON plc
(Translation of registrant's name into English)


333-08704
(Commission file number)


South County Business Park, Leopardstown, Dublin 18, D18 X5R3, Ireland
(Address of principal executive offices)



Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F___X___
Form 40-F______
Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes______
No___X___
Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes______
No___X___



ICON plc
This report on Form 6-K is hereby incorporated by reference in the registration statement on Form F-4 (Registration No. 333-254891) of ICON plc and in the prospectus contained therein, registration statement on Form S-8 (Registration No. 333-152802) of ICON plc, registration statement on Form S-8 (Registration No. 333-204153) of ICON plc, registration statement on Form S-8 (Registration No. 333-231527) of ICON plc, registration statement on Form S-8 (Registration No. 333-254891) of ICON plc, and registration statement on Form S-8 (Registration No. 333-257578) of ICON plc, and this report on Form 6-K shall be deemed a part of each such registration statement from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished by ICON plc under the Securities Act of 1933 or the Securities Exchange Act of 1934.
1


GENERAL

As used herein, “ICON”, the “Company”, the "Group", and “we” refer to ICON plc and its consolidated subsidiaries, unless the context requires otherwise.

Business

ICON is a clinical research organization (“CRO”), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. Our vision is to be the healthcare intelligence partner of choice by delivering industry leading solutions and best in class performance in clinical development.

We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated “full service” solution. At September 30, 2023 we had approximately 41,150 employees in 106 locations in 53 countries. During the nine months ended September 30, 2023, we derived approximately 41.7%, 47.5% and 10.8% of our revenue in the United States, Europe and Rest of World, respectively.

We began operations in 1990 and have expanded our business through organic growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, D18 X5R3, Republic of Ireland. The contact telephone number of this office is +353-1-291-2000.

Recent developments

Senior Secured Credit Facilities repayment

On September 29, 2023, the Company repaid $300.0 million of the senior secured term loan facility and made a quarterly interest payment of $74.5 million. This repayment resulted in an accelerated charge associated with previously capitalized fees of $2.5 million.

On June 30, 2023, the Company repaid $150.0 million of the senior secured term loan facility and made a quarterly interest payment of $74.0 million. This repayment resulted in an accelerated charge associated with previously capitalized fees of $1.2 million.


On March 31, 2023, the Company repaid $250.0 million of the senior secured term loan facility and made a quarterly interest payment of $75.3 million. This repayment resulted in an accelerated charge associated with previously capitalized fees of $2.2 million.

On December 30, 2022, the Company repaid $200.0 million of the senior secured term loan facility and made a quarterly interest payment of $66.1 million. This repayment resulted in an accelerated charge associated with previously capitalized fees of $1.8 million.

On September 30, 2022, the Company repaid $200.0 million of the senior secured term loan facility and made a quarterly interest payment of $53.6 million. This repayment resulted in an accelerated charge associated with previously capitalized fees of $1.9 million.

On June 30, 2022, the Company repaid $100.0 million of the senior secured term loan facility and made a quarterly interest payment of $39.4 million. This repayment resulted in an accelerated charge associated with previously capitalized fees of $0.9 million.

On March 31, 2022, the Company repaid $300.0 million of the senior secured term loan facility and made a quarterly interest payment of $35.1 million. This repayment resulted in an accelerated charge associated with previously capitalized fees of $3.2 million.









2



Senior secured revolving loan facility

In January 2023, $100.0 million of the senior secured revolving loan facility was drawn down, in the aggregate, at interest rates of 5.89% and 5.80%, representing one month SOFR plus a margin of 1.25%. This was repaid in full in March 2023. On March 31, 2023, $80.0 million of the senior secured revolving loan facility was drawn down at an interest rate of 6.17%, representing one month SOFR plus a margin of 1.25%. In April 2023, the Company drew down a further $50.0 million of the senior secured revolving loan facility at an interest rate of 6.25%, representing one month SOFR plus a margin of 1.25%. The Company repaid $80.0 million of the senior secured revolving loan facility on June 30, 2023. The remaining $50.0 million was repaid on August 17, 2023. On September 29, 2023, $75.0 million of the senior secured revolving loan facility was drawn down at an interest rate of 6.68%, representing one month SOFR plus a margin of 1.25%.

On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300 million to $500 million.


Foreign exchange translation

The Company prepares its financial statements in United States dollar while the local results of a certain number of our subsidiaries are prepared in currencies other than United States dollars, including, amongst others, the pound sterling and the euro. In addition, the Company's contracts with clients are sometimes denominated in currencies other than the United States dollar. Finally, the Company is exposed to a wider variety of currencies in the expenses line due to most expenses being incurred in the local currencies of where our global operations are based. Accordingly, changes in exchange rates between the United States dollar and those other currencies can impact the Company’s financial results.


Ukraine situation

On February 24, 2022, Russia invaded Ukraine, creating significant instability and unrest in the region. Since that time, the Company's key focus has been on the safety of our employees and their families, patients, investigators and on the mitigation of adverse impacts on ongoing clinical trials. The Company has worked to ensure the safety of employees and their families based in Ukraine through the implementation of a number of employee assistance programs. These programs aim to provide affected employees and their families with transportation, accommodation in neighboring countries, financial assistance, communications and other support services as needed.

The Company's operations in these affected regions have been significantly curtailed as a result of these events. The ongoing conflict in Ukraine has resulted in an increasingly complex economic sanctions and export controls environment applicable to our business operations in the region (including Russia and Belarus) as a result of additional trade compliance measures enacted by the United States, United Kingdom and European Union member states. These economic sanctions and export controls restrict our ability to do business with sanctioned entities, require additional compliance resources, and could have a material adverse effect on the results of our operations. The financial impact of the conflict was not material to the Company during the nine months ended September 30, 2023.


Israel and the conflict area in the Middle East

We are all saddened by recent developments in Israel and the conflict area in the Middle East. The Company's key focus has been on the safety of our employees and their families, patients, investigators and on the mitigation of adverse impacts on ongoing clinical trials. The Company has worked to ensure the safety of employees and their families through the implementation of a number of employee assistance programs. The team have been advised to work remotely as they continue to support our customers’ studies. The financial impact of the developments was not material to the Company during the three and nine months ended September 30, 2023.


3


     ICON plc
CONDENSED CONSOLIDATED BALANCE SHEETS
AS AT SEPTEMBER 30, 2023 AND DECEMBER 31, 2022
(Unaudited)(Audited)
September 30,
2023
December 31, 2022
ASSETS(in thousands)
Current assets:
Cash and cash equivalents$313,065 $288,768 
Available for sale investments1,954 1,713 
Accounts receivable, net of allowance for credit losses1,850,362 1,731,388 
Unbilled revenue941,884 957,655 
Other receivables121,687 63,658 
Prepayments and other current assets150,193 137,094 
Income taxes receivable42,039 48,790 
Total current assets3,421,184 3,229,066 
Non-current assets:
Property, plant and equipment, net342,262 350,320 
Goodwill8,982,896 8,971,670 
Intangible assets3,934,673 4,278,659 
Operating right-of-use assets132,319 153,832 
Other receivables52,797 70,790 
Income taxes receivable40,481 21,380 
Deferred tax asset83,095 76,930 
Investments in equity- long term 41,790 32,631 
Total Assets$17,031,497 $17,185,278 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable$87,317 $81,194 
Unearned revenue1,663,183 1,507,449 
Other liabilities948,829 1,005,025 
Income taxes payable41,518 41,783 
Current bank credit lines and loan facilities130,150 55,150 
Total current liabilities2,870,997 2,690,601 
Non-current liabilities:
Non-current bank credit lines and loan facilities3,911,522 4,599,037 
Lease liabilities121,424 131,644 
Non-current other liabilities41,661 38,260 
Non-current income taxes payable242,972 239,188 
Deferred tax liability883,887 988,585 
Commitments and contingencies  
Total Liabilities8,072,463 8,687,315 
Shareholders' Equity:
Ordinary shares, par value 6 euro cents per share; 100,000,000 shares authorized,
82,326,976 shares issued and outstanding at September 30, 2023 and
81,723,555 shares issued and outstanding at December 31, 2022
6,688 6,649 
Additional paid-in capital6,924,073 6,840,306 
Other undenominated capital1,162 1,162 
Accumulated other comprehensive loss(190,190)(171,538)
Retained earnings2,217,301 1,821,384 
       Total Shareholders' Equity8,959,034 8,497,963 
Total Liabilities and Shareholders' Equity$17,031,497 $17,185,278 

The accompanying notes are an integral part of these condensed consolidated financial statements.
4


ICON plc
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND SEPTEMBER 30, 2022
(UNAUDITED)
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands except share and per share data)
Revenue$2,055,099 $1,942,427 $6,053,928 $5,779,384 
Costs and expenses: 
Direct costs (excluding depreciation and amortization)1,449,136 1,375,837 4,274,222 4,146,366 
Selling, general and administrative expense185,187 166,787 572,999 552,000 
Depreciation and amortization146,032 141,861 436,217 427,285 
Transaction and integration-related expenses10,433 8,001 34,516 28,970 
Restructuring 6,197 45,390 32,890 
Total costs and expenses1,790,788 1,698,683 5,363,344 5,187,511 
Income from operations264,311 243,744 690,584 591,873 
Interest income1,273 1,434 3,294 1,727 
Interest expense(83,908)(63,010)(255,665)(154,546)
Income before provision for income taxes181,676 182,168 438,213 439,054 
Provision for income taxes(18,011)(21,012)(41,913)(48,552)
Income before share of earnings from equity method investments163,665 161,156 396,300 390,502 
Share of losses in equity method investments (1,002)(383)(2,643)
Net income attributable to the Group$163,665 $160,154 $395,917 $387,859 
Net income per Ordinary Share attributable to the Group (note 13): 
Basic$1.99 $1.96 $4.83 $4.76 
Diluted$1.97 $1.94 $4.79 $4.70 
Weighted average number of Ordinary Shares outstanding (note 13):  
Basic82,215,627 81,582,375 82,001,500 81,481,686 
Diluted82,972,888 82,493,211 82,737,073 82,473,521 

The accompanying notes are an integral part of these condensed consolidated financial statements.

5



ICON plc
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND SEPTEMBER 30, 2022
(UNAUDITED)

Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Comprehensive income (net of tax):
Net income attributable to the Group$163,665 $160,154 $395,917 $387,859 
Currency translation adjustment$(38,648)$(98,966)$(33,786)(200,964)
Gain on cash flow hedge$4,986 $ $15,134  
Total comprehensive income attributable to the Group$130,003 $61,188 $377,265 $186,895 

The accompanying notes are an integral part of these condensed consolidated financial statements.
6


ICON plc
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(UNAUDITED)
 
Group
SharesAmountAdditional
Paid-in
Capital
Other
Undenominated
Capital
Accumulated
Other
Comprehensive
Loss
Retained
Earnings
Total
(dollars in thousands, except share data)
Balance at December 31, 202281,723,555 $6,649 $6,840,306 $1,162 $(171,538)$1,821,384 $8,497,963 
Net income— — — — — 116,654 116,654 
Exercise of share options136,649 9 12,927 — — — 12,936 
Issue of restricted share units / performance share units68,218 4 — — — — 4 
Non-cash stock compensation expense— — 14,658 — — — 14,658 
Share issuance costs— — (4)— — — (4)
Other comprehensive income, net of tax— — — — 11,642 — 11,642 
Balance at March 31, 202381,928,422 6,662 6,867,887 1,162 (159,896)1,938,038 8,653,853 
Net income— — — — — 115,598 115,598 
Exercise of share options93,304 6 7,223 — — — 7,229 
Issue of restricted share units / performance share units129,323 8 — — — — 8 
Non-cash stock compensation expense— — 16,389 — — — 16,389 
Share issuance costs— — (5)— — — (5)
Other comprehensive income, net of tax— — — — 3,368 — 3,368 
Balance at June 30, 202382,151,049 6,676 6,891,494 1,162 (156,528)2,053,636 8,796,440 
Net income— — — — — 163,665 163,665 
Exercise of share options147,661 9 16,328 — — — 16,337 
Issue of restricted share units / performance share units 28,266 3 — — — — 3 
Non-cash stock compensation expense— — 16,256 — — — 16,256 
Share issuance costs— — (5)— — — (5)
Other comprehensive loss, net of tax— — — — (33,662)— (33,662)
Balance at September 30, 202382,326,976 6,688 6,924,073 1,162 (190,190)2,217,301 8,959,034 

The accompanying notes are an integral part of these condensed consolidated financial statements
7


Group
SharesAmountAdditional
Paid-in
Capital
Other
Undenominated
Capital
Accumulated
Other
Comprehensive
Loss
Retained
Earnings
Total
(dollars in thousands, except share data)
Balance at December 31, 202181,554,683 $6,640 $6,733,910 $1,134 $(90,937)$1,416,080 $8,066,827 
Net income— — — — — 111,970 111,970 
Exercise of share options84,090 6 7,491 — — — 7,497 
Issue of restricted share units / performance share units74,769 4 — — — — 4 
Non-cash stock compensation expense— — 18,840 — — — 18,840 
Share issuance costs— — (3)— — — (3)
Share repurchase program(420,530)(28)— 28 — (99,983)(99,983)
Share repurchase costs— — — — — (17)(17)
Other comprehensive loss, net of tax— — — — (35,818)— (35,818)
Balance at March, 31 202281,293,012 6,622 6,760,238 1,162 (126,755)1,428,050 8,069,317 
Net income— — — — — 115,734 115,734 
Exercise of share options75,671 4 7,649 — — — 7,653 
Issue of restricted share units / performance share units157,924 11 — — — — 11 
Non-cash stock compensation expense— — 19,478 — — — 19,478 
Other comprehensive loss, net of tax— — — — (66,180)— (66,180)
Balance at June, 30 202281,526,607 6,637 6,787,365 1,162 (192,935)1,543,784 8,146,013 
Net income
— — — — — 160,154 160,154 
Exercise of share options117,140 4 13,827 — — — 13,831 
Issue of restricted share units1,532 4 — — — — 4 
Non-cash stock compensation expense— — 17,686 — — — 17,686 
Share issuance costs— — (1)— — — (1)
Other comprehensive loss, net of tax— — — — (98,966)— (98,966)
Balance at September 30, 202281,645,279 6,645 6,818,877 1,162 (291,901)1,703,938 8,238,721 

The accompanying notes are an integral part of these condensed consolidated financial statements
8


ICON plc
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 AND SEPTEMBER 30, 2022 (UNAUDITED)
Nine Months Ended
September 30, 2023September 30, 2022
(in thousands)
Cash flows from operating activities:
Net income$395,917 $387,859 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense436,217 427,285 
Impairment of long lived assets8,845 27,727 
Reduction in carrying value of operating right-of-use assets33,979 35,238 
Loss on equity method investments383 2,643 
Acquisition-related gain(6,160) 
Charge on cash flow hedge3,335  
Amortization of financing costs and debt discount12,485 13,544 
Stock compensation expense47,303 55,703 
Deferred taxes(114,487)(126,620)
Foreign exchange movements(7,670)(52,334)
Other non-cash items21,966 18,595 
Changes in operating assets and liabilities:
Accounts receivable(139,096)(140,760)
Unbilled revenue14,370 (221,104)
Unearned revenue158,269 28,352 
Other net assets(144,760)166,613 
Net cash provided by operating activities720,896 622,741 
Cash flows from investing activities:  
Purchase of property, plant and equipment(87,980)(85,145)
Purchase of subsidiary undertakings(5,100) 
Sale of available for sale investments1,611  
Purchase of available for sale investments(1,852) 
Purchase of investments in equity - long term(10,829)(1,840)
Net cash used in investing activities(104,150)(86,985)
Cash flows from financing activities:  
Drawdown of bank credit lines and loan facilities305,000 25,000 
Repayment of bank credit lines and loan facilities(930,000)(625,000)
Proceeds from exercise of equity compensation36,517 28,967 
Share issue costs(14)(3)
Repurchase of ordinary shares (99,983)
Share repurchase costs (17)
Net cash used in financing activities(588,497)(671,036)
Effect of exchange rate movements on cash(3,952)(7,775)
Net increase (decrease) in cash and cash equivalents24,297 (143,055)
Cash and cash equivalents at beginning of period288,768 752,213 
Cash and cash equivalents at end of period313,065 609,158 

The accompanying notes are an integral part of these condensed consolidated financial statements.
9


ICON plc
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
September 30, 2023
1. Basis of presentation

These condensed consolidated financial statements which have been prepared in accordance with United States Generally Accepted Accounting Principles (“US GAAP”) have not been audited. The condensed consolidated financial statements reflect all adjustments, which are, in the opinion of management, necessary to present a fair statement of the operating results and financial position for the periods presented. The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures in the condensed consolidated financial statements. Actual results could differ from those estimates.

The condensed consolidated financial statements should be read in conjunction with the accounting policies and notes to the consolidated financial statements included in ICON’s Form 20-F for the year ended December 31, 2022 (see note 2 - Summary of significant accounting policies). Operating results for the nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal period ending December 31, 2023.
2. Summary of significant accounting policies
Revenue recognition
The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years.

ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.

Clinical trial service revenue

A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.

Laboratory services revenue

Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.

Contracting services revenue

The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff.
10



Consulting services revenue

Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.

Data services revenue

The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.

When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the “units delivered” output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.

Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.

The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract.

Commissions

Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.
Business Combinations
The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.

The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.

The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership.
11



Intangible Assets
Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives. The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist.

Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:

Estimated Useful Life
Customer relationships23 years
Order backlog3 years
Trade names3 years
Patient database7 years
Technology assets5 years

The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.


Income taxes

The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (“global intangible low-taxed income”) in the period it arises and has therefore not provided for deferred taxes in respect of this item.
3. Revenue

Revenue disaggregated by customer concentration is as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Clients 1-5$527,345 $539,907 $1,615,713 $1,595,007 
Clients 6-10$302,407 $270,073 $868,753 $831,660 
Clients 11-25$448,428 $405,171 $1,267,750 $1,100,118 
Other$776,919 $727,276 $2,301,712 $2,252,599 
Total$2,055,099 $1,942,427 $6,053,928 $5,779,384 

There was no revenue from individual customers greater than 10% of consolidated revenue in the respective periods.





12





4. Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)

Accounts receivables and unbilled revenue are as follows:
September 30, 2023December 31, 2022
(in thousands)
Contract assets:
Billed services (accounts receivable)$1,883,296 $1,751,950 
Unbilled services (unbilled revenue)941,884 957,655 
Accounts receivable and unbilled revenue, gross2,825,180 2,709,605 
Allowance for credit losses(32,934)(20,562)
Accounts receivable and unbilled revenue, net$2,792,246 $2,689,043 
    
Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:
(in thousands, except percentages)September 30, 2023December 31, 2022$ Change% Change
Unbilled services (unbilled revenue)$941,884 $957,655 $(15,771)(1.6)%
Unearned revenue (payments on account)(1,663,183)(1,507,449)(155,734)10.3 %
Net balance$(721,299)$(549,794)$(171,505)31.2 %

Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled services and therefore contract assets rather than accounts receivables when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned.

Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right to set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Condensed Consolidated Balance Sheet.

Unbilled services as at September 30, 2023 decreased by $15.8 million compared to December 31, 2022. Unearned revenue increased by $155.7 million over the same period resulting in an increase of $171.5 million in the net balance of unbilled services and unearned revenue or payments on account between December 31, 2022 and September 30, 2023. These fluctuations are primarily due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer.

As of September 30, 2023 approximately $14.3 billion (September 30, 2022: $13.5 billion) of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations. The Company expects to recognize revenue on approximately 51% of the unsatisfied performance obligations over the next 12 months, with the remainder recognized thereafter over the duration of the customer contracts.

13


5. Goodwill
Nine Months EndedYear Ended
September 30, 2023December 31, 2022
(in thousands)
Opening balance$8,971,670 $9,037,931 
Current period acquisition13,379  
Prior period acquisition (35,692)
Foreign exchange movement(2,153)(30,569)
Closing balance$8,982,896 $8,971,670 
On April 20, 2023, the Company completed the purchase of the majority investor's 51% majority voting share capital of Oncacare Limited ("Oncacare"), such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group. The Oncacare acquisition resulted in goodwill of $13.4 million and also gave rise to an acquisition-related gain of $6.2 million.
There were no impairment charges for the nine months ended September 30, 2023 or for the year ended December 31, 2022.


6. Intangible assets

Intangible assets, net consisted of the following:
Nine Months EndedYear Ended
September 30, 2023December 31, 2022
Cost(in thousands)
Customer relationships$4,076,010 $4,076,435 
Order backlog536,716 536,934 
Trade names & brands204,608 204,621 
Patient database170,262 170,238 
Technology assets120,875 120,984 
Total cost5,108,471 5,109,212 
Accumulated amortization(1,173,798)(830,553)
 Net book value$3,934,673 $4,278,659 

The identifiable intangible assets are amortized over their estimated useful lives.


7. Fair value measurements

The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
Level 3 — Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
14



The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, unbilled services, contract assets, accounts payable and unearned revenue approximate fair value due to the short maturities of these instruments.

As of September 30, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
(in thousands)
Assets:
Available for sale securities (short-term) (a)1,954    1,954 
Available for sale investments (long-term) (b)   41,790 41,790 
Derivative instruments (c) 13,111   13,111 
Total assets$1,954 $13,111 $ $41,790 $56,855 
Liabilities:
Derivative instruments (c)     
Total liabilities$ $ $ $ $ 

As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
(in thousands)
Assets:
Available for sale securities (short-term) (a)1,713    1,713 
Available for sale investments (long-term) (b)   32,631 32,631 
Derivative instruments (c) 12   12 
Total assets$1,713 $12 $ $32,631 $34,356 
Liabilities:
Derivative instruments (c) 3,670   3,670 
Total liabilities$ $3,670 $ $ $3,670 

(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.

(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds meet the definition of equity securities without readily determinable fair values, which qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.

(c) Represents the fair value of interest rate cap and interest rate swap agreements. The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread.
15



Non-recurring Fair Value Measurements

Certain assets and liabilities are carried on the accompanying Condensed Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of September 30, 2023, assets carried on the balance sheet at cost and not re-measured to fair value on a recurring basis totaled approximately $12,917.6 million and are identified as Level 3 assets. These assets are comprised of goodwill of $8,982.9 million and net identifiable intangible assets of $3,934.7 million.

The estimated fair value of the Company’s debt was $4,032.0 million at September 30, 2023. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility is recorded as its carrying value, due to the short term duration.


8. Restructuring

In the nine months ended September 30, 2023, a restructuring charge of $45.4 million was recorded in the Condensed Consolidated Statement of Operations under a restructuring plan adopted following a review of operations. The restructuring plan reflected a workforce reduction of $34.1 million and an office consolidation program to optimize the Company's office footprint of $11.3 million.

 Nine Months Ended
September 30, 2023September 30, 2022
 (in thousands)
Restructuring charges$45,390 $32,890 
Net charge$45,390 $32,890 

At September 30, 2023, a total liability of $19.6 million was recorded on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $16.2 million of personnel related liabilities as a result of the workforce reduction; all of which have been classified as short-term. The total liability also included $3.4 million of facilities related liabilities of which $1.1 million is included within other liabilities and $2.3 million is included within non-current other liabilities.

Nine Months EndedYear ended
September 30, 2023December 31, 2022
(in thousands)
Opening provision$6,022 $10,311 
Additional provisions36,704 4,364 
Utilization(23,106)(8,653)
Ending provision$19,620 $6,022 











16


9. Operating leases
Lease costs recorded under operating leases for the three and nine months ended September 30, 2023 and September 30, 2022 were as follows:

Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Operating lease costs11,850 12,164 $37,539 $40,976 
Income from sub-leases(284)(268)(845)(898)
Net operating lease costs11,566 11,896 $36,694 $40,078 

Of the total cost of $36.7 million incurred in the nine months ended September 30, 2023 (September 30, 2022: $40.1 million), $28.1 million (September 30, 2022: $38.1 million) is recorded within selling, general and administration costs and $8.6 million (September 30, 2022: $2.0 million) is recorded within direct costs.

During the nine months ended September 30, 2023 and September 30, 2022, costs incurred by the Group related to variable lease payments was de minimis.

Right-of-use assets obtained, in exchange for lease obligations during the three months ended September 30, 2023, totaled $2.1 million (September 30, 2022: $1.7 million). Right-of-use assets obtained, in exchange for lease obligations during the nine months ended September 30, 2023, totaled $24.6 million (September 30, 2022: $37.6 million).

The weighted average remaining lease term and weighted-average discount rate at September 30, 2023 were 6.75 years and 3.15%, respectively.

Future minimum lease payments under non-cancelable leases as of September 30, 2023 were as follows:
Minimum rental payments
(in thousands)September 30, 2023
Year 1$38,084 
Year 231,545 
Year 326,709 
Year 421,934 
Year 515,039 
Thereafter35,884 
Total future minimum lease payments169,195 
Lease imputed interest(13,883)
Total$155,312 

Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $33.9 million have been included in other liabilities as at September 30, 2023 (September 30, 2022: $42.2 million).













17



10. Bank credit lines and loan facilities

The Company had the following debt outstanding as of September 30, 2023 and December 31, 2022:

Principal amount
Interest rate as ofInterest rate as ofSeptember 30,December 31,
(in thousands)September 30, 2023December 31, 202220232022Maturity Date
Credit Facilities:
Senior Secured Term Loan7.75 %7.09 %$3,501,213 $4,201,213 July 2028
Senior Secured Notes
2.88 %2.88 %500,000 500,000 July 2026
Senior Secured Revolving Loan Facility6.68 %— 75,000  October 2023
Total debt4,076,213 4,701,213 
Less current portion of long-term debt(130,150)(55,150)
Total long-term debt3,946,063 4,646,063 
Less debt issuance costs and debt discount
(34,541)(47,026)
Total long-term debt, net$3,911,522 $4,599,037 

As of September 30, 2023, the contractual maturities of the Company's debt obligations were as follows:

Contractual maturities of long-term debt:(in thousands)
2023 (remaining)$88,788 
202455,150 
202555,150 
2026555,150 
2027 and thereafter3,321,975 
Total$4,076,213 

The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").

Senior Secured Credit Facilities

On July 1, 2021, the Company completed the acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences ("the Merger"). In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The Company paid a $27.6 million debt discount in connection with the Senior Secured Credit Facility and Senior Secured Notes. On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300 million to $500 million.

Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin which is dependent on the Company's net leverage ratio. At September 30, 2023, the applicable margin is 2.25%. The senior secured term loan facility is subject to a floor of 0.50%.

The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON’s current corporate family rating assigned by S&P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON’s current corporate family rating assigned by S&P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility
18


are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn.

In January 2023, $100.0 million of the senior secured revolving loan facility was drawn down, in the aggregate, at interest rates of 5.89% and 5.80%, representing one month SOFR plus a margin of 1.25%. This was repaid in full in March 2023. On March 31, 2023, $80.0 million of the senior secured revolving loan facility was drawn down at an interest rate of 6.17%, representing one month SOFR plus a margin of 1.25%. In April 2023, the Company drew down a further $50.0 million of the senior secured revolving loan facility at an interest rate of 6.25%, representing one month SOFR plus a margin of 1.25%. The Company repaid $80.0 million of the senior secured revolving loan facility on June 30, 2023. The remaining $50.0 million was repaid on August 17, 2023. On September 29, 2023, $75.0 million of the senior secured revolving loan facility was drawn down at an interest rate of 6.68%, representing one month SOFR plus a margin of 1.25%.

The Borrowers’ (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON’s, the Borrowers’ and each of the subsidiary guarantor’s assets (subject to certain exceptions), and the Senior Secured Credit Facilities have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes, subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty.

On March 31, 2023 the Company repaid $250.0 million of the senior secured term loan facility and made a quarterly
interest payment of $75.3 million. This repayment resulted in an additional charge associated with previously capitalized fees of
$2.2 million.

On June 30, 2023 the Company repaid $150.0 million of the senior secured term loan facility and made a quarterly interest payment of $74.0 million. This repayment resulted in an additional charge associated with previously capitalized fees of $1.2 million.

On September 29, 2023, the Company repaid $300.0 million of the senior secured term loan facility and made a quarterly interest payment of $74.5 million. This repayment resulted in an additional charge associated with previously capitalized fees of $2.5 million.

Senior Secured Notes

In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500 million in aggregate principal amount of 2.875% senior secured notes due 2026 (the "Senior Secured Notes") in a private offering (the “Offering”). The Senior Secured Notes will mature on July 15, 2026.

Fair Value of Debt

The estimated fair value of the Company’s debt was $4,032.0 million at September 30, 2023. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility is recorded as its carrying value due to the short term duration.






















19


11. Derivatives

On November 29, 2022, the Company entered into two interest rate cap agreements ("2022 Caps") with an initial total notional value of $2,101 million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate caps expires on December 31, 2024. The Company pays a fixed rate of 0.42% and receives a variable rate equal to the amount that the three-month SOFR exceeds 4.75%.

On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $1,101 million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swap begins accruing on December 31, 2024 and the interest rate swap expires on September 30, 2026. The Company pays a fixed rate of 3.4% and receives a variable rate of interest equal to the three-month SOFR on the 2022 Swap.

The fair value of the Company’s derivative financial instruments, on a gross basis, are summarized in the following table:

September 30, 2023December 31, 2022
AssetLiabilityNotionalAssetLiabilityNotional
(in thousands)(in thousands)
Derivatives designated as hedging instruments:
Interest Rate Caps$4,262$$1,750,606$12$3,363$2,100,606
Interest Rate Swap$8,849$$1,100,606$$307$1,100,606
Total derivatives designated as hedging instruments$13,111$$2,851,212$12$3,670$3,201,212
As of September 30, 2023, the Company recognized a current derivative asset of $3.8 million within other receivables (December 31, 2022, current derivative asset of $0.01 million recognized within other receivables and a current derivative liability of $3.3 million recognized within other liabilities). A further $9.3 million non-current derivative asset was recognized within non-current other receivables (December 31,2022, non-current derivative liability of $0.4 million recognized within non-current other liabilities).

During the next 12 months, the Company estimates that an additional $2.3 million will be reflected as interest income in the consolidated statements.

The Company recognized $5.0 million of a gain within other comprehensive income ("OCI") for the three months ended September 30, 2023 (September 30, 2022: $nil) after a reclassification of $0.3 million from OCI to the income statement (September 30, 2022: $nil). The Company recognized $15.1 million of a net gain within OCI for the nine months ended September 30, 2023 (September 30, 2022: $nil) after a reclassification of $3.3 million from OCI to the income statement (September 30, 2022: $nil).


20



12. Income taxes
Income taxes recognized during the three and nine months ended September 30, 2023 and September 30, 2022, comprise:

Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Provision for income taxes $18,011 $21,012 $41,913 $48,552 

As at September 30, 2023 the Company maintains a $251.1 million liability (December 31, 2022: $240.2 million) for unrecognized tax benefit, which is comprised of $221.1 million (December 31, 2022: $217.6 million) related to items generating unrecognized tax benefits and $30.0 million (December 31, 2022: $22.6 million) for interest and penalties related to such items. The Company recognizes interest accrued on unrecognized tax benefits as an additional income tax expense.

The Company has analyzed the filing positions in all of the significant federal, state and foreign jurisdictions where it is required to file income tax returns, as well as open tax years in these jurisdictions. The only periods subject to audit by the major tax jurisdictions where the Company does business are the 2016 through 2022 tax years. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.
13. Net income per ordinary share

Basic net income per ordinary share attributable to the Group has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share.

The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
Weighted average number of ordinary shares outstanding for basic net income per ordinary share82,215,627 81,582,375 82,001,500 81,481,686 
Effect of dilutive share options and other awards outstanding under share based compensation programs757,261 910,836 735,573 991,835 
Weighted average number of ordinary shares outstanding for diluted net income per ordinary share82,972,888 82,493,211 82,737,073 82,473,521 

Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
Net income per Ordinary Share attributable to the Group:
Basic1.99 1.96 4.83 4.76 
Diluted1.97 1.94 4.79 4.70 

21


14. Share-based awards

Share Options

The following table summarizes option activity for the nine months ended September 30, 2023:
 Options
Outstanding
Number of Shares 
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life
Outstanding at December 31, 20221,378,119 $119.86 4.69
Granted82,472 $232.48 
Exercised(377,614)$96.67 
Canceled/expired(6,885)$116.33 
Outstanding at September 30, 20231,076,092 $136.65 4.45
Exercisable at September 30, 2023804,953 $113.75 3.91

The Company issues ordinary shares for all options exercised. The total amount of fully vested share options which remained outstanding at September 30, 2023 was 804,953. Fully vested share options at September 30, 2023 have an average remaining contractual term of 3.91 years and an average exercise price of $113.75.


Fair value of Stock Options Assumptions

The weighted average fair value of options granted during the nine months ended September 30, 2023 and September 30, 2022 was calculated using the Black-Scholes option pricing model. The weighted average grant date fair values and assumptions used were as follows:
Nine Months Ended
September 30, 2023September 30, 2022
Weighted average grant date fair value$85.12 $68.40 
Assumptions:  
Expected volatility33 %31 %
Dividend yield % %
Risk-free interest rate3.98 %1.85 %
Expected life5 years5 years

Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.

Restricted Share Units and Performance Share Units 

On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the 2013 RSU Plan by 2.5 million shares. Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company. No awards may be granted under the 2013 RSU Plan after May 11, 2025.

22


On April 30, 2019 the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the “2019 Consultants RSU Plan”), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company’s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors during 2020, 2021 and 2022 vest in twelve months.

    The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the nine months ended September 30, 2023:
  
PSU
Outstanding
Number of
Shares
 
PSU
Weighted
Average Grant Date
Fair Value
 
RSU
Outstanding
Number of
Shares
 
RSU
Weighted
Average Grant Date
Fair Value
Outstanding at December 31, 2022152,420 $192.29 582,612 $207.73 
Granted60,374 $232.51 306,780 $218.68 
Shares vested(47,026)$159.57 (178,781)$186.35 
Forfeited $ (59,260)$211.45 
Outstanding at September 30, 2023165,768 $216.22 651,351 $218.41 

The fair value of PSUs vested for the nine months ended September 30, 2023 totaled $7.5 million (full year 2022: $6.5 million).

The fair value of RSUs vested for the nine months ended September 30, 2023 totaled $33.3 million (full year 2022: $34.1 million).

The PSUs vest based on service and specified EPS targets over the periods 2021 - 2023, 2022 - 2024, and 2023 - 2025. Depending on the amount of EPS from 2021 to 2025, up to an additional 82,884 PSUs may also be granted.

Stock compensation expense

Stock compensation expense for the three and nine months ended September 30, 2023 and September 30, 2022 has been allocated as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Direct costs$6,637 $6,285 $18,725 $17,117 
Selling, general and administrative$9,828 $11,232 $29,097 $38,586 
Total$16,465 $17,517 $47,822 $55,703 

15. Share capital

The Company can acquire up to 10% of its outstanding ordinary shares (by way of redemption), in accordance with Irish law and the Company’s constitutional documents through open market share acquisitions.

On February 18, 2022, the Company commenced a share buyback program which was fully complete at March 31, 2022. Under this buyback program, 420,530 ordinary shares were redeemed by the Company for total consideration of $100.0 million. The buyback program gives a broker authority to acquire the Company’s ordinary shares from time to time on the open market in accordance with agreed terms and limitations. All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital reserve as required under Irish Company Law.
23


16. Business Segment and Geographical Information

The Company is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. It specializes in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.

The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (‘CODM’) in accordance with ASC 280 'Segment Reporting'. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.

The Company operates as one reporting segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries.

Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group’s transfer pricing model.

ICON Ireland (Ireland Segment) acts as the Group entrepreneur under the Company’s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company’s global network. ICON Ireland enters into the majority of the Company’s customer contracts.

ICON Ireland remunerates other operating entities in the Group on the basis of a guaranteed cost plus mark-up for the services they perform in each of their local territories. The cost plus mark-up for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate arms-length return having regard to the assets owned, risks borne and functions performed by each entity from these intercompany transactions. The cost plus mark-up policy is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model remains ongoing.

The geographic split of revenue disclosed for each region outside Ireland is the cost plus revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the cost plus revenues attributable to the activities performed outside Ireland.

24


The geographical distribution of the Company’s segment measures for the three and nine months ended September 30, 2023 and September 30, 2022 and at September 30, 2023 and December 31, 2022 is as follows:

a) The distribution of revenue by geographical area was as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Ireland $596,337 $526,867 $1,701,580 $1,395,198 
Rest of Europe384,720 397,538 1,172,752 1,281,996 
U.S.831,789 903,200 2,524,212 2,767,844 
Rest of World242,253 114,822 655,384 334,346 
Total$2,055,099 $1,942,427 $6,053,928 $5,779,384 

b) The distribution of income from operations by geographical area was as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Ireland *$121,343 $93,640 $298,567 $159,059 
Rest of Europe56,705 76,178 138,959 194,860 
U.S.70,013 63,356 213,846 177,145 
Rest of World16,250 10,570 39,212 60,809 
Total$264,311 $243,744 $690,584 $591,873 
* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger.

c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:
September 30, 2023December 31, 2022
(in thousands)
Ireland$172,016 $143,025 
Rest of Europe89,265 99,721 
U.S.165,597 213,311 
Rest of World47,703 48,095 
Total$474,581 $504,152 
    

17. Subsequent events

On October 2, 2023, the Company acquired 100% of the equity of BioTel Research, LLC which comprised the business formerly known as Philips Pharma Solutions, a leading provider of medical imaging and cardiac safety monitoring services. The initial consideration paid on the closing date of the acquisition was $68.1 million.

The Company has evaluated subsequent events from the balance sheet date through to the date at which the financial
statements were available to be issued. The Company has determined that there are no items, other than the items described above, to disclose.
25


ICON plc

Management’s discussion and analysis of financial condition and results of operations

The following discussion and analysis should be read in conjunction with the unaudited condensed consolidated financial statements and accompanying notes included elsewhere herein and the consolidated financial statements and related notes thereto included in our Form 20-F for the year ended December 31, 2022. The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States.

Overview

We are a CRO providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. Our vision is to be the healthcare intelligence partner of choice by delivering industry leading solutions and best in class performance in clinical development.

We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated “full service” solution. At September 30, 2023, we employed approximately 41,150 employees in 106 locations in 53 countries. During the three months ended September 30, 2023 we derived approximately 40.5%, 47.7% and 11.8% of our revenue in the United States, Europe and Rest of World, respectively.

Revenue consists of fees earned under contracts with third-party clients. In most cases, a portion of the contract fee is paid at the time the study or trial is started, with the balance of the contract fee generally payable in installments over the study or trial duration, based on the delivery of certain performance targets or milestones. Revenue from long term contracts is recognized on a proportional performance method based on the relationship between cost incurred and the total estimated costs of the trial or on a fee-for-service basis according to the particular circumstances of the contract. As is customary in the CRO industry, we contract with third party investigators in connection with clinical trials. Investigator costs and certain other third party costs are included in our assessment of progress towards completion and costs incurred in measuring revenue. Where these costs are reimbursed by clients, they are included in the total contract value recognized over time, based on our assessment of progress towards completion.    

As the nature of our business involves the management of projects, the majority of which have a duration of one to four years, the commencement or completion of projects in a fiscal year can have a material impact on revenues earned with the relevant clients in such years. In addition, as we typically work with some, but not all, divisions of a client, fluctuations in the number and status of available projects within such divisions can also have a material impact on revenues earned from clients from year to year.

Termination or delay in the performance of an individual contract may occur for various reasons, including, but not limited to, unexpected or undesired results, production problems resulting in shortages of the drug, adverse patient reactions to the drug, the client’s decision to de-emphasize a particular trial or inadequate patient enrollment or investigator recruitment. In the event of termination, the Company is usually entitled to all sums owed for work performed through the notice of termination and certain costs associated with the termination of the study. In addition, contracts generally contain provisions for renegotiation in the event of changes in the scope, nature, duration, or volume of services of the contract.

Our unsatisfied performance obligation comprises our assessment of contracted revenue yet to be earned from projects awarded by clients. At September 30, 2023 we had unsatisfied performance obligations of approximately $14.3 billion (see note 4 - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) for further details). We believe that our unsatisfied performance obligations as of any date is not necessarily a meaningful predictor of future results, due to the potential for cancellation or delay of the projects included in the unsatisfied performance obligation, and no assurances can be given on the extent to which we will be able to realize the unsatisfied performance obligation.

Although we are domiciled in Ireland, we report our results in U.S. dollars. As a consequence, the results of our non-U.S. based operations, when translated into U.S. dollars, could be materially affected by fluctuations in exchange rates between the U.S. dollar and the currencies of those operations.

In addition to translation exposures, we are also subject to transaction exposures where the currency in which contracts are priced can be different from the currencies in which costs relating to those contracts are incurred. Our operations in the United States are not materially exposed to such currency differences as the majority of our revenues and costs are in U.S. dollars. However, outside of the United States the multinational nature of our activities means that contracts are usually priced in a single currency, most often U.S. dollars or euro, while costs arise in a number of currencies, depending, among other things, on which of our offices provide staff for the contract and the location of investigator sites. Although many such contracts benefit from some degree of natural hedging, due to the matching of contract revenues and costs in the same
26


currency, where costs are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material effect on our results of operations. We regularly review our currency exposures.

As we conduct operations on a global basis, our effective tax rate has depended, and will depend, on the geographic distribution of our revenue and earnings among locations with varying tax rates. Our results therefore may be affected by changes in the tax rates of the various jurisdictions. In particular, as the geographic mix of our results of operations among various tax jurisdictions changes, our effective tax rate may vary significantly from period to period.

Operating Results

The following tables sets forth for the periods indicated certain financial data as a percentage of revenue and the percentage change in these items compared to the prior comparable period. The trends illustrated in the following table may not be indicative of future results. 

Three Months Ended September 30, 2023

Three Months Ended
September 30, 2023September 30, 20222022 to 2023
Percentage of RevenuePercentage
 Increase/
(Decrease)
Revenue100.0 %100.0 %5.8 %
Costs and expenses:
Direct costs70.5 %70.8 %5.3 %
Selling, general and administrative9.0 %8.6 %11.0 %
Depreciation1.5 %1.5 %17.1 %
Amortization5.6 %5.9 %(0.4)%
Transaction and integration-related0.5 %0.4 %30.4 %
Restructuring— %0.3 %(100.0)%
Income from operations12.9 %12.5 %8.4 %

























27


Nine Months Ended September 30, 2023

Nine Months Ended
September 30, 2023September 30, 20222022 to 2023
Percentage of RevenuePercentage
 Increase/
(Decrease)
Revenue100.0 %100.0 %4.8 %
Costs and expenses:
Direct costs70.6 %71.7 %3.1 %
Selling, general and administrative9.5 %9.6 %3.8 %
Depreciation1.5 %1.4 %16.7 %
Amortization5.7 %6.0 %(1.2)%
Transaction and integration-related0.6 %0.5 %19.1 %
Restructuring0.7 %0.6 %38.0 %
Income from operations11.4 %10.2 %16.7 %

Revenue
Three Months Ended
September 30,
Change
(dollars in thousands)20232022$%
Revenue$2,055,099 $1,942,427 $112,672 5.8 %

Revenue for the three months ended September 30, 2023 increased by $112.7 million, or 5.8%, to $2,055.1 million, compared to $1,942.4 million for the three months ended September 30, 2022. Revenue increased by 4.8% in constant currency terms. The increase in revenue for the three months ended September 30, 2023 is due to continued organic growth across the Company's markets.

During the three months ended September 30, 2023, we derived approximately 40.5%, 47.7% and 11.8% of our revenue in the United States, Europe and Rest of World respectively. During the three months ended September 30, 2023, $527.3 million or 25.7% of our revenues were derived from our top 5 customers. New customer accounts are continually added across the full portfolio of large pharma customers, mid-tier pharma customers and biotech customers.

Revenue in Ireland for the three months ended September 30, 2023 increased to $596.3 million compared to $526.9 million for the three months ended September 30, 2022. Regional revenue is principally a function of the Company’s global transfer pricing model (see note 16 - Business Segment and Geographical Information for further details). Revenue in our Rest of Europe region decreased to $384.7 million compared to $397.5 million for the three months ended September 30, 2022. Revenue in the Rest of World region increased to $242.3 million compared to $114.8 million for the three months ended September 30, 2022. Revenue in the U.S. region decreased to $831.8 million from $903.2 million for the three months ended September 30, 2022.


Nine Months Ended
September 30,
Change
(dollars in thousands)20232022$%
Revenue$6,053,928 $5,779,384 $274,544 4.8 %

Revenue for the nine months ended September 30, 2023 increased by $274.5 million, or 4.8%, to $6,053.9 million, compared to $5,779.4 million for the nine months ended September 30, 2022. Revenue increased by 4.8% in constant currency terms. The increase in revenue for the nine months ended September 30, 2023 is due to continued organic growth across the Company's markets.

28


During the nine months ended September 30, 2023 we derived approximately 41.7%, 47.5% and 10.8% of our revenue in the United States, Europe and Rest of World, respectively. During the nine months ended September 30, 2023, $1,615.7 million or 26.7% of our revenues were derived from our top 5 customers. New customer accounts are continually added across the full portfolio of large pharma customers, mid-tier pharma customers and biotech customers.

Revenue in Ireland for the nine months ended September 30, 2023 increased to $1,701.6 million compared to $1,395.2 million for the nine months ended September 30, 2022. Revenue in Ireland is principally a function of the Company’s global transfer pricing model (see note 16 - Business segment information for further details). Revenue in our Rest of Europe region decreased to $1,172.8 million compared to $1,282.0 million for the nine months ended September 30, 2022. Revenue in the Rest of World region increased to $655.4 million compared to $334.3 million for the nine months ended September 30, 2022. Revenue in the U.S. region decreased to $2,524.2 million compared to $2,767.8 million for the nine months ended September 30, 2022.

Direct costs

Three Months Ended
September 30,
Nine Months Ended
September 30,
(dollars in thousands)20232022Change20232022Change
Direct costs$1,449,136 $1,375,837 $73,299 $4,274,222 $4,146,366 $127,856 
% of revenue70.5 %70.8 %5.3 %70.6 %71.7 %3.1 %

Direct costs for the three months ended September 30, 2023 increased by $73.3 million, or 5.3%, to $1,449.1 million compared to $1,375.8 million for the three months ended September 30, 2022. Direct costs consist primarily of investigator and other reimbursable costs, compensation, associated fringe benefits and share based compensation expense for project-related employees and other direct project driven costs. The increase in direct costs arose due to an increase in personnel related costs, laboratory costs, travel and other direct project driven costs. This was offset by a decrease in third party investigator and other reimbursable costs in the period to September 30, 2023.

Direct costs for the nine months ended September 30, 2023 increased by $127.9 million, or 3.1%, to $4,274.2 million compared to $4,146.4 million for the nine months ended September 30, 2022. The increase in direct costs arose due to an increase in personnel related costs, laboratory costs, travel and other direct project driven costs. This was offset by a decrease in third party investigator and other reimbursable costs in the period. As a percentage of revenue, direct costs have decreased to 70.6% compared to 71.7% for the nine months ended September 30, 2022.

Selling, general and administrative expense

Three Months Ended
September 30,
Nine Months Ended
September 30,
(dollars in thousands)20232022Change20232022Change
Selling, general and administrative expense$185,187 $166,787 $18,400 $572,999 $552,000 $20,999 
% of revenue9.0 %8.6 %11.0 %9.5 %9.6 %3.8 %
    
Selling, general and administrative expenses for the three months ended September 30, 2023 increased by $18.4 million, or 11%, to $185.2 million, compared to $166.8 million for the three months ended September 30, 2022. Selling, general and administrative expenses comprise primarily of compensation, related fringe benefits and routine share based compensation expense for non-project-related employees, recruitment expenditure, professional service costs, advertising costs and all costs related to facilities and information systems. As a percentage of revenue, selling, general and administrative expenses increased to 9.0% compared to 8.6% for the three months ended September 30, 2022. The increase in selling, general and administrative expenses primarily relates to foreign exchange movements, professional fees and personnel costs offset by decreases in general overhead costs and marketing costs.

Selling, general and administrative expenses for the nine months ended September 30, 2023 increased by $21.0 million, or 3.8%, to $573.0 million compared to $552.0 million for the nine months ended September 30, 2022. As a percentage of revenue, selling, general and administrative expenses have decreased to 9.5% compared to 9.6% for the nine months ended September 30, 2022. The increase in costs for the nine months ended September 30, 2023 primarily relates to foreign exchange movements and professional fees offset by decreases in personnel costs, general overhead costs, acquisition related costs, marketing costs and a gain of $6.2 million related to the Oncacare acquisition.



29


Depreciation and amortization
Three Months Ended
September 30,
Nine Months Ended
September 30,
(dollars in thousands)20232022Change20232022Change
Depreciation$31,459 $26,870 $4,589 $92,349 $79,167 $13,182 
% of revenue1.5 %1.5 %17.1 %1.5 %1.4 %16.7 %
Amortization$114,573 $114,991 $(418)$343,868 $348,118 $(4,250)
% of revenue5.6 %5.9 %(0.4)%5.7 %6.0 %(1.2)%

The depreciation charge reflects investments in facilities, information systems and equipment to support the Company’s continued growth. The depreciation expense for the three months ended September 30, 2023 increased by $4.6 million, or 17.1%, to $31.5 million compared to $26.9 million for the three months ended September 30, 2022. As a percentage of revenue the depreciation expense was 1.5%, which increased from 1.5% for the three months ended September 30, 2022.

The depreciation expense for the nine months ended September 30, 2023 increased by $13.2 million, or 16.7%, to $92.3 million compared to $79.2 million for the nine months ended September 30, 2022. As a percentage of revenue the depreciation expense was 1.5%, which increased from 1.4% for the nine months ended September 30, 2022. The depreciation charge, from a value perspective, for the three and nine months ended September 30, 2023 has increased mainly due to an increase in our depreciable asset base and additional spend related to computer hardware and software.

The amortization expense represents the amortization of intangible assets acquired in business combinations. Amortization of intangibles for the three months ended September 30, 2023 decreased by $0.4 million, or 0.4%, to $114.6 million compared to $115.0 million for the three months ended September 30, 2022. As a percentage of revenue, the amortization expense decreased to 5.6%, compared to 5.9% for the three months ended September 30, 2022.

The amortization expense for the nine months ended September 30, 2023 decreased by $4.3 million, or 1.2%, to $343.9 million compared to $348.1 million for the nine months ended September 30, 2022. As a percentage of revenue, the amortization expense was 5.7%, which decreased from 6.0% for the nine months ended September 30, 2022.


Restructuring, transaction and integration-related expenses associated with the Merger

Three Months Ended
September 30,
Nine Months Ended
September 30,
(dollars in thousands)20232022Change20232022Change
Transaction and integration-related expenses$10,433 $8,001 $2,432 $34,516 $28,970 $5,546 
% of revenue0.5 %0.4 %30.4 %0.6 %0.5 %19.1 %
Restructuring costs$— $6,197 $(6,197)$45,390 $32,890 $12,500 
% of revenue— %0.3 %(100.0)%0.7 %0.6 %38.0 %

During the three and nine months ended September 30, 2023, the Company incurred $10.4 million and $79.9 million, respectively, for restructuring, transaction and integration-related expenses. The charge includes transaction and integration costs of $10.4 million and costs amounting to $34.5 million comprising professional fees, retention agreements and ongoing integration activities.

During the nine months ended September 30, 2023 the Company has undertaken a restructuring program aimed at realigning its workforce as well as reviewing its global office footprint and optimizing its locations to best fit the requirements of the Company. This program has resulted in a restructuring charge of $45.4 million in the nine months ended September 30, 2023.

We expect to incur additional integration expenses associated with the Merger; however, the timing and the amount of these expenses depends on various factors such as, but not limited to, the execution of integration activities and the aggregate amount of synergies we achieve from these activities.




30




Income from operations
Three Months Ended
September 30,
(dollars in thousands)20232022Change
Income from operations $264,311 $243,744 $20,567 
% of revenue12.9 %12.5 %8.4 %

Income from operations for the three months ended September 30, 2023 increased by $20.6 million or 8.4% to $264.3 million compared to $243.7 million for the three months ended September 30, 2022. As a percentage of revenue, income from operations increased to 12.9% compared to 12.5% of revenue for the three months ended September 30, 2022.

Income from operations in Ireland increased to $121.3 million compared to $93.6 million for the three months ended September 30, 2022.Income from operations in Ireland and other geographic regions are reflective of the Company’s global transfer pricing model.

In the Rest of Europe region, income from operations decreased to $56.7 million compared to $76.2 million for the three months ended September 30, 2022. As a percentage of revenues in the Rest of Europe region, income from operations in the Rest of Europe region decreased to 14.7% compared to 19.2% for the period ended September 30, 2022.

In the U.S. region, income from operations increased to $70.0 million, compared to $63.4 million for the period ended September 30, 2022. As a percentage of revenues in the U.S. region, income from operations in the U.S. region increased to 8.4% compared to 7.0% for the period ended September 30, 2022.
    
In the Rest of World region, income from operations increased by $5.7 million to $16.3 million compared to $10.6 million for the three months ended September 30, 2022. As percentage of revenues in other regions, income from operations in other regions decreased to 6.7% compared to 9.2% for the period ended September 30, 2022.


Nine Months Ended
September 30,
(dollars in thousands)20232022Change
Income from operations $690,584 $591,873 $98,711 
% of revenue11.4 %10.2 %16.7 %


Income from operations for the nine months ended September 30, 2023 increased by $98.7 million or 16.7% to $690.6 million compared to $591.9 million for the nine months ended September 30, 2022. As a percentage of revenue, income from operations increased to 11.4% compared to 10.2% of revenue for the nine months ended September 30, 2022.

Income from operations in Ireland increased to $298.6 million compared to $159.1 million for the nine months ended September 30, 2022. Income from operations in Ireland and other geographic regions are reflective of the Company’s global transfer pricing model.

In the Rest of Europe region, income from operations decreased to $139.0 million compared to $194.9 million for the nine months ended September 30, 2022. As a percentage of revenues in the Rest of Europe region, income from operations in the Rest of Europe region decreased to 11.8% compared to 15.2% for the nine months ended September 30, 2022.

In the U.S. region, income from operations increased by $36.7 million, to $213.8 million compared to $177.1 million, for the nine months ended September 30, 2022. As a percentage of revenues in the US region, income from operations in the U.S. region increased to 8.5% compared to 6.4% for the nine months ended September 30, 2022.
    
In other regions, income from operations decreased by $21.6 million to $39.2 million compared to $60.8 million for the nine months ended September 30, 2022. As percentage of revenues in other regions, income from operations in other regions decreased to 6.0% compared to 18.2% for the nine months ended September 30, 2022.





31





Interest income and expense

Three Months Ended
September 30,
ChangeNine Months Ended
September 30,
Change
(dollars in thousands)20232022$%20232022$%
Interest income$1,273 $1,434 $(161)(11.2)%$3,294 $1,727 $1,567 90.7 %
Interest expense$(83,908)$(63,010)$(20,898)33.2 %$(255,665)$(154,546)$(101,119)65.4 %

Interest expense for the three months ended September 30, 2023 increased to $83.9 million, compared to $63.0 million for the three months ended September 30, 2022. The increase during the period reflects the impact of financing costs associated with the Merger and the impact of rising interest rates. Interest income for the three months ended September 30, 2023 decreased to $1.3 million, compared to $1.4 million for the three months ended September 30, 2022.

Interest expense for the nine months ended September 30, 2023 increased to $255.7 million, compared to $154.5 million for the nine months ended September 30, 2022 due to the impact of financing costs associated with the Merger. Interest income for the nine months ended September 30, 2023 increased to $3.3 million, compared to $1.7 million for the nine months ended September 30, 2022. The increase in interest income can be attributed to rising interest rates over the last nine months.

Income tax expense


Three Months Ended
September 30,
ChangeNine Months Ended
September 30,
Change
(dollars in thousands)2023202220232022
Income tax expense$18,011 $21,012 $(3,001)$41,913 $48,552 (6,639)
Effective income tax rate 9.9 %11.5 %(14.3)%9.6 %11.1 %(13.7)%

Provision for income taxes decreased to a $18.0 million charge for the three months ended September 30, 2023, compared to a $21.0 million charge for the three months ended September 30, 2022. The Company’s effective tax rate for the three months ended September 30, 2023 was 9.9% compared with 11.5% for the three months ended September 30, 2022.

Provision for income taxes decreased to a $41.9 million charge for the nine months ended September 30, 2023, compared to $48.6 million for the nine months ended September 30, 2022. The Company’s effective tax rate for the nine months ended September 30, 2023 was 9.6% compared with 11.1% for the nine months ended September 30, 2022.

The Company’s effective tax rate remains principally a function of the distribution of pre-tax profits amongst the territories in which it operates.

Liquidity and capital resources

The CRO industry is generally not capital intensive. The Company’s principal operating cash needs are payment of salaries, office rents, travel expenditures and payments to investigators. Investing activities primarily reflect capital expenditures for facilities and information systems enhancements, the purchase and sale of short term investments and acquisitions. Financing activities primarily reflect the servicing of the Company's external debt.

Our clinical research and development contracts are generally fixed price with some variable components and range in duration from a few weeks to several years. Revenue from contracts is generally recognized as income on the basis of the relationship between time incurred and the total estimated contract duration or on a fee-for-service basis. The cash flow from contracts typically consists of a down payment at the time the contract is entered into, with the balance paid in installments over the contract's duration, in some cases on the achievement of certain milestones. Therefore, cash receipts do not correspond to costs incurred and revenue recognized on contracts.






32


Cash and cash equivalents and net borrowings
Balance December 31, 2022(Drawn Down)RepaidNet cash
inflow/
(outflow)
Other non-
cash
Effect of
exchange
rates
Balance September 30, 2023
 $ (in thousands) 
Cash and cash equivalents288,768 — — 28,249 — (3,952)313,065 
Available for sale investments1,713 — — 241 — — 1,954 
Senior Secured Credit Facilities & Senior Secured Notes(4,654,187)(305,000)930,000 — (12,485)— (4,041,672)
(4,363,706)(305,000)930,000 28,490 (12,485)(3,952)(3,726,653)

The Company’s cash and short term investment balances at September 30, 2023 amounted to $315.0 million compared with cash and short term investment balances of $290.5 million at December 31, 2022. 

In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026. In January 2023, $100.0 million of the senior secured revolving loan facility was drawn down, in the aggregate, at interest rates of 5.89% and 5.80%, representing one month SOFR plus a margin of 1.25%. This was repaid in full in March 2023. On March 31, 2023, $80.0 million of the senior secured revolving loan facility was drawn down at an interest rate of 6.68%, representing one month SOFR plus a margin of 1.25%. In April 2023, the Company drew down $50.0 million of the senior secured revolving loan facility at an interest rate of 6.25%, representing one month SOFR plus a margin of 1.25%. In May 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300.0 million to $500.0 million. The Company repaid $80.0 million of the senior secured revolving loan facility on June 30, 2023. The remaining $50.0 million was repaid on August 17, 2023. On September 29, 2023, $75.0 million of the of the senior secured revolving loan facility was drawn down at an interest rate of 6.68%, representing one month SOFR plus a margin of 1.25%.

On March 31, 2023 the Company repaid $250.0 million of the senior secured term loan facility and made a quarterly
interest payment of $75.3 million. This repayment resulted in an accelerated charge associated with previously capitalized fees of $2.2 million.

On June 30, 2023 the Company repaid $150.0 million of the senior secured term loan facility and made a quarterly interest payment of $74.0 million. This repayment resulted in an accelerated charge associated with previously capitalized fees of $1.2 million.

On September 29, 2023, the Company repaid $300.0 million of the senior secured term loan facility and made a quarterly interest payment of $74.5 million. This repayment resulted in an accelerated charge associated with previously capitalized fees of $2.5 million.

In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500 million in aggregate principal amount of 2.875% senior secured notes due 2026 in a private offering. The senior secured notes will mature on July 15, 2026.

Cash flows

Net cash from operating activities

Net cash provided by operating activities increased by $98.2 million to $720.9 million for the nine months ended September 30, 2023 as compared to net cash provided by operating activities of $622.7 million for the nine months ended September 30, 2022. The increase in net cash provided by operating activities of $98.2 million is primarily due to an increase in underlying operating activity and improved working capital.

33


The change in working capital is primarily attributable to an increase in the movement of unbilled revenue of $235.5 million and an increase in the movement of unearned revenue of $129.9 million for the nine months ended September 30, 2023 in comparison with the nine months ended September 30, 2022. These changes result from differences in timing of revenue recognition and billing on clinical trials. The number of days’ revenue outstanding at September 30, 2023 was 49 days compared to 54 days at December 31, 2022 and 43 days at September 30, 2022. Cash generated from working capital and days’ revenue outstanding may be positively or negatively impacted by, amongst others, the scheduling of contractual milestones over a study or trial duration, the achievement of a particular milestone during the period, the timing of receipt of invoices from third parties for reimbursable costs and the timing of cash receipts from customers. Contract fees are generally payable in installments based on the achievement of certain performance targets or “milestones” (e.g. target patient enrollment rates, clinical testing sites initiated or case report forms completed), such milestones being specific to the terms of each individual contract, while revenues on contracts are recognized as contractual obligations are performed. A decrease in the number of days’ revenue outstanding during a period will result in cash inflows to the Company while an increase in days revenue outstanding will lead to cash outflows.

Net cash used in investing activities

Net cash used in investing activities was $104.2 million for the nine months ended September 30, 2023 compared to net cash used in investing activities of $87.0 million for the nine months ended September 30, 2022. Net cash used in investing activities during the nine months ended September 30, 2023 was primarily related to cash outflows of $88.0 million for capital expenditures made mainly relating to investment in facilities and IT infrastructure, $5.1 million in relation to purchase of subsidiary undertakings, and $10.8 million in relation to investments in long-term equity.

Net cash used in financing activities

Net cash used in financing activities during the nine months ended September 30, 2023 amounted to $588.5 million compared to net cash used in financing activities of $671.0 million for the nine months ended September 30, 2022. During the nine months ended September 30, 2023, the Company made a net repayment of $625.0 million on external financing. This was offset by $36.5 million that was received by the Company from the exercise of share options.

Net cash inflow

As a result of these cash flows, cash and cash equivalents increased by $24.3 million for the nine months ended September 30, 2023 compared to a decrease of $143.1 million for the nine months ended September 30, 2022.


Legal proceedings

We are not party to any material pending legal proceedings, and we do not expect any litigation which could have an adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.



Forward-Looking Statements

Certain statements contained herein are forward looking statements, particularly in the discussion under the caption “Management’s discussion and analysis of financial condition and results of operations”. All statements other than statements of historical fact are forward-looking. Examples of forward-looking statements include, but are not limited to, statements regarding industry prospects, future business, future results of operations or financial condition, our ability to integrate the businesses we have acquired into our existing operations, management strategies and our competitive position. You can identify many forward-looking statements by words such as “may,” “will,” “would,” “should,” “could,” “expects,” “aims,” “anticipates,” “believes,” “estimates,” “intends,” “plans,” “predicts,” “projects,” “seeks,” “potential,” “opportunities” and other similar expressions and the negatives of such expressions. However, not all forward-looking statements contain these words. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. Actual results may differ materially from those stated or implied by forward looking statements due to risks and uncertainties associated with the Company’s business and forward looking statements are not guarantees of future performance. Such risks and uncertainties include, but are not limited to, dependence on the pharmaceutical industry and certain clients, the need to regularly win projects and then to execute them efficiently and correctly, the challenges presented by rapid growth, the challenges associated with the integration of the PRA, competition and the continuing consolidation of the industry, the dependence on certain key executives, changes in the regulatory environment and other factors. Forward-looking statements speak only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. Please also refer to the Form 20-F filed on February 24, 2023 for risks and uncertainties facing the Company.



34






SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ICON plc
/s/Brendan Brennan 
Date:October 27, 2023Brendan Brennan
Chief Financial Officer
35
EX-101.SCH 2 iclr-20230930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Basis of presentation link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Summary of significant accounting policies link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Intangible assets link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Fair value measurements link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Restructuring link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Operating leases link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Bank credit lines and loan facilities link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Derivatives link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Income taxes link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Net income per ordinary share link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Share-based awards link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Share capital link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Business Segment and Geographical Information link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Subsequent events link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Summary of significant accounting policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Summary of significant accounting policies (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Intangible assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Fair Value Measures and Disclosures (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Restructuring (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Operating leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Bank credit lines and loan facilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Derivatives (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Income taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Net income per ordinary share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Share-based awards (Tables) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Business Segment and Geographical Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Summary of significant accounting policies - Estimated Useful Lives of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Accounts Receivables and Unbilled Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Unbilled Services and Unearned Revenue or Payments on Account (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Goodwill - Schedule of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Goodwill - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Intangible assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Fair value measurements - Measurement of Fair Value of Major Asset and Liability classed (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Fair value measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Restructuring - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Restructuring - Summary of Restructuring Charges (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Restructuring - Summary of Details of Movement in Restructuring Charges (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Operating leases - Schedule of Lease Costs (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Operating leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Operating leases - Schedule of Operating Lease Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Operating leases - Schedule of Operating Lease Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Bank credit lines and loan facilities - Schedule of Outstanding Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Bank credit lines and loan facilities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Bank credit lines and loan facilities - Schedule of Contractual Maturities of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Derivatives - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Income taxes - Components of Tax (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Income taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Net income per ordinary share - Schedule of Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Net income per ordinary share - Schedule of Reconciliation of Net Income Attributable to the Group (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Share-based awards - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Share-based awards - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Share-based awards - Schedule of Weighted Average Fair Values and Assumptions Used (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - Share-based awards - Summary of RSU and PSU Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - Share-based awards - Schedule of Non-cash Stock Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - Share capital (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - Business Segment and Geographical Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954518 - Disclosure - Business Segment and Geographical Information - Schedule of Distribution of Revenue by Geographical Area (Details) link:presentationLink link:calculationLink link:definitionLink 9954519 - Disclosure - Business Segment and Geographical Information - Schedule of Distribution of Income from Operations by Geographical Area (Details) link:presentationLink link:calculationLink link:definitionLink 9954520 - Disclosure - Business Segment and Geographical Information - Schedule of Distribution of Depreciation and Amortization by Geographical Area (Details) link:presentationLink link:calculationLink link:definitionLink 9954521 - Disclosure - Subsequent events - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 3 iclr-20230930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 4 iclr-20230930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 iclr-20230930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Deferred taxes Deferred Income Taxes and Tax Credits Variable Rate [Domain] Variable Rate [Domain] Sale of available for sale investments Proceeds from Sale of Debt Securities, Available-for-Sale Non-current other liabilities Other Noncurrent Liabilities [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] PSUs based on service and EPS targets Performance Based Grants [Member] Performance Based Grants [Member] Debt instrument, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Schedule of Distribution of Income from Operations by Geographical Area Shcedule Of Operating Income By Geography [Table Text Block] Shcedule Of Operating Income By Geography Award Type [Domain] Award Type [Domain] Revenue, remaining performance obligation, expected timing of satisfaction, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Line of credit facility, interest rate at period end Line of Credit Facility, Interest Rate at Period End Other liabilities Other Current Liabilities [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Purchase of subsidiary undertakings Payments to Acquire Businesses, Gross Change in unearned revenue (payments on account) Decrease in unearned revenue (payments on account) Increase (Decrease) In Contract With Customer, Liability, Gross, Current Increase (Decrease) In Contract With Customer, Liability, Gross, Current Investments in equity- long term Other Long-Term Investments Senior Secured Revolving Loan Facility Revolving Credit Facility [Member] Effect of exchange rate movements on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Variable Rate Component [Axis] Variable Rate Component [Axis] Variable Rate Component Deferred tax liability Deferred Income Tax Liabilities, Net Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts payable Accounts Payable, Current Weighted average contractual term of options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Commitments and contingencies Commitments and Contingencies Share repurchase costs Adjustment to Retained Earning Share Repurchase costs Adjustment to Retained Earning Share Repurchase costs Exercisable at end of period (in shares) Number of shares exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Derivative asset, current Derivative Asset, Current Change in net balance Increase in net balance Change In Advance Payments Netted Against Unbilled Contracts Receivable Change In Advance Payments Netted Against Unbilled Contracts Receivable Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Year 5 Lessee, Operating Lease, Liability, to be Paid, Year Five Items generating unrecognized tax benefits Unrecognized Tax Benefits, Current Year Tax Positions Unrecognized Tax Benefits, Current Year Tax Positions Share capital Equity [Text Block] Geographical [Axis] Geographical [Axis] Percentage change in net balance Change In Advance Payments Netted Against Unbilled Contracts Receivable, Percent Change In Advance Payments Netted Against Unbilled Contracts Receivable, Percent Income taxes Income Tax Disclosure [Text Block] Unearned revenue Increase (Decrease) in Contract with Customer, Liability Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Percentage change in unbilled services (unbilled revenue) Increase (Decrease) In Contract With Customer, Asset, Gross, Current, Percent Increase (Decrease) In Contract With Customer, Asset, Gross, Current, Percent Number of interest rate derivatives held Number of Interest Rate Derivatives Held Customer [Axis] Customer [Axis] Current Liabilities: Liabilities, Current [Abstract] Accumulated impairment loss Goodwill, Impaired, Accumulated Impairment Loss Business Acquisition [Line Items] Business Acquisition [Line Items] Subsequent event type [Domain] Subsequent Event Type [Domain] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Canceled/expired (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Summary of RSU and PSU activity Summary Of Share Based Compensation Restricted Stock Units Performance Stock Units, Award, Activity [Table Text Block] Summary Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block] Impairment of long lived assets Impairment, Long-Lived Asset, Held-for-Use Diluted (in USD per share) Earnings Per Share, Diluted Intangible Assets Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Accounts receivable, net of allowance for credit losses Accounts Receivable, after Allowance for Credit Loss, Current Goodwill [Roll Forward] Goodwill [Roll Forward] Level 3 Fair Value, Inputs, Level 3 [Member] Senior Secured Revolving Loan Facility Line of Credit [Member] Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Non-current assets: Assets, Noncurrent [Abstract] Senior Secured Term Loan Term Loan Facility [Member] Term Loan Facility Derivative Asset, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Exercise of share options Stock Issued During Period, Value, Stock Options Exercised Restructuring Plan [Domain] Restructuring Plan [Domain] Granted (in USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Long-term debt at fair value Long-Term Debt, Fair Value Net income Net Income (Loss) Total current liabilities Liabilities, Current SOFR Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] Derivative Contract [Domain] Derivative Contract [Domain] Fair Value Disclosures [Abstract] Operating leases Lessee, Operating Leases [Text Block] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Costs and expenses: Cost of Revenue [Abstract] LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities and Equity [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Less current portion of long-term debt Long-term Debt, Current Maturities, Gross Long-term Debt, Current Maturities, Gross Shareholders' Equity: Equity, Attributable to Parent [Abstract] Exercise of share options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Schedule of reconciliation of number of shares used in computation of basic and diluted net income per ordinary share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Shares vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Senior Secured Notes Senior Secured Notes [Member] Senior Secured Notes Outstanding Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Summary of significant accounting policies Significant Accounting Policies [Text Block] Exercised (in USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Level 1 Fair Value, Inputs, Level 1 [Member] Goodwill Opening balance Closing balance Goodwill Equity Components [Axis] Equity Components [Axis] Stock units to be granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] 2025 Long-Term Debt, Maturity, Year Two Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Philips Pharma Solutions (formerly BioTel Research, LLC) Philips Pharma Solutions (Formerly BioTel Research, LLC) [Member] Philips Pharma Solutions (Formerly BioTel Research, LLC) Accounts receivable Increase (Decrease) in Accounts Receivable Derivative, notional amount Derivative, Notional Amount 2023 (remaining) Long-Term Debt, Maturity, Remainder of Fiscal Year Selling, general and administration costs Selling, general and administrative Selling, General and Administrative Expenses [Member] Measurement Frequency [Axis] Measurement Frequency [Axis] Lease liabilities Operating Lease, Liability, Noncurrent Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Income before provision for income taxes Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax Share issue costs Payments of Stock Issuance Costs Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Purchase of investments in equity - long term Payments to Acquire Long-Term Investments Income Statement Location [Axis] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line Income Statement Location [Axis] Compensation Related Costs Share Based Payments Disclosure [Table] Compensation Related Costs Share Based Payments Disclosure [Table] Compensation Related Costs Share Based Payments Disclosure [Table] Less debt issuance costs and debt discount Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Schedule of Operating Lease Maturity Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Effect of dilutive share options and other awards outstanding under share based compensation programs (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Repayments of senior debt Repayments of Senior Debt Share issuance costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Income taxes payable Accrued Income Taxes, Current Schedule of Lease Costs Lease, Cost [Table Text Block] Share repurchase costs Payments For Share Repurchase Costs Payments For Share Repurchase Costs Opening provision Ending provision Restructuring Reserve Transaction and integration-related expenses Business Combination, Acquisition Related Costs Award Type [Axis] Award Type [Axis] Derivative Instruments and Hedging Activities Disclosure [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Income taxes receivable Income Taxes Receivable, Current Interest expense Interest Expense Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Ordinary shares which have been reserved for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Hedging Designation [Axis] Hedging Designation [Axis] Weighted average contractual term of options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Right-of-use assets obtained in exchange for lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Lease imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Schedule of Components of Income Tax Expense Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Debt discount paid Debt Instrument, Unamortized Discount Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Operating lease liabilities Operating Lease, Liability, Current Accounts receivable and unbilled revenue, net Contracts Receivable, Net Contracts Receivable, Net 2026 Long-Term Debt, Maturity, Year Three Clients 6-10 Clients 6-10 [Member] Clients 6-10 [Member] Year 3 Lessee, Operating Lease, Liability, to be Paid, Year Three Payments of debt restructuring costs Payments of Debt Restructuring Costs Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Other Undenominated Capital Other Undenominated Capital [Member] Other undenominated capital. Intangible assets  Net book value Finite-Lived Intangible Assets, Net Notional Derivative Asset, Notional Amount Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Year 2 Lessee, Operating Lease, Liability, to be Paid, Year Two Interest income Investment Income, Interest Operating lease costs Operating Lease, Cost Ordinary shares, shares issued (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Issued Business combination, consideration transferred Business Combination, Consideration Transferred Shares vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Severance costs Severance Costs Unearned revenue Unearned revenue (payments on account) Contract with Customer, Liability, Current Schedule of weighted average fair values and assumptions used Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Total assets Assets, Fair Value Disclosure Selling, general and administrative expense Selling, General and Administrative Expense Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Employee Stock Option Employee Stock Option [Member] Derivatives Derivative Instruments and Hedging Activities Disclosure [Text Block] Income before share of earnings from equity method investments Income (Loss) From Continuing Operations Before Equity Method Investments, Noncontrolling Interest Income (Loss) From Continuing Operations Before Equity Method Investments, Noncontrolling Interest Total costs and expenses Costs and Expenses Maximum Maximum [Member] Total comprehensive income attributable to the Group Comprehensive Income (Loss), Net of Tax, Attributable to Parent Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Summary of Restructuring Charges Restructuring and Related Costs [Table Text Block] Document Type Document Type Current period acquisition Goodwill, Acquired During Period Direct costs (excluding depreciation and amortization) Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization Derivative liability, current Derivative Liability, Current Clients 1-5 Clients 1-5 [Member] Clients 2-5 [Member] Share-based awards Share-Based Payment Arrangement [Text Block] Other non-cash items Other Noncash Income (Expense) Purchase of available for sale investments Payments to Acquire Debt Securities, Available-for-Sale Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Business Acquisition [Axis] Business Acquisition [Axis] Revenue, remaining performance obligation percentage Revenue, Remaining Performance Obligation, Percentage Subsequent event Subsequent Event [Member] Interest and related penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Other liabilities Other Liabilities, Current Variable Rate [Axis] Variable Rate [Axis] Income Statement [Abstract] Income Statement [Abstract] Unbilled revenue Increase (Decrease) in Contract with Customer, Asset Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Summary of details of movement in restructuring charges Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Income from sub-leases Sublease Income Derivative instruments Derivative liability Derivative Liability Net balance Advance Payments Netted Against Unbilled Contracts Receivable Advance Payments Netted Against Unbilled Contracts Receivable Share repurchase program, authorized percentage Stock Repurchase Program, Authorized Percentage Stock Repurchase Program, Authorized Percentage Outstanding at beginning of period (in USD per share) Outstanding at end of period (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Comprehensive income (net of tax): Net Income (Loss) Attributable to Parent [Abstract] Issue of restricted share units / performance share units Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture 2021 restructuring plan 2021 Restructuring Plan [Member] 2021 Restructuring Plan Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Derivative, fixed interest rate Derivative, Fixed Interest Rate Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Foreign exchange movement Goodwill, Foreign Currency Translation Gain (Loss) Non-current bank credit lines and loan facilities Long-Term Line of Credit, Noncurrent Net operating lease costs Total lease cost Lease, Cost Total long-term debt Long-term Debt, Excluding Current Maturities, Gross Long-term Debt, Excluding Current Maturities, Gross Statistical Measurement [Axis] Statistical Measurement [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Bank credit lines and loan facilities Long-Term Debt [Text Block] Restricted stock units 2013 Restricted Stock Units Twenty Thirteen [Member] Restricted Stock Units Twenty Thirteen [Member] Repurchase of ordinary shares Payments for Repurchase of Common Stock Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Retained earnings Retained Earnings (Accumulated Deficit) Revenue recognition Revenue from Contract with Customer [Policy Text Block] Debt instrument, principal amount Debt Instrument, Face Amount Current assets: Assets, Current [Abstract] Leases [Abstract] Leases [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Ordinary shares, shares outstanding (in shares) Common Stock, Shares, Outstanding Variable rate component two Variable Rate Component Two [Member] Variable Rate Component Two Derivative, variable interest rate, reference rate in excess of Derivative, Variable Interest Rate, Reference Rate In Excess Of Derivative, Variable Interest Rate, Reference Rate In Excess Of Other undenominated capital Other Undenominated Capital Other undenominated capital. Senior Secured Notes Senior Subordinated Notes [Member] Ordinary shares, par value (in EUR cents per share) Common Stock, Par or Stated Value Per Share Patient database Database Rights [Member] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Non-executive directors Non-Executive Director [Member] Non-executive Director [Member] Customer [Domain] Customer [Domain] Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Options Outstanding Number of Shares  Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Interest Rate Swap Interest Rate Swap [Member] Debt Instrument [Axis] Debt Instrument [Axis] Other liability Other Liability [Member] Other Liability Share repurchase program Share repurchase program, value of shares repurchased Stock Repurchased and Retired During Period, Value Derivative liability, noncurrent Derivative Liability, Noncurrent Total Operating Lease, Liability Credit Facility [Axis] Credit Facility [Axis] Schedule of Contractual Maturities of Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Total Liabilities Liabilities Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Basis of presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Net income per Ordinary Share attributable to the Group: Earnings Per Share, Basic and Diluted EPS [Abstract] Earnings Per Share, Basic and Diluted EPS Measurement Frequency [Domain] Measurement Frequency [Domain] Non-current liabilities: Liabilities, Noncurrent [Abstract] Title of Individual [Axis] Title of Individual [Axis] Other receivables Nontrade Receivables, Current Debt Disclosure [Abstract] Net income per Ordinary Share attributable to the Group (note 13): Earnings Per Share [Abstract] Ordinary shares, par value 6 euro cents per share; 100,000,000 shares authorized, 82,326,976 shares issued and outstanding at September 30, 2023 and 81,723,555 shares issued and outstanding at December 31, 2022 Common Stock, Value, Issued Investments Measured at Net Asset Value Fair Value Measured at Net Asset Value Per Share [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Trade names Trade names & brands Trade Names [Member] Reduction in carrying value of operating right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Total current assets Assets, Current Fair Value, Liabilities Measured on Recurring Basis Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Oncacare Oncacare [Member] Oncacare Interest Rate Caps Interest Rate Cap [Member] Restructuring Type [Axis] Restructuring Type [Axis] Goodwill at fair value Goodwill, Fair Value Disclosure Interest rate cap and interest rate swap Interest Rate Cap And Interest Rate Swap [Member] Interest Rate Cap And Interest Rate Swap Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Clients 11-25 Clients 11-25 [Member] Clients 11-25 [Member] Liability for unrecognized tax benefit Unrecognized Tax Benefits Accounts receivable and unbilled revenue, gross Contracts Receivable, Gross Contracts Receivable Base rate Base Rate [Member] Granted (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Schedule of Goodwill Schedule of Goodwill [Table Text Block] Ireland IRELAND Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Fair value, nonrecurring Fair Value, Nonrecurring [Member] Available for sale investments Available for sale securities (short-term) Debt Securities, Available-for-Sale, Current Current bank credit lines and loan facilities Line of Credit, Current Depreciation and amortization expense Depreciation, Depletion and Amortization Debt instrument, interest rate Debt Instrument, Interest Rate, Stated Percentage Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total Shareholders' Equity Beginning balance Ending balance Equity, Attributable to Parent Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Long-lived assets Long-Lived Assets Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Expected life Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Subsequent Events [Abstract] Senior Secured Revolving Loan Facility Senior Secured Revolving Loan Facility [Member] Senior Secured Revolving Loan Facility Restructuring Restructuring and Related Activities Disclosure [Text Block] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Hedging Designation [Domain] Hedging Designation [Domain] Level 2 Fair Value, Inputs, Level 2 [Member] Assumptions: Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Schedule of Distribution of Depreciation and Amortization by Geographical Area Long-Lived Assets by Geographic Areas [Table Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Document Fiscal Period Focus Document Fiscal Period Focus Year 1 Lessee, Operating Lease, Liability, to be Paid, Year One Estimated Useful Life Finite-Lived Intangible Asset, Useful Life Contract Assets [Abstract] Contract Assets [Abstract] Contract Assets Year 4 Lessee, Operating Lease, Liability, to be Paid, Year Four Outstanding at beginning of period (in USD per share) Outstanding at end of period (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock compensation expense Share-Based Payment Arrangement, Noncash Expense Schedule of Distribution of Revenue by Geographical Area Revenue from External Customers by Geographic Areas [Table Text Block] Ordinary shares Common Stock [Member] Non-current income taxes payable Accrued Income Taxes, Noncurrent Available for sale investments (long-term) Debt Securities, Available-for-Sale, Noncurrent Net income per ordinary share Earnings Per Share [Text Block] Variable rate component one Variable Rate Component One [Member] Variable Rate Component One Income Statement Location [Domain] Income Statement Location [Domain] Derivative asset, noncurrent Derivative Asset, Noncurrent Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Minimum Minimum [Member] Weighted average number of Ordinary Shares outstanding (note 13): Weighted Average Number of Shares Outstanding, Diluted [Abstract] Property, plant and equipment, net Property, Plant and Equipment, Net Share Repurchase Program [Domain] Share Repurchase Program [Domain] Summary of stock option activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] ASSETS Assets [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Total liabilities Liabilities, Fair Value Disclosure Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Billed services (accounts receivable) Billed Contracts Receivable Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Net income attributable to the Group Net income attributable to the Group Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Deferred tax asset Deferred Income Tax Assets, Net Fair Value, Assets Measured on Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Percentage of share capital acquired Business Acquisition, Percentage of Voting Interests Acquired Unbilled revenue Unbilled services (unbilled revenue) Contract with Customer, Asset, before Allowance for Credit Loss, Current Retained Earnings Retained Earnings [Member] Total Liabilities and Shareholders' Equity Liabilities and Equity Other receivables Other Assets, Noncurrent Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Basic (in USD per share) Earnings Per Share, Basic Operating right-of-use assets Operating Lease, Right-of-Use Asset Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Class of Treasury Stock [Table] Class of Treasury Stock [Table] Restructuring Restructuring Costs Indefinite-Lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets [Line Items] Income taxes receivable Income Taxes Receivable, Noncurrent Additional provisions Restructuring Charges Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Prior period acquisition Goodwill, Purchase Accounting Adjustments Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Technology assets Technology-Based Intangible Assets [Member] Consultants Restricted Stock Units 2019 Consultants Restricted Stock Units Twenty Nineteen [Member] Consultants Restricted Stock Units Twenty Nineteen [Member] Ordinary shares, shares authorized (in shares) Common Stock, Shares Authorized Repayment of bank credit lines and loan facilities Repayments of Lines of Credit Performance Share Unit (PSUs) Performance Share Unit [Member] Performance Share Unit [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Derivative Instrument [Axis] Derivative Instrument [Axis] Total debt Long-Term Debt, Gross Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Interest rate cash flow hedge gain (loss) to be reclassified during next 12 months, net Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net Title of Individual [Domain] Title of Individual [Domain] Net intangible assets at fair value Finite-Lived Intangible Assets, Fair Value Disclosure Fair value of stock units vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Schedule of non-cash stock compensation expense Schedule of Non Cash Stock Compensation Expense [Table Text Block] Schedule of Non Cash Stock Compensation Expense. Derivative instruments Derivative assets Derivative Asset Forfeited (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Subsequent event type [Axis] Subsequent Event Type [Axis] Restructuring Plan [Axis] Restructuring Plan [Axis] Proceeds from exercise of equity compensation Proceeds from Stock Options Exercised Statement of Comprehensive Income [Abstract] Other Other Customers [Member] Other Customers [Member] Order backlog Order or Production Backlog [Member] Income taxes Income Tax, Policy [Policy Text Block] Prepayments and other current assets Prepaid Expense and Other Assets, Current Rest of Europe Rest Of Europe [Member] Rest Of Europe [Member] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Senior secured credit facility and senior secured notes Senior Secured Credit Facility And Senior Secured Notes [Member] Senior Secured Credit Facility And Senior Secured Notes Other net assets Increase (Decrease) in Other Current Assets and Liabilities, Net Allowance for credit losses Accounts Receivable, Allowance for Credit Loss 2024 Long-Term Debt, Maturity, Year One Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] Issue of restricted share units / performance share units (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Entity Registrant Name Entity Registrant Name Direct costs Cost of Sales [Member] Utilization Payments for Restructuring Document Period End Date Document Period End Date Drawdown of bank credit lines and loan facilities Proceeds from Lines of Credit Foreign exchange movements Translation Adjustment Functional to Reporting Currency, Increase (Decrease), Gross of Tax Rest of World Rest of World [Member] Rest of World [Member] Exercisable at end of period (in USD per share) Weighted average exercise price of options exercisble (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Charge on cash flow hedge Amortization of Deferred Hedge Gains Entity Central Index Key Entity Central Index Key Acquisition-related gain Acquisition-related gain Business Combination, Bargain Purchase, Gain Recognized, Amount Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total Share-Based Payment Arrangement, Expense Total cost Finite-Lived Intangible Assets, Gross Provision for income taxes Provision for income taxes Income Tax Expense (Benefit) Total derivatives designated as hedging instruments Designated as Hedging Instrument [Member] Fair value measurements Fair Value Disclosures [Text Block] Number of operating segments Number of Operating Segments Other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 2027 and thereafter Long-Term Debt, Maturity, Year Four And Thereafter Long-Term Debt, Maturity, Year Four And Thereafter Personnel related liabilities Personnel Related Liabilities [Member] Personnel Related Liabilities Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Equity [Abstract] Equity [Abstract] Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Revenue Revenue from Contract with Customer, Excluding Assessed Tax Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Facility liability Facility Liability [Member] Facility Liability Amendment Flag Amendment Flag Intangible assets Intangible Assets Disclosure [Text Block] Compensation Related Costs Share Based Payments Disclosure [Line Items] Compensation Related Costs Share Based Payments Disclosure [Line Items] Compensation Related Costs Share Based Payments Disclosure [Line Items] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Credit Facility [Domain] Credit Facility [Domain] Share repurchase program (in shares) Share repurchase program, number of shares repurchased (in shares) Stock Repurchased and Retired During Period, Shares Business Combinations Business Combinations Policy [Policy Text Block] Basis spread on variable rate (in percent) Debt Instrument, Basis Spread on Variable Rate Total long-term debt, net Long-Term Debt, Excluding Current Maturities Goodwill Goodwill Disclosure [Text Block] Buyback Program Buyback Program [Member] Buyback Program [Member] Diluted (in shares) Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares) Weighted Average Number of Shares Outstanding, Diluted Schedule of accounts receivables and unbilled revenue, and unbilled services and unearned revenue Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Ordinary shares which have been reserved for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Revenue Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) Revenue from Contract with Customer [Text Block] Purchase of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Weighted Average Remaining Contractual Life Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract] Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid-in Capital Additional Paid-in Capital [Member] Gain on cash flow hedge Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Balance Sheet Location [Axis] Balance Sheet Location [Axis] Total Assets Assets Share of losses in equity method investments Loss on equity method investments Income (Loss) from Equity Method Investments Share Repurchase Program Share Repurchase Program [Axis] Cover [Abstract] Subsequent Events Subsequent Events [Text Block] Non-cash stock compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amortization of financing costs and debt discount Amortization of Debt Issuance Costs U.S. UNITED STATES Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Non-current other liabilities Other Liabilities, Noncurrent Shares vested (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Canceled/expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Revenue, remaining performance obligation Revenue, Remaining Performance Obligation, Amount Business Segment and Geographical Information Segment Reporting Disclosure [Text Block] Other receivables Other Receivables [Member] Other Receivables Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Variable Rate Component [Domain] Variable Rate Component [Domain] Variable Rate Component [Domain] Senior Secured Term Loan Secured Debt [Member] Percentage change in unearned revenue (payments on account) Increase (Decrease) In Contract With Customer, Liability, Gross, Current, Percent Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent Equity Component [Domain] Equity Component [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Basic (in shares) Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares) Weighted Average Number of Shares Outstanding, Basic Income from operations Income from operations Operating Income (Loss) Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Statement [Line Items] Statement [Line Items] Change in unbilled services (unbilled revenue) Increase in unbilled services (unbilled revenue) Increase (Decrease) In Contract With Customer, Asset, Gross, Current Increase (Decrease) In Contract With Customer, Asset, Gross, Current Schedule of Outstanding Debt Schedule of Debt [Table Text Block] Customer relationships Customer Relationships [Member] Type of Restructuring [Domain] Type of Restructuring [Domain] Other restructuring costs Other Restructuring Costs Other Liabilities EX-101.PRE 6 iclr-20230930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
9 Months Ended
Sep. 30, 2023
Cover [Abstract]  
Document Type 6-K
Document Fiscal Year Focus 2023
Entity Registrant Name ICON plc
Amendment Flag false
Document Fiscal Period Focus Q3
Entity Central Index Key 0001060955
Current Fiscal Year End Date --12-31
Document Period End Date Sep. 30, 2023
XML 8 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 313,065 $ 288,768
Available for sale investments 1,954 1,713
Accounts receivable, net of allowance for credit losses 1,850,362 1,731,388
Unbilled revenue 941,884 957,655
Other receivables 121,687 63,658
Prepayments and other current assets 150,193 137,094
Income taxes receivable 42,039 48,790
Total current assets 3,421,184 3,229,066
Non-current assets:    
Property, plant and equipment, net 342,262 350,320
Goodwill 8,982,896 8,971,670
Intangible assets 3,934,673 4,278,659
Operating right-of-use assets 132,319 153,832
Other receivables 52,797 70,790
Income taxes receivable 40,481 21,380
Deferred tax asset 83,095 76,930
Investments in equity- long term 41,790 32,631
Total Assets 17,031,497 17,185,278
Current Liabilities:    
Accounts payable 87,317 81,194
Unearned revenue 1,663,183 1,507,449
Other liabilities 948,829 1,005,025
Income taxes payable 41,518 41,783
Current bank credit lines and loan facilities 130,150 55,150
Total current liabilities 2,870,997 2,690,601
Non-current liabilities:    
Non-current bank credit lines and loan facilities 3,911,522 4,599,037
Lease liabilities 121,424 131,644
Non-current other liabilities 41,661 38,260
Non-current income taxes payable 242,972 239,188
Deferred tax liability 883,887 988,585
Commitments and contingencies 0 0
Total Liabilities 8,072,463 8,687,315
Shareholders' Equity:    
Ordinary shares, par value 6 euro cents per share; 100,000,000 shares authorized, 82,326,976 shares issued and outstanding at September 30, 2023 and 81,723,555 shares issued and outstanding at December 31, 2022 6,688 6,649
Additional paid-in capital 6,924,073 6,840,306
Other undenominated capital 1,162 1,162
Accumulated other comprehensive loss (190,190) (171,538)
Retained earnings 2,217,301 1,821,384
Total Shareholders' Equity 8,959,034 8,497,963
Total Liabilities and Shareholders' Equity $ 17,031,497 $ 17,185,278
XML 9 R3.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - € / shares
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Ordinary shares, par value (in EUR cents per share) € 0.06 € 0.06
Ordinary shares, shares authorized (in shares) 100,000,000 100,000,000
Ordinary shares, shares issued (in shares) 82,326,976 81,723,555
Ordinary shares, shares outstanding (in shares) 82,326,976 81,723,555
XML 10 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue $ 2,055,099 $ 1,942,427 $ 6,053,928 $ 5,779,384
Costs and expenses:        
Direct costs (excluding depreciation and amortization) 1,449,136 1,375,837 4,274,222 4,146,366
Selling, general and administrative expense 185,187 166,787 572,999 552,000
Depreciation and amortization 146,032 141,861 436,217 427,285
Transaction and integration-related expenses 10,433 8,001 34,516 28,970
Restructuring 0 6,197 45,390 32,890
Total costs and expenses 1,790,788 1,698,683 5,363,344 5,187,511
Income from operations 264,311 243,744 690,584 591,873
Interest income 1,273 1,434 3,294 1,727
Interest expense (83,908) (63,010) (255,665) (154,546)
Income before provision for income taxes 181,676 182,168 438,213 439,054
Provision for income taxes (18,011) (21,012) (41,913) (48,552)
Income before share of earnings from equity method investments 163,665 161,156 396,300 390,502
Share of losses in equity method investments 0 (1,002) (383) (2,643)
Net income attributable to the Group $ 163,665 $ 160,154 $ 395,917 $ 387,859
Net income per Ordinary Share attributable to the Group (note 13):        
Basic (in USD per share) $ 1.99 $ 1.96 $ 4.83 $ 4.76
Diluted (in USD per share) $ 1.97 $ 1.94 $ 4.79 $ 4.70
Weighted average number of Ordinary Shares outstanding (note 13):        
Basic (in shares) 82,215,627 81,582,375 82,001,500 81,481,686
Diluted (in shares) 82,972,888 82,493,211 82,737,073 82,473,521
XML 11 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Comprehensive income (net of tax):        
Net income attributable to the Group $ 163,665 $ 160,154 $ 395,917 $ 387,859
Currency translation adjustment (38,648) (98,966) (33,786) (200,964)
Gain on cash flow hedge 4,986 0 15,134 0
Total comprehensive income attributable to the Group $ 130,003 $ 61,188 $ 377,265 $ 186,895
XML 12 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Ordinary shares
Additional Paid-in Capital
Other Undenominated Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2021   81,554,683        
Beginning balance at Dec. 31, 2021 $ 8,066,827 $ 6,640 $ 6,733,910 $ 1,134 $ (90,937) $ 1,416,080
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 111,970         111,970
Exercise of share options (in shares)   84,090        
Exercise of share options 7,497 $ 6 7,491      
Issue of restricted share units / performance share units (in shares)   74,769        
Issue of restricted share units / performance share units 4 $ 4        
Non-cash stock compensation expense 18,840   18,840      
Share issuance costs (3)   (3)      
Share repurchase program (in shares)   (420,530)        
Share repurchase program (99,983) $ (28)   28   (99,983)
Share repurchase costs (17)         (17)
Other comprehensive loss, net of tax (35,818)       (35,818)  
Ending balance (in shares) at Mar. 31, 2022   81,293,012        
Ending balance at Mar. 31, 2022 8,069,317 $ 6,622 6,760,238 1,162 (126,755) 1,428,050
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 115,734         115,734
Exercise of share options (in shares)   75,671        
Exercise of share options 7,653 $ 4 7,649      
Issue of restricted share units / performance share units (in shares)   157,924        
Issue of restricted share units / performance share units 11 $ 11        
Non-cash stock compensation expense 19,478   19,478      
Other comprehensive loss, net of tax (66,180)       (66,180)  
Ending balance (in shares) at Jun. 30, 2022   81,526,607        
Ending balance at Jun. 30, 2022 8,146,013 $ 6,637 6,787,365 1,162 (192,935) 1,543,784
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 160,154         160,154
Exercise of share options (in shares)   117,140        
Exercise of share options 13,831 $ 4 13,827      
Issue of restricted share units / performance share units (in shares)   1,532        
Issue of restricted share units / performance share units 4 $ 4        
Non-cash stock compensation expense 17,686   17,686      
Share issuance costs (1)   (1)      
Other comprehensive loss, net of tax (98,966)       (98,966)  
Ending balance (in shares) at Sep. 30, 2022   81,645,279        
Ending balance at Sep. 30, 2022 $ 8,238,721 $ 6,645 6,818,877 1,162 (291,901) 1,703,938
Beginning balance (in shares) at Dec. 31, 2022 81,723,555 81,723,555        
Beginning balance at Dec. 31, 2022 $ 8,497,963 $ 6,649 6,840,306 1,162 (171,538) 1,821,384
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 116,654         116,654
Exercise of share options (in shares)   136,649        
Exercise of share options 12,936 $ 9 12,927      
Issue of restricted share units / performance share units (in shares)   68,218        
Issue of restricted share units / performance share units 4 $ 4        
Non-cash stock compensation expense 14,658   14,658      
Share issuance costs (4)   (4)      
Other comprehensive loss, net of tax 11,642       11,642  
Ending balance (in shares) at Mar. 31, 2023   81,928,422        
Ending balance at Mar. 31, 2023 $ 8,653,853 $ 6,662 6,867,887 1,162 (159,896) 1,938,038
Beginning balance (in shares) at Dec. 31, 2022 81,723,555 81,723,555        
Beginning balance at Dec. 31, 2022 $ 8,497,963 $ 6,649 6,840,306 1,162 (171,538) 1,821,384
Ending balance (in shares) at Sep. 30, 2023 82,326,976 82,326,976        
Ending balance at Sep. 30, 2023 $ 8,959,034 $ 6,688 6,924,073 1,162 (190,190) 2,217,301
Beginning balance (in shares) at Mar. 31, 2023   81,928,422        
Beginning balance at Mar. 31, 2023 8,653,853 $ 6,662 6,867,887 1,162 (159,896) 1,938,038
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 115,598         115,598
Exercise of share options (in shares)   93,304        
Exercise of share options 7,229 $ 6 7,223      
Issue of restricted share units / performance share units (in shares)   129,323        
Issue of restricted share units / performance share units 8 $ 8        
Non-cash stock compensation expense 16,389   16,389      
Share issuance costs (5)   (5)      
Other comprehensive loss, net of tax 3,368       3,368  
Ending balance (in shares) at Jun. 30, 2023   82,151,049        
Ending balance at Jun. 30, 2023 8,796,440 $ 6,676 6,891,494 1,162 (156,528) 2,053,636
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 163,665         163,665
Exercise of share options (in shares)   147,661        
Exercise of share options 16,337 $ 9 16,328      
Issue of restricted share units / performance share units (in shares)   28,266        
Issue of restricted share units / performance share units 3 $ 3        
Non-cash stock compensation expense 16,256   16,256      
Share issuance costs (5)   (5)      
Other comprehensive loss, net of tax $ (33,662)       (33,662)  
Ending balance (in shares) at Sep. 30, 2023 82,326,976 82,326,976        
Ending balance at Sep. 30, 2023 $ 8,959,034 $ 6,688 $ 6,924,073 $ 1,162 $ (190,190) $ 2,217,301
XML 13 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net income $ 395,917 $ 387,859
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 436,217 427,285
Impairment of long lived assets 8,845 27,727
Reduction in carrying value of operating right-of-use assets 33,979 35,238
Loss on equity method investments 383 2,643
Acquisition-related gain (6,160) 0
Charge on cash flow hedge 3,335 0
Amortization of financing costs and debt discount 12,485 13,544
Stock compensation expense 47,303 55,703
Deferred taxes (114,487) (126,620)
Foreign exchange movements (7,670) (52,334)
Other non-cash items 21,966 18,595
Changes in operating assets and liabilities:    
Accounts receivable (139,096) (140,760)
Unbilled revenue 14,370 (221,104)
Unearned revenue 158,269 28,352
Other net assets (144,760) 166,613
Net cash provided by operating activities 720,896 622,741
Cash flows from investing activities:    
Purchase of property, plant and equipment (87,980) (85,145)
Purchase of subsidiary undertakings (5,100) 0
Sale of available for sale investments 1,611 0
Purchase of available for sale investments (1,852) 0
Purchase of investments in equity - long term (10,829) (1,840)
Net cash used in investing activities (104,150) (86,985)
Cash flows from financing activities:    
Drawdown of bank credit lines and loan facilities 305,000 25,000
Repayment of bank credit lines and loan facilities (930,000) (625,000)
Proceeds from exercise of equity compensation 36,517 28,967
Share issue costs (14) (3)
Repurchase of ordinary shares 0 (99,983)
Share repurchase costs 0 (17)
Net cash used in financing activities (588,497) (671,036)
Effect of exchange rate movements on cash (3,952) (7,775)
Net increase (decrease) in cash and cash equivalents 24,297 (143,055)
Cash and cash equivalents at beginning of period 288,768 752,213
Cash and cash equivalents at end of period $ 313,065 $ 609,158
XML 14 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Basis of presentation
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of presentation Basis of presentation
These condensed consolidated financial statements which have been prepared in accordance with United States Generally Accepted Accounting Principles (“US GAAP”) have not been audited. The condensed consolidated financial statements reflect all adjustments, which are, in the opinion of management, necessary to present a fair statement of the operating results and financial position for the periods presented. The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures in the condensed consolidated financial statements. Actual results could differ from those estimates.

The condensed consolidated financial statements should be read in conjunction with the accounting policies and notes to the consolidated financial statements included in ICON’s Form 20-F for the year ended December 31, 2022 (see note 2 - Summary of significant accounting policies). Operating results for the nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal period ending December 31, 2023.
XML 15 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of significant accounting policies
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Summary of significant accounting policies Summary of significant accounting policies
Revenue recognition
The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years.

ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.

Clinical trial service revenue

A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.

Laboratory services revenue

Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.

Contracting services revenue

The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff.
Consulting services revenue

Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.

Data services revenue

The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.

When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the “units delivered” output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.

Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.

The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract.

Commissions

Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.
Business Combinations
The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.

The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.

The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership.
Intangible Assets
Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives. The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist.

Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:

Estimated Useful Life
Customer relationships23 years
Order backlog3 years
Trade names3 years
Patient database7 years
Technology assets5 years

The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.


Income taxes

The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (“global intangible low-taxed income”) in the period it arises and has therefore not provided for deferred taxes in respect of this item.
XML 16 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue
9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Revenue disaggregated by customer concentration is as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Clients 1-5$527,345 $539,907 $1,615,713 $1,595,007 
Clients 6-10$302,407 $270,073 $868,753 $831,660 
Clients 11-25$448,428 $405,171 $1,267,750 $1,100,118 
Other$776,919 $727,276 $2,301,712 $2,252,599 
Total$2,055,099 $1,942,427 $6,053,928 $5,779,384 

There was no revenue from individual customers greater than 10% of consolidated revenue in the respective periods.
Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)
Accounts receivables and unbilled revenue are as follows:
September 30, 2023December 31, 2022
(in thousands)
Contract assets:
Billed services (accounts receivable)$1,883,296 $1,751,950 
Unbilled services (unbilled revenue)941,884 957,655 
Accounts receivable and unbilled revenue, gross2,825,180 2,709,605 
Allowance for credit losses(32,934)(20,562)
Accounts receivable and unbilled revenue, net$2,792,246 $2,689,043 
    
Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:
(in thousands, except percentages)September 30, 2023December 31, 2022$ Change% Change
Unbilled services (unbilled revenue)$941,884 $957,655 $(15,771)(1.6)%
Unearned revenue (payments on account)(1,663,183)(1,507,449)(155,734)10.3 %
Net balance$(721,299)$(549,794)$(171,505)31.2 %

Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled services and therefore contract assets rather than accounts receivables when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned.

Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right to set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Condensed Consolidated Balance Sheet.

Unbilled services as at September 30, 2023 decreased by $15.8 million compared to December 31, 2022. Unearned revenue increased by $155.7 million over the same period resulting in an increase of $171.5 million in the net balance of unbilled services and unearned revenue or payments on account between December 31, 2022 and September 30, 2023. These fluctuations are primarily due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer.
As of September 30, 2023 approximately $14.3 billion (September 30, 2022: $13.5 billion) of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations. The Company expects to recognize revenue on approximately 51% of the unsatisfied performance obligations over the next 12 months, with the remainder recognized thereafter over the duration of the customer contracts.
XML 17 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)
9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) Revenue
Revenue disaggregated by customer concentration is as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Clients 1-5$527,345 $539,907 $1,615,713 $1,595,007 
Clients 6-10$302,407 $270,073 $868,753 $831,660 
Clients 11-25$448,428 $405,171 $1,267,750 $1,100,118 
Other$776,919 $727,276 $2,301,712 $2,252,599 
Total$2,055,099 $1,942,427 $6,053,928 $5,779,384 

There was no revenue from individual customers greater than 10% of consolidated revenue in the respective periods.
Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)
Accounts receivables and unbilled revenue are as follows:
September 30, 2023December 31, 2022
(in thousands)
Contract assets:
Billed services (accounts receivable)$1,883,296 $1,751,950 
Unbilled services (unbilled revenue)941,884 957,655 
Accounts receivable and unbilled revenue, gross2,825,180 2,709,605 
Allowance for credit losses(32,934)(20,562)
Accounts receivable and unbilled revenue, net$2,792,246 $2,689,043 
    
Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:
(in thousands, except percentages)September 30, 2023December 31, 2022$ Change% Change
Unbilled services (unbilled revenue)$941,884 $957,655 $(15,771)(1.6)%
Unearned revenue (payments on account)(1,663,183)(1,507,449)(155,734)10.3 %
Net balance$(721,299)$(549,794)$(171,505)31.2 %

Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled services and therefore contract assets rather than accounts receivables when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned.

Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right to set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Condensed Consolidated Balance Sheet.

Unbilled services as at September 30, 2023 decreased by $15.8 million compared to December 31, 2022. Unearned revenue increased by $155.7 million over the same period resulting in an increase of $171.5 million in the net balance of unbilled services and unearned revenue or payments on account between December 31, 2022 and September 30, 2023. These fluctuations are primarily due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer.
As of September 30, 2023 approximately $14.3 billion (September 30, 2022: $13.5 billion) of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations. The Company expects to recognize revenue on approximately 51% of the unsatisfied performance obligations over the next 12 months, with the remainder recognized thereafter over the duration of the customer contracts.
XML 18 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill
9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill Goodwill
Nine Months EndedYear Ended
September 30, 2023December 31, 2022
(in thousands)
Opening balance$8,971,670 $9,037,931 
Current period acquisition13,379 — 
Prior period acquisition— (35,692)
Foreign exchange movement(2,153)(30,569)
Closing balance$8,982,896 $8,971,670 
On April 20, 2023, the Company completed the purchase of the majority investor's 51% majority voting share capital of Oncacare Limited ("Oncacare"), such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group. The Oncacare acquisition resulted in goodwill of $13.4 million and also gave rise to an acquisition-related gain of $6.2 million.
There were no impairment charges for the nine months ended September 30, 2023 or for the year ended December 31, 2022.
XML 19 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Intangible assets
9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible assets Intangible assets
Intangible assets, net consisted of the following:
Nine Months EndedYear Ended
September 30, 2023December 31, 2022
Cost(in thousands)
Customer relationships$4,076,010 $4,076,435 
Order backlog536,716 536,934 
Trade names & brands204,608 204,621 
Patient database170,262 170,238 
Technology assets120,875 120,984 
Total cost5,108,471 5,109,212 
Accumulated amortization(1,173,798)(830,553)
 Net book value$3,934,673 $4,278,659 
The identifiable intangible assets are amortized over their estimated useful lives.
XML 20 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Fair value measurements
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair value measurements Fair value measurements
The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
Level 3 — Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, unbilled services, contract assets, accounts payable and unearned revenue approximate fair value due to the short maturities of these instruments.

As of September 30, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
(in thousands)
Assets:
Available for sale securities (short-term) (a)1,954 — — — 1,954 
Available for sale investments (long-term) (b)— — — 41,790 41,790 
Derivative instruments (c)— 13,111 — — 13,111 
Total assets$1,954 $13,111 $— $41,790 $56,855 
Liabilities:
Derivative instruments (c)— — — — — 
Total liabilities$— $— $— $— $— 

As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
(in thousands)
Assets:
Available for sale securities (short-term) (a)1,713 — — — 1,713 
Available for sale investments (long-term) (b)— — — 32,631 32,631 
Derivative instruments (c)— 12 — — 12 
Total assets$1,713 $12 $— $32,631 $34,356 
Liabilities:
Derivative instruments (c)— 3,670 — — 3,670 
Total liabilities$— $3,670 $— $— $3,670 

(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.

(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds meet the definition of equity securities without readily determinable fair values, which qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.

(c) Represents the fair value of interest rate cap and interest rate swap agreements. The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread.
Non-recurring Fair Value Measurements

Certain assets and liabilities are carried on the accompanying Condensed Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of September 30, 2023, assets carried on the balance sheet at cost and not re-measured to fair value on a recurring basis totaled approximately $12,917.6 million and are identified as Level 3 assets. These assets are comprised of goodwill of $8,982.9 million and net identifiable intangible assets of $3,934.7 million.

The estimated fair value of the Company’s debt was $4,032.0 million at September 30, 2023. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility is recorded as its carrying value, due to the short term duration.
XML 21 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Restructuring
9 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
Restructuring Restructuring
In the nine months ended September 30, 2023, a restructuring charge of $45.4 million was recorded in the Condensed Consolidated Statement of Operations under a restructuring plan adopted following a review of operations. The restructuring plan reflected a workforce reduction of $34.1 million and an office consolidation program to optimize the Company's office footprint of $11.3 million.

 Nine Months Ended
September 30, 2023September 30, 2022
 (in thousands)
Restructuring charges$45,390 $32,890 
Net charge$45,390 $32,890 

At September 30, 2023, a total liability of $19.6 million was recorded on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $16.2 million of personnel related liabilities as a result of the workforce reduction; all of which have been classified as short-term. The total liability also included $3.4 million of facilities related liabilities of which $1.1 million is included within other liabilities and $2.3 million is included within non-current other liabilities.

Nine Months EndedYear ended
September 30, 2023December 31, 2022
(in thousands)
Opening provision$6,022 $10,311 
Additional provisions36,704 4,364 
Utilization(23,106)(8,653)
Ending provision$19,620 $6,022 
XML 22 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Operating leases
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Operating leases Operating leases
Lease costs recorded under operating leases for the three and nine months ended September 30, 2023 and September 30, 2022 were as follows:

Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Operating lease costs11,850 12,164 $37,539 $40,976 
Income from sub-leases(284)(268)(845)(898)
Net operating lease costs11,566 11,896 $36,694 $40,078 

Of the total cost of $36.7 million incurred in the nine months ended September 30, 2023 (September 30, 2022: $40.1 million), $28.1 million (September 30, 2022: $38.1 million) is recorded within selling, general and administration costs and $8.6 million (September 30, 2022: $2.0 million) is recorded within direct costs.

During the nine months ended September 30, 2023 and September 30, 2022, costs incurred by the Group related to variable lease payments was de minimis.

Right-of-use assets obtained, in exchange for lease obligations during the three months ended September 30, 2023, totaled $2.1 million (September 30, 2022: $1.7 million). Right-of-use assets obtained, in exchange for lease obligations during the nine months ended September 30, 2023, totaled $24.6 million (September 30, 2022: $37.6 million).

The weighted average remaining lease term and weighted-average discount rate at September 30, 2023 were 6.75 years and 3.15%, respectively.

Future minimum lease payments under non-cancelable leases as of September 30, 2023 were as follows:
Minimum rental payments
(in thousands)September 30, 2023
Year 1$38,084 
Year 231,545 
Year 326,709 
Year 421,934 
Year 515,039 
Thereafter35,884 
Total future minimum lease payments169,195 
Lease imputed interest(13,883)
Total$155,312 
Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $33.9 million have been included in other liabilities as at September 30, 2023 (September 30, 2022: $42.2 million).
XML 23 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Bank credit lines and loan facilities
9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Bank credit lines and loan facilities Bank credit lines and loan facilities
The Company had the following debt outstanding as of September 30, 2023 and December 31, 2022:

Principal amount
Interest rate as ofInterest rate as ofSeptember 30,December 31,
(in thousands)September 30, 2023December 31, 202220232022Maturity Date
Credit Facilities:
Senior Secured Term Loan7.75 %7.09 %$3,501,213 $4,201,213 July 2028
Senior Secured Notes
2.88 %2.88 %500,000 500,000 July 2026
Senior Secured Revolving Loan Facility6.68 %— 75,000 — October 2023
Total debt4,076,213 4,701,213 
Less current portion of long-term debt(130,150)(55,150)
Total long-term debt3,946,063 4,646,063 
Less debt issuance costs and debt discount
(34,541)(47,026)
Total long-term debt, net$3,911,522 $4,599,037 

As of September 30, 2023, the contractual maturities of the Company's debt obligations were as follows:

Contractual maturities of long-term debt:(in thousands)
2023 (remaining)$88,788 
202455,150 
202555,150 
2026555,150 
2027 and thereafter3,321,975 
Total$4,076,213 

The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").

Senior Secured Credit Facilities

On July 1, 2021, the Company completed the acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences ("the Merger"). In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The Company paid a $27.6 million debt discount in connection with the Senior Secured Credit Facility and Senior Secured Notes. On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300 million to $500 million.

Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin which is dependent on the Company's net leverage ratio. At September 30, 2023, the applicable margin is 2.25%. The senior secured term loan facility is subject to a floor of 0.50%.

The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON’s current corporate family rating assigned by S&P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON’s current corporate family rating assigned by S&P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility
are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn.

In January 2023, $100.0 million of the senior secured revolving loan facility was drawn down, in the aggregate, at interest rates of 5.89% and 5.80%, representing one month SOFR plus a margin of 1.25%. This was repaid in full in March 2023. On March 31, 2023, $80.0 million of the senior secured revolving loan facility was drawn down at an interest rate of 6.17%, representing one month SOFR plus a margin of 1.25%. In April 2023, the Company drew down a further $50.0 million of the senior secured revolving loan facility at an interest rate of 6.25%, representing one month SOFR plus a margin of 1.25%. The Company repaid $80.0 million of the senior secured revolving loan facility on June 30, 2023. The remaining $50.0 million was repaid on August 17, 2023. On September 29, 2023, $75.0 million of the senior secured revolving loan facility was drawn down at an interest rate of 6.68%, representing one month SOFR plus a margin of 1.25%.

The Borrowers’ (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON’s, the Borrowers’ and each of the subsidiary guarantor’s assets (subject to certain exceptions), and the Senior Secured Credit Facilities have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes, subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty.

On March 31, 2023 the Company repaid $250.0 million of the senior secured term loan facility and made a quarterly
interest payment of $75.3 million. This repayment resulted in an additional charge associated with previously capitalized fees of
$2.2 million.

On June 30, 2023 the Company repaid $150.0 million of the senior secured term loan facility and made a quarterly interest payment of $74.0 million. This repayment resulted in an additional charge associated with previously capitalized fees of $1.2 million.

On September 29, 2023, the Company repaid $300.0 million of the senior secured term loan facility and made a quarterly interest payment of $74.5 million. This repayment resulted in an additional charge associated with previously capitalized fees of $2.5 million.

Senior Secured Notes

In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500 million in aggregate principal amount of 2.875% senior secured notes due 2026 (the "Senior Secured Notes") in a private offering (the “Offering”). The Senior Secured Notes will mature on July 15, 2026.

Fair Value of Debt
The estimated fair value of the Company’s debt was $4,032.0 million at September 30, 2023. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility is recorded as its carrying value due to the short term duration.
XML 24 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Derivatives
9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives Derivatives
On November 29, 2022, the Company entered into two interest rate cap agreements ("2022 Caps") with an initial total notional value of $2,101 million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate caps expires on December 31, 2024. The Company pays a fixed rate of 0.42% and receives a variable rate equal to the amount that the three-month SOFR exceeds 4.75%.

On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $1,101 million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swap begins accruing on December 31, 2024 and the interest rate swap expires on September 30, 2026. The Company pays a fixed rate of 3.4% and receives a variable rate of interest equal to the three-month SOFR on the 2022 Swap.

The fair value of the Company’s derivative financial instruments, on a gross basis, are summarized in the following table:

September 30, 2023December 31, 2022
AssetLiabilityNotionalAssetLiabilityNotional
(in thousands)(in thousands)
Derivatives designated as hedging instruments:
Interest Rate Caps$4,262$—$1,750,606$12$3,363$2,100,606
Interest Rate Swap$8,849$—$1,100,606$—$307$1,100,606
Total derivatives designated as hedging instruments$13,111$—$2,851,212$12$3,670$3,201,212
As of September 30, 2023, the Company recognized a current derivative asset of $3.8 million within other receivables (December 31, 2022, current derivative asset of $0.01 million recognized within other receivables and a current derivative liability of $3.3 million recognized within other liabilities). A further $9.3 million non-current derivative asset was recognized within non-current other receivables (December 31,2022, non-current derivative liability of $0.4 million recognized within non-current other liabilities).

During the next 12 months, the Company estimates that an additional $2.3 million will be reflected as interest income in the consolidated statements.
The Company recognized $5.0 million of a gain within other comprehensive income ("OCI") for the three months ended September 30, 2023 (September 30, 2022: $nil) after a reclassification of $0.3 million from OCI to the income statement (September 30, 2022: $nil). The Company recognized $15.1 million of a net gain within OCI for the nine months ended September 30, 2023 (September 30, 2022: $nil) after a reclassification of $3.3 million from OCI to the income statement (September 30, 2022: $nil).
XML 25 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Income taxes
9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
Income taxes Income taxes
Income taxes recognized during the three and nine months ended September 30, 2023 and September 30, 2022, comprise:

Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Provision for income taxes $18,011 $21,012 $41,913 $48,552 

As at September 30, 2023 the Company maintains a $251.1 million liability (December 31, 2022: $240.2 million) for unrecognized tax benefit, which is comprised of $221.1 million (December 31, 2022: $217.6 million) related to items generating unrecognized tax benefits and $30.0 million (December 31, 2022: $22.6 million) for interest and penalties related to such items. The Company recognizes interest accrued on unrecognized tax benefits as an additional income tax expense.

The Company has analyzed the filing positions in all of the significant federal, state and foreign jurisdictions where it is required to file income tax returns, as well as open tax years in these jurisdictions. The only periods subject to audit by the major tax jurisdictions where the Company does business are the 2016 through 2022 tax years. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.
XML 26 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Net income per ordinary share
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Net income per ordinary share Net income per ordinary share
Basic net income per ordinary share attributable to the Group has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share.

The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
Weighted average number of ordinary shares outstanding for basic net income per ordinary share82,215,627 81,582,375 82,001,500 81,481,686 
Effect of dilutive share options and other awards outstanding under share based compensation programs757,261 910,836 735,573 991,835 
Weighted average number of ordinary shares outstanding for diluted net income per ordinary share82,972,888 82,493,211 82,737,073 82,473,521 

Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
Net income per Ordinary Share attributable to the Group:
Basic1.99 1.96 4.83 4.76 
Diluted1.97 1.94 4.79 4.70 
XML 27 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Share-based awards
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Share-based awards Share-based awards
Share Options

The following table summarizes option activity for the nine months ended September 30, 2023:
 Options
Outstanding
Number of Shares 
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life
Outstanding at December 31, 20221,378,119 $119.86 4.69
Granted82,472 $232.48 
Exercised(377,614)$96.67 
Canceled/expired(6,885)$116.33 
Outstanding at September 30, 20231,076,092 $136.65 4.45
Exercisable at September 30, 2023804,953 $113.75 3.91

The Company issues ordinary shares for all options exercised. The total amount of fully vested share options which remained outstanding at September 30, 2023 was 804,953. Fully vested share options at September 30, 2023 have an average remaining contractual term of 3.91 years and an average exercise price of $113.75.


Fair value of Stock Options Assumptions

The weighted average fair value of options granted during the nine months ended September 30, 2023 and September 30, 2022 was calculated using the Black-Scholes option pricing model. The weighted average grant date fair values and assumptions used were as follows:
Nine Months Ended
September 30, 2023September 30, 2022
Weighted average grant date fair value$85.12 $68.40 
Assumptions:  
Expected volatility33 %31 %
Dividend yield— %— %
Risk-free interest rate3.98 %1.85 %
Expected life5 years5 years

Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.

Restricted Share Units and Performance Share Units 

On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the 2013 RSU Plan by 2.5 million shares. Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company. No awards may be granted under the 2013 RSU Plan after May 11, 2025.
On April 30, 2019 the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the “2019 Consultants RSU Plan”), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company’s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors during 2020, 2021 and 2022 vest in twelve months.

    The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the nine months ended September 30, 2023:
  
PSU
Outstanding
Number of
Shares
 
PSU
Weighted
Average Grant Date
Fair Value
 
RSU
Outstanding
Number of
Shares
 
RSU
Weighted
Average Grant Date
Fair Value
Outstanding at December 31, 2022152,420 $192.29 582,612 $207.73 
Granted60,374 $232.51 306,780 $218.68 
Shares vested(47,026)$159.57 (178,781)$186.35 
Forfeited— $— (59,260)$211.45 
Outstanding at September 30, 2023165,768 $216.22 651,351 $218.41 

The fair value of PSUs vested for the nine months ended September 30, 2023 totaled $7.5 million (full year 2022: $6.5 million).

The fair value of RSUs vested for the nine months ended September 30, 2023 totaled $33.3 million (full year 2022: $34.1 million).

The PSUs vest based on service and specified EPS targets over the periods 2021 - 2023, 2022 - 2024, and 2023 - 2025. Depending on the amount of EPS from 2021 to 2025, up to an additional 82,884 PSUs may also be granted.

Stock compensation expense

Stock compensation expense for the three and nine months ended September 30, 2023 and September 30, 2022 has been allocated as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Direct costs$6,637 $6,285 $18,725 $17,117 
Selling, general and administrative$9,828 $11,232 $29,097 $38,586 
Total$16,465 $17,517 $47,822 $55,703 
XML 28 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Share capital
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Share capital Share capital
The Company can acquire up to 10% of its outstanding ordinary shares (by way of redemption), in accordance with Irish law and the Company’s constitutional documents through open market share acquisitions.

On February 18, 2022, the Company commenced a share buyback program which was fully complete at March 31, 2022. Under this buyback program, 420,530 ordinary shares were redeemed by the Company for total consideration of $100.0 million. The buyback program gives a broker authority to acquire the Company’s ordinary shares from time to time on the open market in accordance with agreed terms and limitations. All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital reserve as required under Irish Company Law.
XML 29 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segment and Geographical Information
9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Business Segment and Geographical Information Business Segment and Geographical Information
The Company is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. It specializes in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.

The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (‘CODM’) in accordance with ASC 280 'Segment Reporting'. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.

The Company operates as one reporting segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries.

Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group’s transfer pricing model.

ICON Ireland (Ireland Segment) acts as the Group entrepreneur under the Company’s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company’s global network. ICON Ireland enters into the majority of the Company’s customer contracts.

ICON Ireland remunerates other operating entities in the Group on the basis of a guaranteed cost plus mark-up for the services they perform in each of their local territories. The cost plus mark-up for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate arms-length return having regard to the assets owned, risks borne and functions performed by each entity from these intercompany transactions. The cost plus mark-up policy is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model remains ongoing.

The geographic split of revenue disclosed for each region outside Ireland is the cost plus revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the cost plus revenues attributable to the activities performed outside Ireland.
The geographical distribution of the Company’s segment measures for the three and nine months ended September 30, 2023 and September 30, 2022 and at September 30, 2023 and December 31, 2022 is as follows:

a) The distribution of revenue by geographical area was as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Ireland $596,337 $526,867 $1,701,580 $1,395,198 
Rest of Europe384,720 397,538 1,172,752 1,281,996 
U.S.831,789 903,200 2,524,212 2,767,844 
Rest of World242,253 114,822 655,384 334,346 
Total$2,055,099 $1,942,427 $6,053,928 $5,779,384 

b) The distribution of income from operations by geographical area was as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Ireland *$121,343 $93,640 $298,567 $159,059 
Rest of Europe56,705 76,178 138,959 194,860 
U.S.70,013 63,356 213,846 177,145 
Rest of World16,250 10,570 39,212 60,809 
Total$264,311 $243,744 $690,584 $591,873 
* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger.

c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:
September 30, 2023December 31, 2022
(in thousands)
Ireland$172,016 $143,025 
Rest of Europe89,265 99,721 
U.S.165,597 213,311 
Rest of World47,703 48,095 
Total$474,581 $504,152 
XML 30 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events Subsequent events
On October 2, 2023, the Company acquired 100% of the equity of BioTel Research, LLC which comprised the business formerly known as Philips Pharma Solutions, a leading provider of medical imaging and cardiac safety monitoring services. The initial consideration paid on the closing date of the acquisition was $68.1 million.

The Company has evaluated subsequent events from the balance sheet date through to the date at which the financial
statements were available to be issued. The Company has determined that there are no items, other than the items described above, to disclose.
XML 31 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of significant accounting policies (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Revenue recognition
Revenue recognition
The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years.

ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.

Clinical trial service revenue

A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.

Laboratory services revenue

Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.

Contracting services revenue

The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff.
Consulting services revenue

Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.

Data services revenue

The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.

When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the “units delivered” output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.

Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.

The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract.

Commissions

Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.
Business Combinations
Business Combinations
The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.

The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.
The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership.
Intangible Assets
Intangible Assets
Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives. The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist.

Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:

Estimated Useful Life
Customer relationships23 years
Order backlog3 years
Trade names3 years
Patient database7 years
Technology assets5 years

The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.
Income taxes
Income taxes

The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (“global intangible low-taxed income”) in the period it arises and has therefore not provided for deferred taxes in respect of this item.
XML 32 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of significant accounting policies (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of Finite-Lived Intangible Assets
Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:

Estimated Useful Life
Customer relationships23 years
Order backlog3 years
Trade names3 years
Patient database7 years
Technology assets5 years
Intangible assets, net consisted of the following:
Nine Months EndedYear Ended
September 30, 2023December 31, 2022
Cost(in thousands)
Customer relationships$4,076,010 $4,076,435 
Order backlog536,716 536,934 
Trade names & brands204,608 204,621 
Patient database170,262 170,238 
Technology assets120,875 120,984 
Total cost5,108,471 5,109,212 
Accumulated amortization(1,173,798)(830,553)
 Net book value$3,934,673 $4,278,659 
XML 33 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue (Tables)
9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
Revenue disaggregated by customer concentration is as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Clients 1-5$527,345 $539,907 $1,615,713 $1,595,007 
Clients 6-10$302,407 $270,073 $868,753 $831,660 
Clients 11-25$448,428 $405,171 $1,267,750 $1,100,118 
Other$776,919 $727,276 $2,301,712 $2,252,599 
Total$2,055,099 $1,942,427 $6,053,928 $5,779,384 

There was no revenue from individual customers greater than 10% of consolidated revenue in the respective periods.
XML 34 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)
9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of accounts receivables and unbilled revenue, and unbilled services and unearned revenue
Accounts receivables and unbilled revenue are as follows:
September 30, 2023December 31, 2022
(in thousands)
Contract assets:
Billed services (accounts receivable)$1,883,296 $1,751,950 
Unbilled services (unbilled revenue)941,884 957,655 
Accounts receivable and unbilled revenue, gross2,825,180 2,709,605 
Allowance for credit losses(32,934)(20,562)
Accounts receivable and unbilled revenue, net$2,792,246 $2,689,043 
    
Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:
(in thousands, except percentages)September 30, 2023December 31, 2022$ Change% Change
Unbilled services (unbilled revenue)$941,884 $957,655 $(15,771)(1.6)%
Unearned revenue (payments on account)(1,663,183)(1,507,449)(155,734)10.3 %
Net balance$(721,299)$(549,794)$(171,505)31.2 %
XML 35 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill (Tables)
9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
Nine Months EndedYear Ended
September 30, 2023December 31, 2022
(in thousands)
Opening balance$8,971,670 $9,037,931 
Current period acquisition13,379 — 
Prior period acquisition— (35,692)
Foreign exchange movement(2,153)(30,569)
Closing balance$8,982,896 $8,971,670 
XML 36 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Intangible assets (Tables)
9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite-Lived Intangible Assets
Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:

Estimated Useful Life
Customer relationships23 years
Order backlog3 years
Trade names3 years
Patient database7 years
Technology assets5 years
Intangible assets, net consisted of the following:
Nine Months EndedYear Ended
September 30, 2023December 31, 2022
Cost(in thousands)
Customer relationships$4,076,010 $4,076,435 
Order backlog536,716 536,934 
Trade names & brands204,608 204,621 
Patient database170,262 170,238 
Technology assets120,875 120,984 
Total cost5,108,471 5,109,212 
Accumulated amortization(1,173,798)(830,553)
 Net book value$3,934,673 $4,278,659 
XML 37 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measures and Disclosures (Tables)
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value, Liabilities Measured on Recurring Basis
As of September 30, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
(in thousands)
Assets:
Available for sale securities (short-term) (a)1,954 — — — 1,954 
Available for sale investments (long-term) (b)— — — 41,790 41,790 
Derivative instruments (c)— 13,111 — — 13,111 
Total assets$1,954 $13,111 $— $41,790 $56,855 
Liabilities:
Derivative instruments (c)— — — — — 
Total liabilities$— $— $— $— $— 

As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
(in thousands)
Assets:
Available for sale securities (short-term) (a)1,713 — — — 1,713 
Available for sale investments (long-term) (b)— — — 32,631 32,631 
Derivative instruments (c)— 12 — — 12 
Total assets$1,713 $12 $— $32,631 $34,356 
Liabilities:
Derivative instruments (c)— 3,670 — — 3,670 
Total liabilities$— $3,670 $— $— $3,670 

(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.

(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds meet the definition of equity securities without readily determinable fair values, which qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.
(c) Represents the fair value of interest rate cap and interest rate swap agreements. The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread.
Fair Value, Assets Measured on Recurring Basis
As of September 30, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
(in thousands)
Assets:
Available for sale securities (short-term) (a)1,954 — — — 1,954 
Available for sale investments (long-term) (b)— — — 41,790 41,790 
Derivative instruments (c)— 13,111 — — 13,111 
Total assets$1,954 $13,111 $— $41,790 $56,855 
Liabilities:
Derivative instruments (c)— — — — — 
Total liabilities$— $— $— $— $— 

As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
(in thousands)
Assets:
Available for sale securities (short-term) (a)1,713 — — — 1,713 
Available for sale investments (long-term) (b)— — — 32,631 32,631 
Derivative instruments (c)— 12 — — 12 
Total assets$1,713 $12 $— $32,631 $34,356 
Liabilities:
Derivative instruments (c)— 3,670 — — 3,670 
Total liabilities$— $3,670 $— $— $3,670 

(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.

(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds meet the definition of equity securities without readily determinable fair values, which qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.
(c) Represents the fair value of interest rate cap and interest rate swap agreements. The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread.
XML 38 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Restructuring (Tables)
9 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
Summary of Restructuring Charges
 Nine Months Ended
September 30, 2023September 30, 2022
 (in thousands)
Restructuring charges$45,390 $32,890 
Net charge$45,390 $32,890 
Summary of details of movement in restructuring charges
Nine Months EndedYear ended
September 30, 2023December 31, 2022
(in thousands)
Opening provision$6,022 $10,311 
Additional provisions36,704 4,364 
Utilization(23,106)(8,653)
Ending provision$19,620 $6,022 
XML 39 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Operating leases (Tables)
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Schedule of Lease Costs
Lease costs recorded under operating leases for the three and nine months ended September 30, 2023 and September 30, 2022 were as follows:

Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Operating lease costs11,850 12,164 $37,539 $40,976 
Income from sub-leases(284)(268)(845)(898)
Net operating lease costs11,566 11,896 $36,694 $40,078 
Schedule of Operating Lease Maturity
Future minimum lease payments under non-cancelable leases as of September 30, 2023 were as follows:
Minimum rental payments
(in thousands)September 30, 2023
Year 1$38,084 
Year 231,545 
Year 326,709 
Year 421,934 
Year 515,039 
Thereafter35,884 
Total future minimum lease payments169,195 
Lease imputed interest(13,883)
Total$155,312 
XML 40 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Bank credit lines and loan facilities (Tables)
9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Schedule of Outstanding Debt
The Company had the following debt outstanding as of September 30, 2023 and December 31, 2022:

Principal amount
Interest rate as ofInterest rate as ofSeptember 30,December 31,
(in thousands)September 30, 2023December 31, 202220232022Maturity Date
Credit Facilities:
Senior Secured Term Loan7.75 %7.09 %$3,501,213 $4,201,213 July 2028
Senior Secured Notes
2.88 %2.88 %500,000 500,000 July 2026
Senior Secured Revolving Loan Facility6.68 %— 75,000 — October 2023
Total debt4,076,213 4,701,213 
Less current portion of long-term debt(130,150)(55,150)
Total long-term debt3,946,063 4,646,063 
Less debt issuance costs and debt discount
(34,541)(47,026)
Total long-term debt, net$3,911,522 $4,599,037 
Schedule of Contractual Maturities of Debt
As of September 30, 2023, the contractual maturities of the Company's debt obligations were as follows:

Contractual maturities of long-term debt:(in thousands)
2023 (remaining)$88,788 
202455,150 
202555,150 
2026555,150 
2027 and thereafter3,321,975 
Total$4,076,213 
XML 41 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Derivatives (Tables)
9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The fair value of the Company’s derivative financial instruments, on a gross basis, are summarized in the following table:

September 30, 2023December 31, 2022
AssetLiabilityNotionalAssetLiabilityNotional
(in thousands)(in thousands)
Derivatives designated as hedging instruments:
Interest Rate Caps$4,262$—$1,750,606$12$3,363$2,100,606
Interest Rate Swap$8,849$—$1,100,606$—$307$1,100,606
Total derivatives designated as hedging instruments$13,111$—$2,851,212$12$3,670$3,201,212
XML 42 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Income taxes (Tables)
9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense
Income taxes recognized during the three and nine months ended September 30, 2023 and September 30, 2022, comprise:

Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Provision for income taxes $18,011 $21,012 $41,913 $48,552 
XML 43 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Net income per ordinary share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of reconciliation of number of shares used in computation of basic and diluted net income per ordinary share
The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
Weighted average number of ordinary shares outstanding for basic net income per ordinary share82,215,627 81,582,375 82,001,500 81,481,686 
Effect of dilutive share options and other awards outstanding under share based compensation programs757,261 910,836 735,573 991,835 
Weighted average number of ordinary shares outstanding for diluted net income per ordinary share82,972,888 82,493,211 82,737,073 82,473,521 

Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
Net income per Ordinary Share attributable to the Group:
Basic1.99 1.96 4.83 4.76 
Diluted1.97 1.94 4.79 4.70 
XML 44 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Share-based awards (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of stock option activity
The following table summarizes option activity for the nine months ended September 30, 2023:
 Options
Outstanding
Number of Shares 
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life
Outstanding at December 31, 20221,378,119 $119.86 4.69
Granted82,472 $232.48 
Exercised(377,614)$96.67 
Canceled/expired(6,885)$116.33 
Outstanding at September 30, 20231,076,092 $136.65 4.45
Exercisable at September 30, 2023804,953 $113.75 3.91
Schedule of weighted average fair values and assumptions used The weighted average grant date fair values and assumptions used were as follows:
Nine Months Ended
September 30, 2023September 30, 2022
Weighted average grant date fair value$85.12 $68.40 
Assumptions:  
Expected volatility33 %31 %
Dividend yield— %— %
Risk-free interest rate3.98 %1.85 %
Expected life5 years5 years
Summary of RSU and PSU activity The following table summarizes RSU and PSU activity for the nine months ended September 30, 2023:
  
PSU
Outstanding
Number of
Shares
 
PSU
Weighted
Average Grant Date
Fair Value
 
RSU
Outstanding
Number of
Shares
 
RSU
Weighted
Average Grant Date
Fair Value
Outstanding at December 31, 2022152,420 $192.29 582,612 $207.73 
Granted60,374 $232.51 306,780 $218.68 
Shares vested(47,026)$159.57 (178,781)$186.35 
Forfeited— $— (59,260)$211.45 
Outstanding at September 30, 2023165,768 $216.22 651,351 $218.41 
Schedule of non-cash stock compensation expense
Stock compensation expense for the three and nine months ended September 30, 2023 and September 30, 2022 has been allocated as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Direct costs$6,637 $6,285 $18,725 $17,117 
Selling, general and administrative$9,828 $11,232 $29,097 $38,586 
Total$16,465 $17,517 $47,822 $55,703 
XML 45 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segment and Geographical Information (Tables)
9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Schedule of Distribution of Revenue by Geographical Area The distribution of revenue by geographical area was as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Ireland $596,337 $526,867 $1,701,580 $1,395,198 
Rest of Europe384,720 397,538 1,172,752 1,281,996 
U.S.831,789 903,200 2,524,212 2,767,844 
Rest of World242,253 114,822 655,384 334,346 
Total$2,055,099 $1,942,427 $6,053,928 $5,779,384 
Schedule of Distribution of Income from Operations by Geographical Area The distribution of income from operations by geographical area was as follows:
Three Months EndedNine Months Ended
September 30, 2023September 30, 2022September 30, 2023September 30, 2022
(in thousands)(in thousands)
Ireland *$121,343 $93,640 $298,567 $159,059 
Rest of Europe56,705 76,178 138,959 194,860 
U.S.70,013 63,356 213,846 177,145 
Rest of World16,250 10,570 39,212 60,809 
Total$264,311 $243,744 $690,584 $591,873 
* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger.
Schedule of Distribution of Depreciation and Amortization by Geographical Area The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:
September 30, 2023December 31, 2022
(in thousands)
Ireland$172,016 $143,025 
Rest of Europe89,265 99,721 
U.S.165,597 213,311 
Rest of World47,703 48,095 
Total$474,581 $504,152 
XML 46 R40.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)
Sep. 30, 2023
Customer relationships  
Indefinite-Lived Intangible Assets [Line Items]  
Estimated Useful Life 23 years
Order backlog  
Indefinite-Lived Intangible Assets [Line Items]  
Estimated Useful Life 3 years
Trade names  
Indefinite-Lived Intangible Assets [Line Items]  
Estimated Useful Life 3 years
Patient database  
Indefinite-Lived Intangible Assets [Line Items]  
Estimated Useful Life 7 years
Technology assets  
Indefinite-Lived Intangible Assets [Line Items]  
Estimated Useful Life 5 years
XML 47 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Disaggregation of Revenue [Line Items]        
Revenue $ 2,055,099 $ 1,942,427 $ 6,053,928 $ 5,779,384
Clients 1-5        
Disaggregation of Revenue [Line Items]        
Revenue 527,345 539,907 1,615,713 1,595,007
Clients 6-10        
Disaggregation of Revenue [Line Items]        
Revenue 302,407 270,073 868,753 831,660
Clients 11-25        
Disaggregation of Revenue [Line Items]        
Revenue 448,428 405,171 1,267,750 1,100,118
Other        
Disaggregation of Revenue [Line Items]        
Revenue $ 776,919 $ 727,276 $ 2,301,712 $ 2,252,599
XML 48 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Accounts Receivables and Unbilled Revenue (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Contract Assets [Abstract]    
Billed services (accounts receivable) $ 1,883,296 $ 1,751,950
Unbilled services (unbilled revenue) 941,884 957,655
Accounts receivable and unbilled revenue, gross 2,825,180 2,709,605
Allowance for credit losses (32,934) (20,562)
Accounts receivable and unbilled revenue, net $ 2,792,246 $ 2,689,043
XML 49 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Unbilled Services and Unearned Revenue or Payments on Account (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]    
Unbilled services (unbilled revenue) $ 941,884 $ 957,655
Change in unbilled services (unbilled revenue) $ (15,771)  
Percentage change in unbilled services (unbilled revenue) (1.60%)  
Unearned revenue (payments on account) $ (1,663,183) (1,507,449)
Change in unearned revenue (payments on account) $ (155,734)  
Percentage change in unearned revenue (payments on account) 10.30%  
Net balance $ (721,299) $ (549,794)
Change in net balance $ 171,505  
Percentage change in net balance 31.20%  
XML 50 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Increase in unbilled services (unbilled revenue) $ (15,771)  
Decrease in unearned revenue (payments on account) 155,734  
Increase in net balance 171,505  
Revenue, remaining performance obligation $ 14,300,000 $ 13,500,000
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Revenue, remaining performance obligation percentage 51.00%  
Revenue, remaining performance obligation, expected timing of satisfaction, period 12 months  
XML 51 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill - Schedule of Goodwill (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Goodwill [Roll Forward]    
Opening balance $ 8,971,670 $ 9,037,931
Current period acquisition 13,379 0
Prior period acquisition 0 (35,692)
Foreign exchange movement (2,153) (30,569)
Closing balance $ 8,982,896 $ 8,971,670
XML 52 R46.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill - Narrative (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Apr. 20, 2023
Acquired Finite-Lived Intangible Assets [Line Items]        
Current period acquisition $ 13,379,000   $ 0  
Acquisition-related gain 6,160,000 $ 0    
Accumulated impairment loss 0   $ 0  
Oncacare        
Acquired Finite-Lived Intangible Assets [Line Items]        
Percentage of share capital acquired       51.00%
Current period acquisition $ 13,400,000      
XML 53 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Intangible assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Total cost $ 5,108,471 $ 5,109,212
Accumulated amortization (1,173,798) (830,553)
 Net book value 3,934,673 4,278,659
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Total cost 4,076,010 4,076,435
Order backlog    
Finite-Lived Intangible Assets [Line Items]    
Total cost 536,716 536,934
Trade names & brands    
Finite-Lived Intangible Assets [Line Items]    
Total cost 204,608 204,621
Patient database    
Finite-Lived Intangible Assets [Line Items]    
Total cost 170,262 170,238
Technology assets    
Finite-Lived Intangible Assets [Line Items]    
Total cost $ 120,875 $ 120,984
XML 54 R48.htm IDEA: XBRL DOCUMENT v3.23.3
Fair value measurements - Measurement of Fair Value of Major Asset and Liability classed (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available for sale securities (short-term) $ 1,954 $ 1,713
Available for sale investments (long-term) 41,790 32,631
Total assets 56,855 34,356
Total liabilities 0 3,670
Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative instruments 13,111 12
Derivative instruments 0 3,670
Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available for sale securities (short-term) 1,954 1,713
Available for sale investments (long-term) 0 0
Total assets 1,954 1,713
Total liabilities 0 0
Level 1 | Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative instruments 0 0
Derivative instruments 0 0
Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available for sale securities (short-term) 0 0
Available for sale investments (long-term) 0 0
Total assets 13,111 12
Total liabilities 0 3,670
Level 2 | Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative instruments 13,111 12
Derivative instruments 0 3,670
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available for sale securities (short-term) 0 0
Available for sale investments (long-term) 0 0
Total assets 0 0
Total liabilities 0 0
Level 3 | Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative instruments 0 0
Derivative instruments 0 0
Investments Measured at Net Asset Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available for sale securities (short-term) 0 0
Available for sale investments (long-term) 41,790 32,631
Total assets 41,790 32,631
Total liabilities 0 0
Investments Measured at Net Asset Value | Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative instruments 0 0
Derivative instruments $ 0 $ 0
XML 55 R49.htm IDEA: XBRL DOCUMENT v3.23.3
Fair value measurements - Narrative (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets $ 56,855 $ 34,356
Long-term debt at fair value 4,032,000  
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 0 $ 0
Level 3 | Fair value, nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 12,917,600  
Goodwill at fair value 8,982,900  
Net intangible assets at fair value $ 3,934,700  
XML 56 R50.htm IDEA: XBRL DOCUMENT v3.23.3
Restructuring - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]            
Restructuring $ 0 $ 6,197 $ 45,390 $ 32,890    
Other restructuring costs     11,300      
Opening provision 19,620   19,620   $ 6,022 $ 10,311
Personnel related liabilities            
Restructuring Cost and Reserve [Line Items]            
Opening provision 16,200   16,200      
Facility liability            
Restructuring Cost and Reserve [Line Items]            
Opening provision 3,400   3,400      
Other liability | Other liabilities            
Restructuring Cost and Reserve [Line Items]            
Opening provision 1,100   1,100      
Other liability | Non-current other liabilities            
Restructuring Cost and Reserve [Line Items]            
Opening provision $ 2,300   2,300      
2021 restructuring plan            
Restructuring Cost and Reserve [Line Items]            
Severance costs     $ 34,100      
XML 57 R51.htm IDEA: XBRL DOCUMENT v3.23.3
Restructuring - Summary of Restructuring Charges (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Restructuring and Related Activities [Abstract]        
Restructuring $ 0 $ 6,197 $ 45,390 $ 32,890
XML 58 R52.htm IDEA: XBRL DOCUMENT v3.23.3
Restructuring - Summary of Details of Movement in Restructuring Charges (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Restructuring and Related Activities [Abstract]    
Opening provision $ 19,620 $ 6,022
Additional provisions 36,704 4,364
Utilization (23,106) (8,653)
Ending provision $ 6,022 $ 10,311
XML 59 R53.htm IDEA: XBRL DOCUMENT v3.23.3
Operating leases - Schedule of Lease Costs (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Leases [Abstract]        
Operating lease costs $ 11,850 $ 12,164 $ 37,539 $ 40,976
Income from sub-leases (284) (268) (845) (898)
Net operating lease costs $ 11,566 $ 11,896 $ 36,694 $ 40,078
XML 60 R54.htm IDEA: XBRL DOCUMENT v3.23.3
Operating leases - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Lessee, Lease, Description [Line Items]        
Total lease cost $ 11,566 $ 11,896 $ 36,694 $ 40,078
Right-of-use assets obtained in exchange for lease obligations $ 2,100 $ 1,700 $ 24,600 $ 37,600
Weighted average remaining lease term 6 years 9 months   6 years 9 months  
Weighted average discount rate 3.15%   3.15%  
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other Liabilities Other Liabilities Other Liabilities Other Liabilities
Other liabilities        
Lessee, Lease, Description [Line Items]        
Operating lease liabilities $ 33,900 $ 42,200 $ 33,900 $ 42,200
Selling, general and administration costs        
Lessee, Lease, Description [Line Items]        
Total lease cost     28,100 38,100
Direct costs        
Lessee, Lease, Description [Line Items]        
Total lease cost     $ 8,600 $ 2,000
XML 61 R55.htm IDEA: XBRL DOCUMENT v3.23.3
Operating leases - Schedule of Operating Lease Maturity (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Leases [Abstract]  
Year 1 $ 38,084
Year 2 31,545
Year 3 26,709
Year 4 21,934
Year 5 15,039
Thereafter 35,884
Total future minimum lease payments 169,195
Lease imputed interest (13,883)
Total $ 155,312
XML 62 R56.htm IDEA: XBRL DOCUMENT v3.23.3
Bank credit lines and loan facilities - Schedule of Outstanding Debt (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Sep. 29, 2023
Apr. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Jul. 01, 2021
Debt Instrument [Line Items]            
Total debt $ 4,076,213       $ 4,701,213  
Less current portion of long-term debt (130,150)       (55,150)  
Total long-term debt 3,946,063       4,646,063  
Less debt issuance costs and debt discount (34,541)       (47,026)  
Total long-term debt, net $ 3,911,522       $ 4,599,037  
Senior Secured Term Loan | Senior Secured Term Loan            
Debt Instrument [Line Items]            
Debt instrument, interest rate 7.75%       7.09% 1.00%
Total debt $ 3,501,213       $ 4,201,213  
Senior Secured Notes | Senior Secured Notes            
Debt Instrument [Line Items]            
Debt instrument, interest rate 2.88%       2.88% 2.875%
Total debt $ 500,000       $ 500,000  
Senior Secured Revolving Loan Facility | Senior Secured Revolving Loan Facility | Senior Secured Revolving Loan Facility            
Debt Instrument [Line Items]            
Debt instrument, interest rate   6.68% 6.25% 6.17%    
Line of credit facility, interest rate at period end 6.68%          
Total debt $ 75,000       $ 0  
XML 63 R57.htm IDEA: XBRL DOCUMENT v3.23.3
Bank credit lines and loan facilities - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended
Sep. 29, 2023
Aug. 17, 2023
Jun. 30, 2023
Mar. 31, 2023
Apr. 30, 2023
Jan. 31, 2023
Sep. 30, 2023
Sep. 30, 2022
May 02, 2023
Jan. 13, 2023
Dec. 31, 2022
Jul. 01, 2021
Debt Instrument [Line Items]                        
Drawdown of bank credit lines and loan facilities             $ 305,000 $ 25,000        
Long-term debt at fair value             $ 4,032,000          
Senior secured credit facility and senior secured notes | Senior Secured Term Loan                        
Debt Instrument [Line Items]                        
Debt discount paid                       $ 27,600
Senior Secured Term Loan | Minimum                        
Debt Instrument [Line Items]                        
Basis spread on variable rate (in percent)     0.50%                  
Senior Secured Term Loan | SOFR                        
Debt Instrument [Line Items]                        
Basis spread on variable rate (in percent)     2.25%                  
Senior Secured Term Loan | Senior Secured Term Loan                        
Debt Instrument [Line Items]                        
Debt instrument, principal amount                       $ 5,515,000
Debt instrument, interest rate             7.75%       7.09% 1.00%
Repayments of senior debt $ 300,000   $ 150,000 $ 250,000                
Interest paid 74,500   74,000 75,300                
Payments of debt restructuring costs $ 2,500   1,200 $ 2,200                
Senior Secured Revolving Loan Facility | Base rate | Variable rate component one                        
Debt Instrument [Line Items]                        
Basis spread on variable rate (in percent)             0.60%          
Senior Secured Revolving Loan Facility | Base rate | Maximum | Variable rate component one                        
Debt Instrument [Line Items]                        
Basis spread on variable rate (in percent)             1.00%          
Senior Secured Revolving Loan Facility | Base rate | Minimum | Variable rate component one                        
Debt Instrument [Line Items]                        
Basis spread on variable rate (in percent)             0.25%          
Senior Secured Revolving Loan Facility | SOFR | Variable rate component two                        
Debt Instrument [Line Items]                        
Basis spread on variable rate (in percent)             1.60%          
Senior Secured Revolving Loan Facility | SOFR | Maximum | Variable rate component two                        
Debt Instrument [Line Items]                        
Basis spread on variable rate (in percent)             2.00%          
Senior Secured Revolving Loan Facility | SOFR | Minimum | Variable rate component two                        
Debt Instrument [Line Items]                        
Basis spread on variable rate (in percent)             1.25%          
Senior Secured Revolving Loan Facility | Senior Secured Revolving Loan Facility                        
Debt Instrument [Line Items]                        
Repayments of senior debt   $ 50,000 $ 80,000                  
Senior Secured Revolving Loan Facility | Senior Secured Revolving Loan Facility | Senior Secured Revolving Loan Facility                        
Debt Instrument [Line Items]                        
Debt instrument, maximum borrowing capacity                 $ 500,000     $ 300,000
Debt instrument, interest rate 6.68%     6.17% 6.25%              
Drawdown of bank credit lines and loan facilities $ 75,000     $ 80,000 $ 50,000 $ 100,000            
Senior Secured Revolving Loan Facility | Senior Secured Revolving Loan Facility | Senior Secured Revolving Loan Facility | Maximum                        
Debt Instrument [Line Items]                        
Debt instrument, interest rate           5.89%            
Senior Secured Revolving Loan Facility | Senior Secured Revolving Loan Facility | Senior Secured Revolving Loan Facility | Minimum                        
Debt Instrument [Line Items]                        
Debt instrument, interest rate                   5.80%    
Senior Secured Revolving Loan Facility | Senior Secured Revolving Loan Facility | Senior Secured Revolving Loan Facility | SOFR                        
Debt Instrument [Line Items]                        
Basis spread on variable rate (in percent) 1.25%     1.25% 1.25% 1.25%            
Senior Secured Notes | Senior Secured Notes                        
Debt Instrument [Line Items]                        
Debt instrument, principal amount                       $ 500,000
Debt instrument, interest rate             2.88%       2.88% 2.875%
XML 64 R58.htm IDEA: XBRL DOCUMENT v3.23.3
Bank credit lines and loan facilities - Schedule of Contractual Maturities of Debt (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Debt Disclosure [Abstract]    
2023 (remaining) $ 88,788  
2024 55,150  
2025 55,150  
2026 555,150  
2027 and thereafter 3,321,975  
Total debt $ 4,076,213 $ 4,701,213
XML 65 R59.htm IDEA: XBRL DOCUMENT v3.23.3
Derivatives - Narrative (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Nov. 29, 2022
USD ($)
instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]          
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other receivables   Other receivables    
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other liabilities   Other liabilities    
Interest rate cash flow hedge gain (loss) to be reclassified during next 12 months, net $ 2,300   $ 2,300    
Gain on cash flow hedge 4,986 $ 0 15,134 $ 0  
Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax 5,000 0 15,100 0  
Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax (300) $ 0 3,300 $ 0  
Interest Rate Caps | Total derivatives designated as hedging instruments          
Derivative Instruments and Hedging Activities Disclosures [Line Items]          
Number of interest rate derivatives held | instrument         2
Derivative, notional amount         $ 2,101,000
Derivative, fixed interest rate         0.42%
Interest Rate Caps | Total derivatives designated as hedging instruments | SOFR          
Derivative Instruments and Hedging Activities Disclosures [Line Items]          
Derivative, variable interest rate, reference rate in excess of         4.75%
Interest Rate Swap          
Derivative Instruments and Hedging Activities Disclosures [Line Items]          
Derivative, notional amount         $ 1,101,000
Derivative, fixed interest rate         3.40%
Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments | Level 2          
Derivative Instruments and Hedging Activities Disclosures [Line Items]          
Derivative asset, current 3,800   3,800    
Derivative liability, current 3,300   3,300    
Derivative asset, noncurrent 9,300   9,300    
Derivative liability, noncurrent 400   400    
Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments | Level 2 | Other receivables          
Derivative Instruments and Hedging Activities Disclosures [Line Items]          
Derivative asset, current $ 10   $ 10    
XML 66 R60.htm IDEA: XBRL DOCUMENT v3.23.3
Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details) - Total derivatives designated as hedging instruments - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Interest Rate Caps    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Derivative assets $ 4,262,000 $ 12,000
Derivative liability 0 3,363,000
Notional 1,750,606,000 2,100,606,000
Interest Rate Swap    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Derivative assets 8,849,000 0
Derivative liability 0 307,000
Notional 1,100,606,000 1,100,606,000
Interest rate cap and interest rate swap    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Derivative assets 13,111,000 12,000
Derivative liability 0 3,670,000
Notional 2,851,212,000 3,201,212,000
Interest rate cap and interest rate swap | Level 2    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Derivative assets 13,111,000 12,000
Derivative liability $ 0 $ 3,670,000
XML 67 R61.htm IDEA: XBRL DOCUMENT v3.23.3
Income taxes - Components of Tax (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Tax Disclosure [Abstract]        
Provision for income taxes $ 18,011 $ 21,012 $ 41,913 $ 48,552
XML 68 R62.htm IDEA: XBRL DOCUMENT v3.23.3
Income taxes - Narrative (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Liability for unrecognized tax benefit $ 251.1 $ 240.2
Items generating unrecognized tax benefits 221.1 217.6
Interest and related penalties $ 30.0 $ 22.6
XML 69 R63.htm IDEA: XBRL DOCUMENT v3.23.3
Net income per ordinary share - Schedule of Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Earnings Per Share [Abstract]        
Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares) 82,215,627 81,582,375 82,001,500 81,481,686
Effect of dilutive share options and other awards outstanding under share based compensation programs (in shares) 757,261 910,836 735,573 991,835
Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares) 82,972,888 82,493,211 82,737,073 82,473,521
XML 70 R64.htm IDEA: XBRL DOCUMENT v3.23.3
Net income per ordinary share - Schedule of Reconciliation of Net Income Attributable to the Group (Details) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Net income per Ordinary Share attributable to the Group:        
Basic (in USD per share) $ 1.99 $ 1.96 $ 4.83 $ 4.76
Diluted (in USD per share) $ 1.97 $ 1.94 $ 4.79 $ 4.70
XML 71 R65.htm IDEA: XBRL DOCUMENT v3.23.3
Share-based awards - Summary of Stock Option Activity (Details) - Employee Stock Option
9 Months Ended
Sep. 30, 2023
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Sep. 30, 2023
$ / shares
shares
Options Outstanding Number of Shares       
Outstanding at beginning of period (in shares) | shares     1,378,119
Granted (in shares) | shares     82,472
Exercised (in shares) | shares     (377,614)
Canceled/expired (in shares) | shares     (6,885)
Outstanding at end of period (in shares) | shares 1,076,092 1,378,119 1,076,092
Exercisable at end of period (in shares) | shares 804,953   804,953
Weighted Average Exercise Price      
Outstanding at beginning of period (in USD per share) | $ / shares     $ 119.86
Granted (in USD per share) | $ / shares     232.48
Exercised (in USD per share) | $ / shares     96.67
Canceled/expired (in USD per share) | $ / shares     116.33
Outstanding at end of period (in USD per share) | $ / shares $ 136.65 $ 119.86 136.65
Exercisable at end of period (in USD per share) | $ / shares $ 113.75   $ 113.75
Weighted Average Remaining Contractual Life      
Weighted average contractual term of options outstanding 4 years 5 months 12 days 4 years 8 months 8 days  
Weighted average contractual term of options exercisable 3 years 10 months 28 days    
XML 72 R66.htm IDEA: XBRL DOCUMENT v3.23.3
Share-based awards - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
9 Months Ended 12 Months Ended 53 Months Ended
Sep. 30, 2023
May 11, 2015
Sep. 30, 2023
Dec. 31, 2022
Sep. 30, 2023
May 16, 2019
Employee Stock Option            
Compensation Related Costs Share Based Payments Disclosure [Line Items]            
Number of shares exercisable (in shares) 804,953   804,953   804,953  
Weighted average contractual term of options exercisable 3 years 10 months 28 days          
Weighted average exercise price of options exercisble (USD per share) $ 113.75   $ 113.75   $ 113.75  
Restricted stock units 2013            
Compensation Related Costs Share Based Payments Disclosure [Line Items]            
Ordinary shares which have been reserved for issuance (in shares)   2,500,000        
Ordinary shares which have been reserved for issuance (in shares)   4,100,000        
Consultants Restricted Stock Units 2019            
Compensation Related Costs Share Based Payments Disclosure [Line Items]            
Ordinary shares which have been reserved for issuance (in shares)           250,000
Consultants Restricted Stock Units 2019 | Non-executive directors            
Compensation Related Costs Share Based Payments Disclosure [Line Items]            
Shares vesting period         12 months  
Performance Share Unit (PSUs)            
Compensation Related Costs Share Based Payments Disclosure [Line Items]            
Fair value of stock units vested     $ 7.5 $ 6.5    
Restricted Stock Units (RSUs)            
Compensation Related Costs Share Based Payments Disclosure [Line Items]            
Fair value of stock units vested     $ 33.3 $ 34.1    
PSUs based on service and EPS targets | Maximum            
Compensation Related Costs Share Based Payments Disclosure [Line Items]            
Stock units to be granted (in shares) 82,884   82,884   82,884  
XML 73 R67.htm IDEA: XBRL DOCUMENT v3.23.3
Share-based awards - Schedule of Weighted Average Fair Values and Assumptions Used (Details) - Employee Stock Option - $ / shares
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Weighted average grant date fair value $ 85.12 $ 68.40
Assumptions:    
Expected volatility 33.00% 31.00%
Dividend yield 0.00% 0.00%
Risk-free interest rate 3.98% 1.85%
Expected life 5 years 5 years
XML 74 R68.htm IDEA: XBRL DOCUMENT v3.23.3
Share-based awards - Summary of RSU and PSU Activity (Details)
9 Months Ended
Sep. 30, 2023
$ / shares
shares
Performance Share Unit (PSUs)  
Outstanding Number of Shares  
Outstanding at beginning of period (in shares) | shares 152,420
Granted (in shares) | shares 60,374
Shares vested (in shares) | shares (47,026)
Forfeited (in shares) | shares 0
Outstanding at end of period (in shares) | shares 165,768
Weighted Average Grant Date Fair Value  
Outstanding at beginning of period (in USD per share) | $ / shares $ 192.29
Granted (in USD per share) | $ / shares 232.51
Shares vested (in USD per share) | $ / shares 159.57
Forfeited (in USD per share) | $ / shares 0
Outstanding at end of period (in USD per share) | $ / shares $ 216.22
Restricted Stock Units (RSUs)  
Outstanding Number of Shares  
Outstanding at beginning of period (in shares) | shares 582,612
Granted (in shares) | shares 306,780
Shares vested (in shares) | shares (178,781)
Forfeited (in shares) | shares (59,260)
Outstanding at end of period (in shares) | shares 651,351
Weighted Average Grant Date Fair Value  
Outstanding at beginning of period (in USD per share) | $ / shares $ 207.73
Granted (in USD per share) | $ / shares 218.68
Shares vested (in USD per share) | $ / shares 186.35
Forfeited (in USD per share) | $ / shares 211.45
Outstanding at end of period (in USD per share) | $ / shares $ 218.41
XML 75 R69.htm IDEA: XBRL DOCUMENT v3.23.3
Share-based awards - Schedule of Non-cash Stock Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total $ 16,465 $ 17,517 $ 47,822 $ 55,703
Direct costs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total 6,637 6,285 18,725 17,117
Selling, general and administrative        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total $ 9,828 $ 11,232 $ 29,097 $ 38,586
XML 76 R70.htm IDEA: XBRL DOCUMENT v3.23.3
Share capital (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2022
Sep. 30, 2023
Equity, Class of Treasury Stock [Line Items]      
Share repurchase program, value of shares repurchased   $ 99,983  
Buyback Program      
Equity, Class of Treasury Stock [Line Items]      
Share repurchase program, number of shares repurchased (in shares) 420,530    
Share repurchase program, value of shares repurchased $ 100,000    
Buyback Program | Maximum      
Equity, Class of Treasury Stock [Line Items]      
Share repurchase program, authorized percentage     10.00%
XML 77 R71.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segment and Geographical Information - Narrative (Details)
9 Months Ended
Sep. 30, 2023
segment
Segment Reporting [Abstract]  
Number of operating segments 1
XML 78 R72.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segment and Geographical Information - Schedule of Distribution of Revenue by Geographical Area (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]        
Revenue $ 2,055,099 $ 1,942,427 $ 6,053,928 $ 5,779,384
Ireland        
Segment Reporting Information [Line Items]        
Revenue 596,337 526,867 1,701,580 1,395,198
Rest of Europe        
Segment Reporting Information [Line Items]        
Revenue 384,720 397,538 1,172,752 1,281,996
U.S.        
Segment Reporting Information [Line Items]        
Revenue 831,789 903,200 2,524,212 2,767,844
Rest of World        
Segment Reporting Information [Line Items]        
Revenue $ 242,253 $ 114,822 $ 655,384 $ 334,346
XML 79 R73.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segment and Geographical Information - Schedule of Distribution of Income from Operations by Geographical Area (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]        
Income from operations $ 264,311 $ 243,744 $ 690,584 $ 591,873
Ireland        
Segment Reporting Information [Line Items]        
Income from operations 121,343 93,640 298,567 159,059
Rest of Europe        
Segment Reporting Information [Line Items]        
Income from operations 56,705 76,178 138,959 194,860
U.S.        
Segment Reporting Information [Line Items]        
Income from operations 70,013 63,356 213,846 177,145
Rest of World        
Segment Reporting Information [Line Items]        
Income from operations $ 16,250 $ 10,570 $ 39,212 $ 60,809
XML 80 R74.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segment and Geographical Information - Schedule of Distribution of Depreciation and Amortization by Geographical Area (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]    
Long-lived assets $ 474,581 $ 504,152
Ireland    
Segment Reporting Information [Line Items]    
Long-lived assets 172,016 143,025
Rest of Europe    
Segment Reporting Information [Line Items]    
Long-lived assets 89,265 99,721
U.S.    
Segment Reporting Information [Line Items]    
Long-lived assets 165,597 213,311
Rest of World    
Segment Reporting Information [Line Items]    
Long-lived assets $ 47,703 $ 48,095
XML 81 R75.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent events - Narrative (Details) - Philips Pharma Solutions (formerly BioTel Research, LLC) - Subsequent event
$ in Millions
Oct. 02, 2023
USD ($)
Business Acquisition [Line Items]  
Percentage of share capital acquired 100.00%
Business combination, consideration transferred $ 68.1
XML 82 iclr-20230930_htm.xml IDEA: XBRL DOCUMENT 0001060955 2023-01-01 2023-09-30 0001060955 2023-09-30 0001060955 2022-12-31 0001060955 us-gaap:FairValueInputsLevel1Member 2023-09-30 0001060955 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001060955 2023-07-01 2023-09-30 0001060955 2022-07-01 2022-09-30 0001060955 2022-01-01 2022-09-30 0001060955 us-gaap:CommonStockMember 2022-12-31 0001060955 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001060955 iclr:OtherUndenominatedCapitalMember 2022-12-31 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001060955 us-gaap:RetainedEarningsMember 2022-12-31 0001060955 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001060955 2023-01-01 2023-03-31 0001060955 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001060955 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001060955 us-gaap:CommonStockMember 2023-03-31 0001060955 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001060955 iclr:OtherUndenominatedCapitalMember 2023-03-31 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001060955 us-gaap:RetainedEarningsMember 2023-03-31 0001060955 2023-03-31 0001060955 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001060955 2023-04-01 2023-06-30 0001060955 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001060955 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001060955 us-gaap:CommonStockMember 2023-06-30 0001060955 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001060955 iclr:OtherUndenominatedCapitalMember 2023-06-30 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001060955 us-gaap:RetainedEarningsMember 2023-06-30 0001060955 2023-06-30 0001060955 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001060955 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001060955 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001060955 us-gaap:CommonStockMember 2023-09-30 0001060955 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001060955 iclr:OtherUndenominatedCapitalMember 2023-09-30 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001060955 us-gaap:RetainedEarningsMember 2023-09-30 0001060955 us-gaap:CommonStockMember 2021-12-31 0001060955 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001060955 iclr:OtherUndenominatedCapitalMember 2021-12-31 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001060955 us-gaap:RetainedEarningsMember 2021-12-31 0001060955 2021-12-31 0001060955 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001060955 2022-01-01 2022-03-31 0001060955 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001060955 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001060955 iclr:OtherUndenominatedCapitalMember 2022-01-01 2022-03-31 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001060955 us-gaap:CommonStockMember 2022-03-31 0001060955 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001060955 iclr:OtherUndenominatedCapitalMember 2022-03-31 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001060955 us-gaap:RetainedEarningsMember 2022-03-31 0001060955 2022-03-31 0001060955 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001060955 2022-04-01 2022-06-30 0001060955 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001060955 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001060955 us-gaap:CommonStockMember 2022-06-30 0001060955 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001060955 iclr:OtherUndenominatedCapitalMember 2022-06-30 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001060955 us-gaap:RetainedEarningsMember 2022-06-30 0001060955 2022-06-30 0001060955 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001060955 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001060955 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001060955 us-gaap:CommonStockMember 2022-09-30 0001060955 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001060955 iclr:OtherUndenominatedCapitalMember 2022-09-30 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001060955 us-gaap:RetainedEarningsMember 2022-09-30 0001060955 2022-09-30 0001060955 us-gaap:CustomerRelationshipsMember 2023-09-30 0001060955 us-gaap:OrderOrProductionBacklogMember 2023-09-30 0001060955 us-gaap:TradeNamesMember 2023-09-30 0001060955 us-gaap:DatabasesMember 2023-09-30 0001060955 us-gaap:TechnologyBasedIntangibleAssetsMember 2023-09-30 0001060955 iclr:Clients15Member 2023-07-01 2023-09-30 0001060955 iclr:Clients15Member 2022-07-01 2022-09-30 0001060955 iclr:Clients15Member 2023-01-01 2023-09-30 0001060955 iclr:Clients15Member 2022-01-01 2022-09-30 0001060955 iclr:Clients610Member 2023-07-01 2023-09-30 0001060955 iclr:Clients610Member 2022-07-01 2022-09-30 0001060955 iclr:Clients610Member 2023-01-01 2023-09-30 0001060955 iclr:Clients610Member 2022-01-01 2022-09-30 0001060955 iclr:Clients1125Member 2023-07-01 2023-09-30 0001060955 iclr:Clients1125Member 2022-07-01 2022-09-30 0001060955 iclr:Clients1125Member 2023-01-01 2023-09-30 0001060955 iclr:Clients1125Member 2022-01-01 2022-09-30 0001060955 iclr:OtherCustomersMember 2023-07-01 2023-09-30 0001060955 iclr:OtherCustomersMember 2022-07-01 2022-09-30 0001060955 iclr:OtherCustomersMember 2023-01-01 2023-09-30 0001060955 iclr:OtherCustomersMember 2022-01-01 2022-09-30 0001060955 2023-10-01 2023-09-30 0001060955 2022-01-01 2022-12-31 0001060955 iclr:OncacareMember 2023-04-20 0001060955 iclr:OncacareMember 2023-01-01 2023-09-30 0001060955 us-gaap:CustomerRelationshipsMember 2022-12-31 0001060955 us-gaap:OrderOrProductionBacklogMember 2022-12-31 0001060955 us-gaap:TradeNamesMember 2022-12-31 0001060955 us-gaap:DatabasesMember 2022-12-31 0001060955 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-12-31 0001060955 us-gaap:FairValueInputsLevel2Member 2023-09-30 0001060955 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001060955 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2023-09-30 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:FairValueInputsLevel1Member us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:FairValueInputsLevel3Member us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001060955 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001060955 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001060955 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2022-12-31 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:FairValueInputsLevel1Member us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:FairValueInputsLevel3Member us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2023-09-30 0001060955 iclr:A2021RestructuringPlanMember 2023-01-01 2023-09-30 0001060955 iclr:PersonnelRelatedLiabilitiesMember 2023-09-30 0001060955 iclr:FacilityLiabilityMember 2023-09-30 0001060955 us-gaap:OtherCurrentLiabilitiesMember iclr:OtherLiabilityMember 2023-09-30 0001060955 us-gaap:OtherNoncurrentLiabilitiesMember iclr:OtherLiabilityMember 2023-09-30 0001060955 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-09-30 0001060955 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-09-30 0001060955 us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001060955 us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0001060955 us-gaap:OtherCurrentLiabilitiesMember 2023-09-30 0001060955 us-gaap:OtherCurrentLiabilitiesMember 2022-09-30 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2023-09-30 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2022-12-31 0001060955 iclr:SeniorSecuredNotesMember us-gaap:SeniorSubordinatedNotesMember 2023-09-30 0001060955 iclr:SeniorSecuredNotesMember us-gaap:SeniorSubordinatedNotesMember 2022-12-31 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2023-09-30 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2022-12-31 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2021-07-01 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2021-07-01 0001060955 iclr:SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember us-gaap:SecuredDebtMember 2021-07-01 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2023-05-02 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-06-30 2023-06-30 0001060955 srt:MinimumMember iclr:TermLoanFacilityMember 2023-06-30 2023-06-30 0001060955 srt:MaximumMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:BaseRateMember iclr:VariableRateComponentOneMember 2023-01-01 2023-09-30 0001060955 iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:BaseRateMember iclr:VariableRateComponentOneMember 2023-01-01 2023-09-30 0001060955 srt:MinimumMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:BaseRateMember iclr:VariableRateComponentOneMember 2023-01-01 2023-09-30 0001060955 srt:MaximumMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember iclr:VariableRateComponentTwoMember 2023-01-01 2023-09-30 0001060955 iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember iclr:VariableRateComponentTwoMember 2023-01-01 2023-09-30 0001060955 srt:MinimumMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember iclr:VariableRateComponentTwoMember 2023-01-01 2023-09-30 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2023-01-01 2023-01-31 0001060955 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2023-01-31 0001060955 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2023-01-13 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-01-01 2023-01-31 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2023-03-31 2023-03-31 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2023-03-31 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-31 2023-03-31 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2023-04-01 2023-04-30 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2023-04-30 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-04-01 2023-04-30 0001060955 iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2023-06-30 2023-06-30 0001060955 iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2023-08-17 2023-08-17 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2023-09-29 2023-09-29 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2023-09-29 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-09-29 2023-09-29 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2023-03-31 2023-03-31 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2023-06-30 2023-06-30 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2023-09-29 2023-09-29 0001060955 iclr:SeniorSecuredNotesMember us-gaap:SeniorSubordinatedNotesMember 2021-07-01 0001060955 us-gaap:InterestRateCapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-11-29 0001060955 us-gaap:InterestRateCapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-11-29 0001060955 us-gaap:InterestRateSwapMember 2022-11-29 0001060955 us-gaap:InterestRateCapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001060955 us-gaap:InterestRateCapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001060955 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 iclr:OtherReceivablesMember iclr:InterestRateCapAndInterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001060955 us-gaap:EmployeeStockOptionMember 2022-12-31 0001060955 us-gaap:EmployeeStockOptionMember 2022-12-31 2022-12-31 0001060955 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001060955 us-gaap:EmployeeStockOptionMember 2023-09-30 0001060955 us-gaap:EmployeeStockOptionMember 2023-09-30 2023-09-30 0001060955 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001060955 iclr:RestrictedStockUnitsTwentyThirteenMember 2015-05-11 2015-05-11 0001060955 iclr:RestrictedStockUnitsTwentyThirteenMember 2015-05-11 0001060955 iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember 2019-05-16 0001060955 iclr:NonExecutiveDirectorMember iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember 2019-05-16 2023-09-30 0001060955 iclr:PerformanceShareUnitMember 2022-12-31 0001060955 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001060955 iclr:PerformanceShareUnitMember 2023-01-01 2023-09-30 0001060955 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001060955 iclr:PerformanceShareUnitMember 2023-09-30 0001060955 us-gaap:RestrictedStockUnitsRSUMember 2023-09-30 0001060955 iclr:PerformanceShareUnitMember 2022-01-01 2022-12-31 0001060955 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001060955 srt:MaximumMember iclr:PerformanceBasedGrantsMember 2023-09-30 0001060955 us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001060955 us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0001060955 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2023-09-30 0001060955 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-01 2022-09-30 0001060955 srt:MaximumMember iclr:BuybackProgramMember 2023-01-01 2023-09-30 0001060955 iclr:BuybackProgramMember 2022-02-18 2022-03-31 0001060955 country:IE 2023-07-01 2023-09-30 0001060955 country:IE 2022-07-01 2022-09-30 0001060955 country:IE 2023-01-01 2023-09-30 0001060955 country:IE 2022-01-01 2022-09-30 0001060955 iclr:RestOfEuropeMember 2023-07-01 2023-09-30 0001060955 iclr:RestOfEuropeMember 2022-07-01 2022-09-30 0001060955 iclr:RestOfEuropeMember 2023-01-01 2023-09-30 0001060955 iclr:RestOfEuropeMember 2022-01-01 2022-09-30 0001060955 country:US 2023-07-01 2023-09-30 0001060955 country:US 2022-07-01 2022-09-30 0001060955 country:US 2023-01-01 2023-09-30 0001060955 country:US 2022-01-01 2022-09-30 0001060955 iclr:RestOfWorldMember 2023-07-01 2023-09-30 0001060955 iclr:RestOfWorldMember 2022-07-01 2022-09-30 0001060955 iclr:RestOfWorldMember 2023-01-01 2023-09-30 0001060955 iclr:RestOfWorldMember 2022-01-01 2022-09-30 0001060955 country:IE 2023-09-30 0001060955 country:IE 2022-12-31 0001060955 iclr:RestOfEuropeMember 2023-09-30 0001060955 iclr:RestOfEuropeMember 2022-12-31 0001060955 country:US 2023-09-30 0001060955 country:US 2022-12-31 0001060955 iclr:RestOfWorldMember 2023-09-30 0001060955 iclr:RestOfWorldMember 2022-12-31 0001060955 iclr:PhilipsPharmaSolutionsFormerlyBioTelResearchLLCMember us-gaap:SubsequentEventMember 2023-10-02 0001060955 iclr:PhilipsPharmaSolutionsFormerlyBioTelResearchLLCMember us-gaap:SubsequentEventMember 2023-10-02 2023-10-02 iso4217:USD iso4217:EUR shares shares iso4217:USD shares pure iclr:instrument iclr:segment false Q3 0001060955 --12-31 2023-09-30 http://fasb.org/us-gaap/2023#OtherLiabilities http://fasb.org/us-gaap/2023#OtherLiabilities http://fasb.org/us-gaap/2023#NontradeReceivablesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent 6-K 2023 ICON plc 313065000 288768000 1954000 1713000 1850362000 1731388000 941884000 957655000 121687000 63658000 150193000 137094000 42039000 48790000 3421184000 3229066000 342262000 350320000 8982896000 8971670000 3934673000 4278659000 132319000 153832000 52797000 70790000 40481000 21380000 83095000 76930000 41790000 32631000 17031497000 17185278000 87317000 81194000 1663183000 1507449000 948829000 1005025000 41518000 41783000 130150000 55150000 2870997000 2690601000 3911522000 4599037000 121424000 131644000 41661000 38260000 242972000 239188000 883887000 988585000 0 0 8072463000 8687315000 0.06 0.06 100000000 100000000 82326976 82326976 81723555 81723555 6688000 6649000 6924073000 6840306000 1162000 1162000 -190190000 -171538000 2217301000 1821384000 8959034000 8497963000 17031497000 17185278000 2055099000 1942427000 6053928000 5779384000 1449136000 1375837000 4274222000 4146366000 185187000 166787000 572999000 552000000 146032000 141861000 436217000 427285000 10433000 8001000 34516000 28970000 0 6197000 45390000 32890000 1790788000 1698683000 5363344000 5187511000 264311000 243744000 690584000 591873000 1273000 1434000 3294000 1727000 83908000 63010000 255665000 154546000 181676000 182168000 438213000 439054000 18011000 21012000 41913000 48552000 163665000 161156000 396300000 390502000 0 -1002000 -383000 -2643000 163665000 160154000 395917000 387859000 1.99 1.96 4.83 4.76 1.97 1.94 4.79 4.70 82215627 81582375 82001500 82001500 81481686 81481686 82972888 82493211 82737073 82737073 82473521 82473521 163665000 160154000 395917000 387859000 -38648000 -98966000 -33786000 -200964000 4986000 0 15134000 0 130003000 61188000 377265000 186895000 81723555 6649000 6840306000 1162000 -171538000 1821384000 8497963000 116654000 116654000 136649 9000 12927000 12936000 68218 4000 4000 14658000 14658000 4000 4000 11642000 11642000 81928422 6662000 6867887000 1162000 -159896000 1938038000 8653853000 115598000 115598000 93304 6000 7223000 7229000 129323 8000 8000 16389000 16389000 5000 5000 3368000 3368000 82151049 6676000 6891494000 1162000 -156528000 2053636000 8796440000 163665000 163665000 147661 9000 16328000 16337000 28266 3000 3000 16256000 16256000 5000 5000 -33662000 -33662000 82326976 6688000 6924073000 1162000 -190190000 2217301000 8959034000 81554683 6640000 6733910000 1134000 -90937000 1416080000 8066827000 111970000 111970000 84090 6000 7491000 7497000 74769 4000 4000 18840000 18840000 3000 3000 420530 28000 -28000 99983000 99983000 17000 17000 -35818000 -35818000 81293012 6622000 6760238000 1162000 -126755000 1428050000 8069317000 115734000 115734000 75671 4000 7649000 7653000 157924 11000 11000 19478000 19478000 -66180000 -66180000 81526607 6637000 6787365000 1162000 -192935000 1543784000 8146013000 160154000 160154000 117140 4000 13827000 13831000 1532 4000 4000 17686000 17686000 1000 1000 -98966000 -98966000 81645279 6645000 6818877000 1162000 -291901000 1703938000 8238721000 395917000 387859000 436217000 427285000 8845000 27727000 33979000 35238000 -383000 -2643000 6160000 0 3335000 0 12485000 13544000 47303000 55703000 -114487000 -126620000 7670000 52334000 -21966000 -18595000 139096000 140760000 -14370000 221104000 158269000 28352000 144760000 -166613000 720896000 622741000 87980000 85145000 5100000 0 1611000 0 1852000 0 10829000 1840000 -104150000 -86985000 305000000 25000000 930000000 625000000 36517000 28967000 14000 3000 0 99983000 0 17000 -588497000 -671036000 -3952000 -7775000 24297000 -143055000 288768000 752213000 313065000 609158000 Basis of presentation<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These condensed consolidated financial statements which have been prepared in accordance with United States Generally Accepted Accounting Principles (“US GAAP”) have not been audited. The condensed consolidated financial statements reflect all adjustments, which are, in the opinion of management, necessary to present a fair statement of the operating results and financial position for the periods presented. The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures in the condensed consolidated financial statements. Actual results could differ from those estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The condensed consolidated financial statements should be read in conjunction with the accounting policies and notes to the consolidated financial statements included in ICON’s Form 20-F for the year ended December 31, 2022 (see</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 2 - Summary of significant accounting policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">). Operating results for the nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal period ending December 31, 2023.</span></div> Summary of significant accounting policies<div style="margin-top:15pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:15pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the “units delivered” output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div><div style="margin-top:15pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:15pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:15pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives. The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (“global intangible low-taxed income”) in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div> <div style="margin-top:15pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:15pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the “units delivered” output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div> <div style="margin-top:15pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:15pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div>The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. <div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:15pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives. The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets, net consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,010 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,435 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">536,716 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">536,934 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,608 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,621 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,238 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,984 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,108,471 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,109,212 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,173,798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(830,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Net book value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,934,673 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,278,659 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> P23Y P3Y P3Y P7Y P5Y <div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (“global intangible low-taxed income”) in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div> Revenue<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer concentration is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 1-5</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">527,345 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539,907 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,615,713 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,595,007 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302,407 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,073 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">868,753 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">831,660 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">448,428 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,267,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100,118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">776,919 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">727,276 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,301,712 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,252,599 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,055,099 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,942,427 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,053,928 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,779,384 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There was no revenue from individual customers greater than 10% of consolidated revenue in the respective periods.</span></div>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivables and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,883,296 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,751,950 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">941,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,825,180 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,709,605 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,934)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,562)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,792,246 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,689,043 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:39.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.147%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">941,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,771)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,663,183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,507,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(155,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(721,299)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(549,794)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171,505)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled services and therefore contract assets rather than accounts receivables when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right to set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Condensed Consolidated Balance Sheet. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at September 30, 2023 decreased by $15.8 million compared to December 31, 2022. Unearned revenue increased by $155.7 million over the same period resulting in an increase of $171.5 million in the net balance of unbilled services and unearned revenue or payments on account between December 31, 2022 and September 30, 2023. These fluctuations are primarily due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer.</span></div>As of September 30, 2023 approximately $14.3 billion (September 30, 2022: $13.5 billion) of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations. The Company expects to recognize revenue on approximately 51% of the unsatisfied performance obligations over the next 12 months, with the remainder recognized thereafter over the duration of the customer contracts. <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer concentration is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 1-5</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">527,345 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539,907 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,615,713 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,595,007 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302,407 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,073 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">868,753 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">831,660 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">448,428 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,267,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100,118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">776,919 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">727,276 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,301,712 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,252,599 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,055,099 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,942,427 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,053,928 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,779,384 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There was no revenue from individual customers greater than 10% of consolidated revenue in the respective periods.</span></div> 527345000 539907000 1615713000 1595007000 302407000 270073000 868753000 831660000 448428000 405171000 1267750000 1100118000 776919000 727276000 2301712000 2252599000 2055099000 1942427000 6053928000 5779384000 <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivables and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,883,296 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,751,950 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">941,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,825,180 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,709,605 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,934)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,562)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,792,246 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,689,043 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:39.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.147%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">941,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,771)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,663,183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,507,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(155,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(721,299)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(549,794)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171,505)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 1883296000 1751950000 941884000 957655000 2825180000 2709605000 32934000 20562000 2792246000 2689043000 941884000 957655000 -15771000 -0.016 1663183000 1507449000 155734000 0.103 -721299000 -549794000 171505000 0.312 -15800000 155700000 171500000 14300000000 13500000000 0.51 P12M Goodwill<div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current period acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior period acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,153)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,569)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,982,896 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 20, 2023, the Company completed the purchase of the majority investor's 51% majority voting share capital of Oncacare Limited ("Oncacare"), such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group. The Oncacare acquisition resulted in goodwill of $13.4 million and also gave rise to an acquisition-related gain of $6.2 million.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no impairment charges for the nine months ended September 30, 2023 or for the year ended December 31, 2022.</span></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current period acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior period acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,153)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,569)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,982,896 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 8971670000 9037931000 13379000 0 0 -35692000 -2153000 -30569000 8982896000 8971670000 0.51 13400000 6200000 0 0 Intangible assets<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets, net consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,010 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,435 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">536,716 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">536,934 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,608 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,621 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,238 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,984 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,108,471 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,109,212 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,173,798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(830,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Net book value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,934,673 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,278,659 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The identifiable intangible assets are amortized over their estimated useful lives. 4076010000 4076435000 536716000 536934000 204608000 204621000 170262000 170238000 120875000 120984000 5108471000 5109212000 1173798000 830553000 3934673000 4278659000 Fair value measurements <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1 — Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3 — Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, unbilled services, contract assets, accounts payable and unearned revenue approximate fair value due to the short maturities of these instruments.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,790 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,790 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">13,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,111 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,790 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,855 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,356 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds meet the definition of equity securities without readily determinable fair values, which qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) Represents the fair value of interest rate cap and interest rate swap agreements. The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-recurring Fair Value Measurements </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain assets and liabilities are carried on the accompanying Condensed Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of September 30, 2023, assets carried on the balance sheet at cost and not re-measured to fair value on a recurring basis totaled approximatel</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">y $12,917.6 million and are identified as Level 3 assets. These assets are comprised of goodwill of $8,982.9 million and net identifiable intangible assets of $3,934.7 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair value of the Company’s debt wa</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s $4,032.0 million at </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">September 30, 2023. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility is recorded as its carrying value, due to the short term duration.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,790 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,790 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">13,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,111 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,790 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,855 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,356 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds meet the definition of equity securities without readily determinable fair values, which qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.</span></div>(c) Represents the fair value of interest rate cap and interest rate swap agreements. The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,790 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,790 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">13,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,111 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,790 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,855 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,356 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds meet the definition of equity securities without readily determinable fair values, which qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.</span></div>(c) Represents the fair value of interest rate cap and interest rate swap agreements. The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. 1954000 0 0 0 1954000 0 0 0 41790000 41790000 0 13111000 0 0 13111000 1954000 13111000 0 41790000 56855000 0 0 0 0 0 0 0 0 0 0 1713000 0 0 0 1713000 0 0 0 32631000 32631000 0 12000 0 0 12000 1713000 12000 0 32631000 34356000 0 3670000 0 0 3670000 0 3670000 0 0 3670000 12917600000 8982900000 3934700000 4032000000 Restructuring<div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the nine months ended September 30, 2023, a restructuring charge of $45.4 million was recorded in the Condensed Consolidated Statement of Operations under a restructuring plan adopted following a review of operations. The restructuring plan reflected a workforce reduction of $34.1 million and an office consolidation program to optimize the Company's office footprint of $11.3 million. </span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net charge</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,890 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At September 30, 2023, a total liability of $19.6 million was recorded on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $16.2 million of personnel related liabilities as a result of the workforce reduction; all of which have been classified as short-term. The total liability also included $3.4 million of facilities related liabilities of which $1.1 million is included within other liabilities and $2.3 million is included within non-current other liabilities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,704 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,620 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div> 45400000 34100000 11300000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net charge</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,890 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table> 45390000 32890000 45390000 32890000 19600000 16200000 3400000 1100000 2300000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,704 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,620 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table> 6022000 10311000 36704000 4364000 23106000 8653000 19620000 6022000 Operating leases<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lease costs recorded under operating leases for the three and nine months ended September 30, 2023 and September 30, 2022 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,164 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,539 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(898)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,566 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,896 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,694 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,078 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Of the total cost of $36.7 million incurred in the nine months ended September 30, 2023 (September 30, 2022: $40.1 million), $28.1 million (September 30, 2022: $38.1 million) is recorded within selling, general and administration costs and $8.6 million (September 30, 2022: $2.0 million) is recorded within direct costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2023 and September 30, 2022, costs incurred by the Group related to variable lease payments was de minimis. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Right-of-use assets obtained, in exchange for lease obligations during the three months ended September 30, 2023, totaled $2.1 million (September 30, 2022: $1.7 million). Right-of-use assets obtained, in exchange for lease obligations during the nine months ended September 30, 2023, totaled $24.6 million (September 30, 2022: $37.6 million).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted-average discount rate at September 30, 2023 were 6.75 years and 3.15%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of September 30, 2023 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.520%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental payments</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,084 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,709 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year 4</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,934 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year 5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,039 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,884 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,195 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155,312 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div>Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $33.9 million have been included in <span style="-sec-ix-hidden:f-631"><span style="-sec-ix-hidden:f-632">other liabilities</span></span> as at September 30, 2023 (September 30, 2022: $42.2 million). <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lease costs recorded under operating leases for the three and nine months ended September 30, 2023 and September 30, 2022 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,164 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,539 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(898)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,566 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,896 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,694 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,078 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div> 11850000 12164000 37539000 40976000 284000 268000 845000 898000 11566000 11896000 36694000 40078000 36700000 40100000 28100000 38100000 8600000 2000000 2100000 1700000 24600000 37600000 P6Y9M 0.0315 <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of September 30, 2023 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.520%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental payments</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,084 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,709 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year 4</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,934 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year 5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,039 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,884 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,195 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155,312 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div> 38084000 31545000 26709000 21934000 15039000 35884000 169195000 13883000 155312000 33900000 42200000 Bank credit lines and loan facilities<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of September 30, 2023 and December 31, 2022:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit Facilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.09 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,501,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,201,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Revolving Loan Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.68 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,213 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,701,213 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(130,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,946,063 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646,063 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,541)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,911,522 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,599,037 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contractual maturities of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 (remaining)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,788 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">555,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,321,975 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,213 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences ("the Merger"). In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company paid a $27.6 million debt discount in connection with the Senior Secured Credit Facility and Senior Secured Notes. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300 million to $500 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin which is dependent on the Company's net leverage ratio. At </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">September 30, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, the applicable margin is 2.25%. The senior secured term loan facility is subject to a floor of 0.50%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON’s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON’s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In January 2023, $100.0 million of the senior secured revolving loan facility was drawn down, in the aggregate, at interest rates of 5.89% and 5.80%, representing one month SOFR plus a margin of 1.25%. This was repaid in full in March 2023. On March 31, 2023, $80.0 million of the senior secured revolving loan facility was drawn down at an interest rate of 6.17%, representing one month SOFR plus a margin of 1.25%. In April 2023, the Company drew down a further $50.0 million of the senior secured revolving loan facility at an interest rate of 6.25%, representing one month SOFR plus a margin of 1.25%. The Company repaid $80.0 million of the senior secured revolving loan facility on June 30, 2023. The remaining $50.0 million was repaid on August 17, 2023. On September 29, 2023, $75.0 million of the senior secured revolving loan facility was drawn down at an interest rate of 6.68%, representing one month SOFR plus a margin of 1.25%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers’ (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON’s, the Borrowers’ and each of the subsidiary guarantor’s assets (subject to certain exceptions), and the Senior Secured Credit Facilities have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes, subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March 31, 2023 the Company repaid $250.0 million of the senior secured term loan facility and made a quarterly </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">interest payment of $75.3 million. This repayment resulted in an additional charge associated with previously capitalized fees of</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$2.2 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On June 30, 2023 the Company repaid $150.0 million of the senior secured term loan facility and made a quarterly interest payment of $74.0 million. This repayment resulted in an additional charge associated with previously capitalized fees of $1.2 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September 29, 2023, the Company repaid $300.0 million of the senior secured term loan facility and made a quarterly interest payment of $74.5 million. This repayment resulted in an additional charge associated with previously capitalized fees of $2.5 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500 million in aggregate principal amount of 2.875% senior secured notes due 2026 (the "Senior Secured Notes") in a private offering (the “Offering”). The Senior Secured Notes will mature on July 15, 2026.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Fair Value of Debt</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The estimated fair value of the Company’s debt wa</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">s $4,032.0 million a</span>t September 30, 2023. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility is recorded as its carrying value due to the short term duration. <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of September 30, 2023 and December 31, 2022:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit Facilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.09 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,501,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,201,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Revolving Loan Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.68 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,213 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,701,213 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(130,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,946,063 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646,063 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,541)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,911,522 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,599,037 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div> 0.0775 0.0709 3501213000 4201213000 0.0288 0.0288 500000000 500000000 0.0668 75000000 0 4076213000 4701213000 130150000 55150000 3946063000 4646063000 34541000 47026000 3911522000 4599037000 <div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contractual maturities of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 (remaining)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,788 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">555,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,321,975 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,213 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 88788000 55150000 55150000 555150000 3321975000 4076213000 5515000000 300000000 27600000 300000000 500000000 0.0100 0.0225 0.0050 0.0100 0.0060 0.0025 0.0200 0.0160 0.0125 100000000 0.0589 0.0580 0.0125 80000000 0.0617 0.0125 50000000 0.0625 0.0125 80000000 50000000 75000000 0.0668 0.0125 250000000 75300000 2200000 150000000 74000000 1200000 300000000 74500000 2500000 500000000 0.02875 4032000000 Derivatives<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On November 29, 2022, the Company entered into two interest rate cap agreements ("2022 Caps") with an initial total notional value of $2,101 million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate caps expires on December 31, 2024. The Company pays a fixed rate of 0.42% and receives a variable rate equal to the amount that the three-month SOFR exceeds 4.75%.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $1,101 million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swap begins accruing on December 31, 2024 and the interest rate swap expires on September 30, 2026. The Company pays a fixed rate of 3.4% and receives a variable rate of interest equal to the three-month SOFR on the 2022 Sw</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ap.</span></div><div style="text-align:justify;text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The fair value of the Company’s derivative financial instruments, on a gross basis, are summarized in the following table:</span></div><div style="text-indent:14.25pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.920%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Caps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$4,262</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$—</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$1,750,606</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$12</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,363</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$2,100,606</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$8,849</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$—</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$1,100,606</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$—</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$307</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$1,100,606</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$13,111</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$—</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$2,851,212</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$12</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,670</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,201,212</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As of September 30, 2023, the Company recognized a current derivative asset of $3.8 million within other receivables (December 31, 2022, current derivative asset of $0.01 million recognized within other receivables and a current derivative liability of $3.3 million recognized within other liabilities). A further $9.3 million non-current derivative asset was recognized within <span style="-sec-ix-hidden:f-735">non-current other receivables</span> (December 31,2022, non-current derivative liability of $0.4 million recognized within <span style="-sec-ix-hidden:f-737">non-current other liabilities</span>). </span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During the ne</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">xt 12 months, the Company estimates that an additional $2.3 million will be reflected as interest income in the consolidated statements.</span></div>The Company recognized $5.0 million of a gain within other comprehensive income ("OCI") for the three months ended September 30, 2023 (September 30, 2022: $nil) after a reclassification of $0.3 million from OCI to the income statement (September 30, 2022: $nil). The Company recognized $15.1 million of a net gain within OCI for the nine months ended September 30, 2023 (September 30, 2022: $nil) after a reclassification of $3.3 million from OCI to the income statement (September 30, 2022: $nil). 2 2101000000 0.0042 0.0475 1101000000 0.034 <div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The fair value of the Company’s derivative financial instruments, on a gross basis, are summarized in the following table:</span></div><div style="text-indent:14.25pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.920%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Caps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$4,262</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$—</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$1,750,606</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$12</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,363</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$2,100,606</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$8,849</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$—</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$1,100,606</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$—</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$307</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$1,100,606</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$13,111</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$—</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$2,851,212</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$12</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,670</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,201,212</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div> 4262000 0 1750606000 12000 3363000 2100606000 8849000 0 1100606000 0 307000 1100606000 13111000 0 2851212000 12000 3670000 3201212000 3800000 10000.00 3300000 9300000 400000 2300000 5000000 0 -300000 0 15100000 0 3300000 0 Income taxes<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income taxes recognized during th</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e three and nine months ended</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> September 30, 2023 and September 30, 2022, comprise:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,011 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,012 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,913 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,552 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As at September 30, 2023 the Company maintains a $251.1 million liability (December 31, 2022: $240.2 million) for unrecognized tax benefit, which is comprised of $221.1 million (December 31, 2022: $217.6 million) related to items generating unrecognized tax benefits and $30.0 million (December 31, 2022: $22.6 million) for interest and penalties related to such items. The Company recognizes interest accrued on unrecognized tax benefits as an additional income tax expense.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has analyzed the filing positions in all of the significant federal, state and foreign jurisdictions where it is required to file income tax returns, as well as open tax years in these jurisdictions. The only periods subject to audit by the major tax jurisdictions where the Company does business are the 2016 through 2022 tax years. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income taxes recognized during th</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e three and nine months ended</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> September 30, 2023 and September 30, 2022, comprise:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,011 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,012 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,913 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,552 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 18011000 21012000 41913000 48552000 251100000 240200000 221100000 217600000 30000000 22600000 Net income per ordinary share<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Group has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,215,627 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,582,375 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,001,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,481,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options and other awards outstanding under share based compensation programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">757,261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">910,836 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">735,573 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">991,835 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,972,888 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,493,211 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,737,073 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,473,521 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per Ordinary Share attributable to the Group:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.96 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.76 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.97 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.94 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.79 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.70 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,215,627 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,582,375 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,001,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,481,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options and other awards outstanding under share based compensation programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">757,261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">910,836 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">735,573 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">991,835 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,972,888 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,493,211 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,737,073 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,473,521 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per Ordinary Share attributable to the Group:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.96 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.76 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.97 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.94 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.79 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.70 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 82215627 81582375 82001500 82001500 81481686 81481686 757261 910836 735573 991835 82972888 82493211 82737073 82737073 82473521 82473521 1.99 1.96 4.83 4.76 1.97 1.94 4.79 4.70 Share-based awards<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Share Options</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes option activity for the nine months ended September 30, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options<br/>Outstanding<br/>Number of Shares </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,378,119 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.86 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.69</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(377,614)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,076,092 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.45</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercisable at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">804,953 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.75 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.91</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company issues ordinary shares for all options exercised. The total amount of fully vested share options which remained outstanding at September 30, 2023 was 804,953. Fully vested share options at September 30, 2023 have an average remaining contractual term of 3.91 years and an average exercise price of $113.75.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value of Stock Options Assumptions</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options granted during the nine months ended September 30, 2023 and September 30, 2022 was calculated using the Black-Scholes option pricing model. The weighted average grant date fair values and assumptions used were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average grant date fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.40 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share Units and Performance Share Units</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a subsidiary to receive an award under the plan. On May 11, 2015 the 20</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the 2013 RSU Plan by 2.5 million shares. Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">option of the Company. No awards may be granted under the 2013 RSU Plan after May 11, 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30, 2019 the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the “2019 Consultants RSU Plan”), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company’s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors during 2020, 2021 and 2022 vest in twelve months. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the nine months ended September 30, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.939%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> <br/>PSU<br/>Outstanding<br/>Number of<br/>Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> <br/>PSU<br/>Weighted<br/>Average Grant Date<br/>Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> <br/>RSU<br/>Outstanding<br/>Number of<br/>Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> <br/>RSU<br/>Weighted<br/>Average Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,420 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192.29 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207.73 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306,780 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.68 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(178,781)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186.35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,768 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216.22 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">651,351 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.41 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of PSUs vested for the nine months ended September 30, 2023 totaled $7.5 million (full year 2022: $6.5 million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of RSUs vested for the nine months ended September 30, 2023 totaled $33.3 million (full year 2022: $34.1 million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PSUs vest based on service and specified EPS targets over the periods 2021 - 2023, 2022 - 2024, and 2023 - 2025. Depending on the amount of EPS from 2021 to 2025, up to an additional 82,884 PSUs may also be granted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Stock compensation expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock compensation expense for the three and nine months ended September 30, 2023 and September 30, 2022 has been allocated as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.939%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,637 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,725 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,117 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,828 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,232 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,097 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,465 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,517 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">47,822 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,703 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes option activity for the nine months ended September 30, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options<br/>Outstanding<br/>Number of Shares </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,378,119 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.86 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.69</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(377,614)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,076,092 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.45</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercisable at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">804,953 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.75 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.91</span></td></tr></table></div> 1378119 119.86 P4Y8M8D 82472 232.48 377614 96.67 6885 116.33 1076092 136.65 P4Y5M12D 804953 113.75 P3Y10M28D 804953 P3Y10M28D 113.75 The weighted average grant date fair values and assumptions used were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average grant date fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.40 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table> 85.12 68.40 0.33 0.31 0 0 0.0398 0.0185 P5Y P5Y 2500000 4100000 250000 P12M The following table summarizes RSU and PSU activity for the nine months ended September 30, 2023:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.939%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> <br/>PSU<br/>Outstanding<br/>Number of<br/>Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> <br/>PSU<br/>Weighted<br/>Average Grant Date<br/>Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> <br/>RSU<br/>Outstanding<br/>Number of<br/>Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> <br/>RSU<br/>Weighted<br/>Average Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,420 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192.29 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207.73 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306,780 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.68 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(178,781)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186.35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,768 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216.22 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">651,351 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.41 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 152420 192.29 582612 207.73 60374 232.51 306780 218.68 47026 159.57 178781 186.35 0 0 59260 211.45 165768 216.22 651351 218.41 7500000 6500000 33300000 34100000 82884 <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock compensation expense for the three and nine months ended September 30, 2023 and September 30, 2022 has been allocated as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.939%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,637 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,725 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,117 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,828 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,232 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,097 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,465 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,517 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">47,822 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,703 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 6637000 6285000 18725000 17117000 9828000 11232000 29097000 38586000 16465000 17517000 47822000 55703000 Share capital<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company can acquire up to 10% of its outstanding ordinary shares (by way of redemption), in accordance with Irish law and the Company’s constitutional documents through open market share acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 18, 2022, the Company commenced a share buyback program which was fully complete at March 31, 2022. Under this buyback program, 420,530 ordinary shares were redeemed by the Company for total consideration of $100.0 million. The buyback program gives a broker authority to acquire the Company’s ordinary shares from time to time on the open market in accordance with agreed terms and limitations. All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital reserve as required under Irish Company Law.</span></div> 0.10 420530 100000000 Business Segment and Geographical Information<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. It specializes in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (‘CODM’) in accordance with ASC 280 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Segment Reporting'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates as one reporting segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group’s transfer pricing model.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland (Ireland Segment) acts as the Group entrepreneur under the Company’s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company’s global network. ICON Ireland enters into the majority of the Company’s customer contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland remunerates other operating entities in the Group on the basis of a guaranteed cost plus mark-up for the services they perform in each of their local territories. The cost plus mark-up for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate arms-length return having regard to the assets owned, risks borne and functions performed by each entity from these intercompany transactions. The cost plus mark-up policy is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model remains ongoing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The geographic split of revenue disclosed for each region outside Ireland is the cost plus revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> model and comprise revenues of the Group after deducting the cost plus revenues attributable to the activities performed outside Ireland. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The geographical distribution of the Company’s segment measures for the three and nine months ended September 30, 2023 and September 30, 2022 and at September 30, 2023 and December 31, 2022 is as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) The distribution of revenue by geographical area was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">596,337 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">526,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,701,580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,395,198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">384,720 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">397,538 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,172,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,281,996 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">831,789 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">903,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,524,212 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,767,844 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">242,253 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114,822 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">655,384 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334,346 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,055,099 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,942,427 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,053,928 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,779,384 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b) The distribution of income from operations by geographical area was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.939%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland *</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,640 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298,567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138,959 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,013 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,356 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,846 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,570 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,809 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,311 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,744 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">690,584 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591,873 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger. </span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,016 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,597 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,703 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,095 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474,581 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504,152 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1 The distribution of revenue by geographical area was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">596,337 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">526,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,701,580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,395,198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">384,720 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">397,538 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,172,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,281,996 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">831,789 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">903,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,524,212 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,767,844 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">242,253 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114,822 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">655,384 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334,346 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,055,099 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,942,427 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,053,928 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,779,384 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 596337000 526867000 1701580000 1395198000 384720000 397538000 1172752000 1281996000 831789000 903200000 2524212000 2767844000 242253000 114822000 655384000 334346000 2055099000 1942427000 6053928000 5779384000 The distribution of income from operations by geographical area was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.939%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland *</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,640 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298,567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138,959 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,013 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,356 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,846 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,570 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,809 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,311 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,744 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">690,584 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591,873 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table>* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger. 121343000 93640000 298567000 159059000 56705000 76178000 138959000 194860000 70013000 63356000 213846000 177145000 16250000 10570000 39212000 60809000 264311000 243744000 690584000 591873000 The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,016 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,597 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,703 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,095 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474,581 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504,152 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 172016000 143025000 89265000 99721000 165597000 213311000 47703000 48095000 474581000 504152000 Subsequent events<div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On October 2, 2023, the Company acquired 100% of the equity of BioTel Research, LLC which comprised the business formerly known as Philips Pharma Solutions, a leading provider of medical imaging and cardiac safety monitoring services. The initial consideration paid on the closing date of the acquisition was $68.1 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events from the balance sheet date through to the date at which the financial </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">statements were available to be issued. The Company has determined that there are no items, other than the items described above, to disclose.</span></div> 1 68100000 EXCEL 83 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 84 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 85 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 86 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 237 278 1 false 62 0 false 7 false false R1.htm 0000001 - Document - Cover Sheet http://www.iconplc.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Sheet http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Statements 5 false false R6.htm 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) Sheet http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) Statements 6 false false R7.htm 0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 7 false false R8.htm 0000008 - Disclosure - Basis of presentation Sheet http://www.iconplc.com/role/Basisofpresentation Basis of presentation Notes 8 false false R9.htm 0000009 - Disclosure - Summary of significant accounting policies Sheet http://www.iconplc.com/role/Summaryofsignificantaccountingpolicies Summary of significant accounting policies Notes 9 false false R10.htm 0000010 - Disclosure - Revenue Sheet http://www.iconplc.com/role/Revenue Revenue Notes 10 false false R11.htm 0000011 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) Sheet http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) Notes 11 false false R12.htm 0000012 - Disclosure - Goodwill Sheet http://www.iconplc.com/role/Goodwill Goodwill Notes 12 false false R13.htm 0000013 - Disclosure - Intangible assets Sheet http://www.iconplc.com/role/Intangibleassets Intangible assets Notes 13 false false R14.htm 0000014 - Disclosure - Fair value measurements Sheet http://www.iconplc.com/role/Fairvaluemeasurements Fair value measurements Notes 14 false false R15.htm 0000015 - Disclosure - Restructuring Sheet http://www.iconplc.com/role/Restructuring Restructuring Notes 15 false false R16.htm 0000016 - Disclosure - Operating leases Sheet http://www.iconplc.com/role/Operatingleases Operating leases Notes 16 false false R17.htm 0000017 - Disclosure - Bank credit lines and loan facilities Sheet http://www.iconplc.com/role/Bankcreditlinesandloanfacilities Bank credit lines and loan facilities Notes 17 false false R18.htm 0000018 - Disclosure - Derivatives Sheet http://www.iconplc.com/role/Derivatives Derivatives Notes 18 false false R19.htm 0000019 - Disclosure - Income taxes Sheet http://www.iconplc.com/role/Incometaxes Income taxes Notes 19 false false R20.htm 0000020 - Disclosure - Net income per ordinary share Sheet http://www.iconplc.com/role/Netincomeperordinaryshare Net income per ordinary share Notes 20 false false R21.htm 0000021 - Disclosure - Share-based awards Sheet http://www.iconplc.com/role/Sharebasedawards Share-based awards Notes 21 false false R22.htm 0000022 - Disclosure - Share capital Sheet http://www.iconplc.com/role/Sharecapital Share capital Notes 22 false false R23.htm 0000023 - Disclosure - Business Segment and Geographical Information Sheet http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation Business Segment and Geographical Information Notes 23 false false R24.htm 0000024 - Disclosure - Subsequent events Sheet http://www.iconplc.com/role/Subsequentevents Subsequent events Notes 24 false false R25.htm 9954471 - Disclosure - Summary of significant accounting policies (Policies) Sheet http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesPolicies Summary of significant accounting policies (Policies) Policies 25 false false R26.htm 9954472 - Disclosure - Summary of significant accounting policies (Tables) Sheet http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesTables Summary of significant accounting policies (Tables) Tables http://www.iconplc.com/role/Summaryofsignificantaccountingpolicies 26 false false R27.htm 9954473 - Disclosure - Revenue (Tables) Sheet http://www.iconplc.com/role/RevenueTables Revenue (Tables) Tables http://www.iconplc.com/role/Revenue 27 false false R28.htm 9954474 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables) Sheet http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables) Tables http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities 28 false false R29.htm 9954475 - Disclosure - Goodwill (Tables) Sheet http://www.iconplc.com/role/GoodwillTables Goodwill (Tables) Tables http://www.iconplc.com/role/Goodwill 29 false false R30.htm 9954476 - Disclosure - Intangible assets (Tables) Sheet http://www.iconplc.com/role/IntangibleassetsTables Intangible assets (Tables) Tables http://www.iconplc.com/role/Intangibleassets 30 false false R31.htm 9954477 - Disclosure - Fair Value Measures and Disclosures (Tables) Sheet http://www.iconplc.com/role/FairValueMeasuresandDisclosuresTables Fair Value Measures and Disclosures (Tables) Tables 31 false false R32.htm 9954478 - Disclosure - Restructuring (Tables) Sheet http://www.iconplc.com/role/RestructuringTables Restructuring (Tables) Tables http://www.iconplc.com/role/Restructuring 32 false false R33.htm 9954479 - Disclosure - Operating leases (Tables) Sheet http://www.iconplc.com/role/OperatingleasesTables Operating leases (Tables) Tables http://www.iconplc.com/role/Operatingleases 33 false false R34.htm 9954480 - Disclosure - Bank credit lines and loan facilities (Tables) Sheet http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesTables Bank credit lines and loan facilities (Tables) Tables http://www.iconplc.com/role/Bankcreditlinesandloanfacilities 34 false false R35.htm 9954481 - Disclosure - Derivatives (Tables) Sheet http://www.iconplc.com/role/DerivativesTables Derivatives (Tables) Tables http://www.iconplc.com/role/Derivatives 35 false false R36.htm 9954482 - Disclosure - Income taxes (Tables) Sheet http://www.iconplc.com/role/IncometaxesTables Income taxes (Tables) Tables http://www.iconplc.com/role/Incometaxes 36 false false R37.htm 9954483 - Disclosure - Net income per ordinary share (Tables) Sheet http://www.iconplc.com/role/NetincomeperordinaryshareTables Net income per ordinary share (Tables) Tables http://www.iconplc.com/role/Netincomeperordinaryshare 37 false false R38.htm 9954484 - Disclosure - Share-based awards (Tables) Sheet http://www.iconplc.com/role/SharebasedawardsTables Share-based awards (Tables) Tables http://www.iconplc.com/role/Sharebasedawards 38 false false R39.htm 9954485 - Disclosure - Business Segment and Geographical Information (Tables) Sheet http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables Business Segment and Geographical Information (Tables) Tables http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation 39 false false R40.htm 9954486 - Disclosure - Summary of significant accounting policies - Estimated Useful Lives of Intangible Assets (Details) Sheet http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails Summary of significant accounting policies - Estimated Useful Lives of Intangible Assets (Details) Details 40 false false R41.htm 9954487 - Disclosure - Revenue (Details) Sheet http://www.iconplc.com/role/RevenueDetails Revenue (Details) Details http://www.iconplc.com/role/RevenueTables 41 false false R42.htm 9954488 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Accounts Receivables and Unbilled Revenue (Details) Sheet http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Accounts Receivables and Unbilled Revenue (Details) Details http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables 42 false false R43.htm 9954489 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Unbilled Services and Unearned Revenue or Payments on Account (Details) Sheet http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Unbilled Services and Unearned Revenue or Payments on Account (Details) Details http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables 43 false false R44.htm 9954490 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details) Sheet http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details) Details http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables 44 false false R45.htm 9954491 - Disclosure - Goodwill - Schedule of Goodwill (Details) Sheet http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails Goodwill - Schedule of Goodwill (Details) Details 45 false false R46.htm 9954492 - Disclosure - Goodwill - Narrative (Details) Sheet http://www.iconplc.com/role/GoodwillNarrativeDetails Goodwill - Narrative (Details) Details 46 false false R47.htm 9954493 - Disclosure - Intangible assets (Details) Sheet http://www.iconplc.com/role/IntangibleassetsDetails Intangible assets (Details) Details http://www.iconplc.com/role/IntangibleassetsTables 47 false false R48.htm 9954494 - Disclosure - Fair value measurements - Measurement of Fair Value of Major Asset and Liability classed (Details) Sheet http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails Fair value measurements - Measurement of Fair Value of Major Asset and Liability classed (Details) Details 48 false false R49.htm 9954495 - Disclosure - Fair value measurements - Narrative (Details) Sheet http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails Fair value measurements - Narrative (Details) Details 49 false false R50.htm 9954496 - Disclosure - Restructuring - Narrative (Details) Sheet http://www.iconplc.com/role/RestructuringNarrativeDetails Restructuring - Narrative (Details) Details 50 false false R51.htm 9954497 - Disclosure - Restructuring - Summary of Restructuring Charges (Details) Sheet http://www.iconplc.com/role/RestructuringSummaryofRestructuringChargesDetails Restructuring - Summary of Restructuring Charges (Details) Details 51 false false R52.htm 9954498 - Disclosure - Restructuring - Summary of Details of Movement in Restructuring Charges (Details) Sheet http://www.iconplc.com/role/RestructuringSummaryofDetailsofMovementinRestructuringChargesDetails Restructuring - Summary of Details of Movement in Restructuring Charges (Details) Details 52 false false R53.htm 9954499 - Disclosure - Operating leases - Schedule of Lease Costs (Details) Sheet http://www.iconplc.com/role/OperatingleasesScheduleofLeaseCostsDetails Operating leases - Schedule of Lease Costs (Details) Details 53 false false R54.htm 9954500 - Disclosure - Operating leases - Narrative (Details) Sheet http://www.iconplc.com/role/OperatingleasesNarrativeDetails Operating leases - Narrative (Details) Details 54 false false R55.htm 9954501 - Disclosure - Operating leases - Schedule of Operating Lease Maturity (Details) Sheet http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails Operating leases - Schedule of Operating Lease Maturity (Details) Details 55 false false R56.htm 9954502 - Disclosure - Bank credit lines and loan facilities - Schedule of Outstanding Debt (Details) Sheet http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails Bank credit lines and loan facilities - Schedule of Outstanding Debt (Details) Details 56 false false R57.htm 9954503 - Disclosure - Bank credit lines and loan facilities - Narrative (Details) Sheet http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails Bank credit lines and loan facilities - Narrative (Details) Details 57 false false R58.htm 9954504 - Disclosure - Bank credit lines and loan facilities - Schedule of Contractual Maturities of Debt (Details) Sheet http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails Bank credit lines and loan facilities - Schedule of Contractual Maturities of Debt (Details) Details 58 false false R59.htm 9954505 - Disclosure - Derivatives - Narrative (Details) Sheet http://www.iconplc.com/role/DerivativesNarrativeDetails Derivatives - Narrative (Details) Details 59 false false R60.htm 9954506 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details) Sheet http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details) Details 60 false false R61.htm 9954507 - Disclosure - Income taxes - Components of Tax (Details) Sheet http://www.iconplc.com/role/IncometaxesComponentsofTaxDetails Income taxes - Components of Tax (Details) Details 61 false false R62.htm 9954508 - Disclosure - Income taxes - Narrative (Details) Sheet http://www.iconplc.com/role/IncometaxesNarrativeDetails Income taxes - Narrative (Details) Details 62 false false R63.htm 9954509 - Disclosure - Net income per ordinary share - Schedule of Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details) Sheet http://www.iconplc.com/role/NetincomeperordinaryshareScheduleofReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails Net income per ordinary share - Schedule of Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details) Details 63 false false R64.htm 9954510 - Disclosure - Net income per ordinary share - Schedule of Reconciliation of Net Income Attributable to the Group (Details) Sheet http://www.iconplc.com/role/NetincomeperordinaryshareScheduleofReconciliationofNetIncomeAttributabletotheGroupDetails Net income per ordinary share - Schedule of Reconciliation of Net Income Attributable to the Group (Details) Details 64 false false R65.htm 9954511 - Disclosure - Share-based awards - Summary of Stock Option Activity (Details) Sheet http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails Share-based awards - Summary of Stock Option Activity (Details) Details 65 false false R66.htm 9954512 - Disclosure - Share-based awards - Narrative (Details) Sheet http://www.iconplc.com/role/SharebasedawardsNarrativeDetails Share-based awards - Narrative (Details) Details 66 false false R67.htm 9954513 - Disclosure - Share-based awards - Schedule of Weighted Average Fair Values and Assumptions Used (Details) Sheet http://www.iconplc.com/role/SharebasedawardsScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails Share-based awards - Schedule of Weighted Average Fair Values and Assumptions Used (Details) Details 67 false false R68.htm 9954514 - Disclosure - Share-based awards - Summary of RSU and PSU Activity (Details) Sheet http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails Share-based awards - Summary of RSU and PSU Activity (Details) Details 68 false false R69.htm 9954515 - Disclosure - Share-based awards - Schedule of Non-cash Stock Compensation Expense (Details) Sheet http://www.iconplc.com/role/SharebasedawardsScheduleofNoncashStockCompensationExpenseDetails Share-based awards - Schedule of Non-cash Stock Compensation Expense (Details) Details 69 false false R70.htm 9954516 - Disclosure - Share capital (Details) Sheet http://www.iconplc.com/role/SharecapitalDetails Share capital (Details) Details http://www.iconplc.com/role/Sharecapital 70 false false R71.htm 9954517 - Disclosure - Business Segment and Geographical Information - Narrative (Details) Sheet http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails Business Segment and Geographical Information - Narrative (Details) Details 71 false false R72.htm 9954518 - Disclosure - Business Segment and Geographical Information - Schedule of Distribution of Revenue by Geographical Area (Details) Sheet http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofRevenuebyGeographicalAreaDetails Business Segment and Geographical Information - Schedule of Distribution of Revenue by Geographical Area (Details) Details 72 false false R73.htm 9954519 - Disclosure - Business Segment and Geographical Information - Schedule of Distribution of Income from Operations by Geographical Area (Details) Sheet http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofIncomefromOperationsbyGeographicalAreaDetails Business Segment and Geographical Information - Schedule of Distribution of Income from Operations by Geographical Area (Details) Details 73 false false R74.htm 9954520 - Disclosure - Business Segment and Geographical Information - Schedule of Distribution of Depreciation and Amortization by Geographical Area (Details) Sheet http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofDepreciationandAmortizationbyGeographicalAreaDetails Business Segment and Geographical Information - Schedule of Distribution of Depreciation and Amortization by Geographical Area (Details) Details 74 false false R75.htm 9954521 - Disclosure - Subsequent events - Narrative (Details) Sheet http://www.iconplc.com/role/SubsequenteventsNarrativeDetails Subsequent events - Narrative (Details) Details 75 false false All Reports Book All Reports iclr-20230930.htm iclr-20230930.xsd iclr-20230930_cal.xml iclr-20230930_def.xml iclr-20230930_lab.xml iclr-20230930_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 88 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "iclr-20230930.htm": { "nsprefix": "iclr", "nsuri": "http://www.iconplc.com/20230930", "dts": { "inline": { "local": [ "iclr-20230930.htm" ] }, "schema": { "local": [ "iclr-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "iclr-20230930_cal.xml" ] }, "definitionLink": { "local": [ "iclr-20230930_def.xml" ] }, "labelLink": { "local": [ "iclr-20230930_lab.xml" ] }, "presentationLink": { "local": [ "iclr-20230930_pre.xml" ] } }, "keyStandard": 256, "keyCustom": 22, "axisStandard": 23, "axisCustom": 1, "memberStandard": 35, "memberCustom": 27, "hidden": { "total": 9, "http://fasb.org/us-gaap/2023": 4, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 237, "entityCount": 1, "segmentCount": 62, "elementCount": 464, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 875, "http://xbrl.sec.gov/dei/2023": 8 }, "report": { "R1": { "role": "http://www.iconplc.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "eurPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "eurPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R5": { "role": "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED", "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R6": { "role": "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED", "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-45", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-45", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R8": { "role": "http://www.iconplc.com/role/Basisofpresentation", "longName": "0000008 - Disclosure - Basis of presentation", "shortName": "Basis of presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.iconplc.com/role/Summaryofsignificantaccountingpolicies", "longName": "0000009 - Disclosure - Summary of significant accounting policies", "shortName": "Summary of significant accounting policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.iconplc.com/role/Revenue", "longName": "0000010 - Disclosure - Revenue", "shortName": "Revenue", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": null }, "R11": { "role": "http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities", "longName": "0000011 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)", "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": null }, "R12": { "role": "http://www.iconplc.com/role/Goodwill", "longName": "0000012 - Disclosure - Goodwill", "shortName": "Goodwill", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.iconplc.com/role/Intangibleassets", "longName": "0000013 - Disclosure - Intangible assets", "shortName": "Intangible assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.iconplc.com/role/Fairvaluemeasurements", "longName": "0000014 - Disclosure - Fair value measurements", "shortName": "Fair value measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.iconplc.com/role/Restructuring", "longName": "0000015 - Disclosure - Restructuring", "shortName": "Restructuring", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.iconplc.com/role/Operatingleases", "longName": "0000016 - Disclosure - Operating leases", "shortName": "Operating leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.iconplc.com/role/Bankcreditlinesandloanfacilities", "longName": "0000017 - Disclosure - Bank credit lines and loan facilities", "shortName": "Bank credit lines and loan facilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.iconplc.com/role/Derivatives", "longName": "0000018 - Disclosure - Derivatives", "shortName": "Derivatives", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.iconplc.com/role/Incometaxes", "longName": "0000019 - Disclosure - Income taxes", "shortName": "Income taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.iconplc.com/role/Netincomeperordinaryshare", "longName": "0000020 - Disclosure - Net income per ordinary share", "shortName": "Net income per ordinary share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.iconplc.com/role/Sharebasedawards", "longName": "0000021 - Disclosure - Share-based awards", "shortName": "Share-based awards", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.iconplc.com/role/Sharecapital", "longName": "0000022 - Disclosure - Share capital", "shortName": "Share capital", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation", "longName": "0000023 - Disclosure - Business Segment and Geographical Information", "shortName": "Business Segment and Geographical Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.iconplc.com/role/Subsequentevents", "longName": "0000024 - Disclosure - Subsequent events", "shortName": "Subsequent events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesPolicies", "longName": "9954471 - Disclosure - Summary of significant accounting policies (Policies)", "shortName": "Summary of significant accounting policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesTables", "longName": "9954472 - Disclosure - Summary of significant accounting policies (Tables)", "shortName": "Summary of significant accounting policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": null }, "R27": { "role": "http://www.iconplc.com/role/RevenueTables", "longName": "9954473 - Disclosure - Revenue (Tables)", "shortName": "Revenue (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables", "longName": "9954474 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)", "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.iconplc.com/role/GoodwillTables", "longName": "9954475 - Disclosure - Goodwill (Tables)", "shortName": "Goodwill (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.iconplc.com/role/IntangibleassetsTables", "longName": "9954476 - Disclosure - Intangible assets (Tables)", "shortName": "Intangible assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": null }, "R31": { "role": "http://www.iconplc.com/role/FairValueMeasuresandDisclosuresTables", "longName": "9954477 - Disclosure - Fair Value Measures and Disclosures (Tables)", "shortName": "Fair Value Measures and Disclosures (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.iconplc.com/role/RestructuringTables", "longName": "9954478 - Disclosure - Restructuring (Tables)", "shortName": "Restructuring (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.iconplc.com/role/OperatingleasesTables", "longName": "9954479 - Disclosure - Operating leases (Tables)", "shortName": "Operating leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesTables", "longName": "9954480 - Disclosure - Bank credit lines and loan facilities (Tables)", "shortName": "Bank credit lines and loan facilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.iconplc.com/role/DerivativesTables", "longName": "9954481 - Disclosure - Derivatives (Tables)", "shortName": "Derivatives (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.iconplc.com/role/IncometaxesTables", "longName": "9954482 - Disclosure - Income taxes (Tables)", "shortName": "Income taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.iconplc.com/role/NetincomeperordinaryshareTables", "longName": "9954483 - Disclosure - Net income per ordinary share (Tables)", "shortName": "Net income per ordinary share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.iconplc.com/role/SharebasedawardsTables", "longName": "9954484 - Disclosure - Share-based awards (Tables)", "shortName": "Share-based awards (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables", "longName": "9954485 - Disclosure - Business Segment and Geographical Information (Tables)", "shortName": "Business Segment and Geographical Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails", "longName": "9954486 - Disclosure - Summary of significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)", "shortName": "Summary of significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-84", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-84", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.iconplc.com/role/RevenueDetails", "longName": "9954487 - Disclosure - Revenue (Details)", "shortName": "Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-89", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R42": { "role": "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails", "longName": "9954488 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Accounts Receivables and Unbilled Revenue (Details)", "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Accounts Receivables and Unbilled Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:BilledContractReceivables", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:BilledContractReceivables", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails", "longName": "9954489 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Unbilled Services and Unearned Revenue or Payments on Account (Details)", "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Unbilled Services and Unearned Revenue or Payments on Account (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:ContractWithCustomerAssetGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "iclr:IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R44": { "role": "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails", "longName": "9954490 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)", "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-1", "name": "iclr:IncreaseDecreaseInContractWithCustomerAssetGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:RevenueRemainingPerformanceObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R45": { "role": "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails", "longName": "9954491 - Disclosure - Goodwill - Schedule of Goodwill (Details)", "shortName": "Goodwill - Schedule of Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-50", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R46": { "role": "http://www.iconplc.com/role/GoodwillNarrativeDetails", "longName": "9954492 - Disclosure - Goodwill - Narrative (Details)", "shortName": "Goodwill - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R47": { "role": "http://www.iconplc.com/role/IntangibleassetsDetails", "longName": "9954493 - Disclosure - Intangible assets (Details)", "shortName": "Intangible assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "longName": "9954494 - Disclosure - Fair value measurements - Measurement of Fair Value of Major Asset and Liability classed (Details)", "shortName": "Fair value measurements - Measurement of Fair Value of Major Asset and Liability classed (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R49": { "role": "http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails", "longName": "9954495 - Disclosure - Fair value measurements - Narrative (Details)", "shortName": "Fair value measurements - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-130", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R50": { "role": "http://www.iconplc.com/role/RestructuringNarrativeDetails", "longName": "9954496 - Disclosure - Restructuring - Narrative (Details)", "shortName": "Restructuring - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:RestructuringCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherRestructuringCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R51": { "role": "http://www.iconplc.com/role/RestructuringSummaryofRestructuringChargesDetails", "longName": "9954497 - Disclosure - Restructuring - Summary of Restructuring Charges (Details)", "shortName": "Restructuring - Summary of Restructuring Charges (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:RestructuringCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": null }, "R52": { "role": "http://www.iconplc.com/role/RestructuringSummaryofDetailsofMovementinRestructuringChargesDetails", "longName": "9954498 - Disclosure - Restructuring - Summary of Details of Movement in Restructuring Charges (Details)", "shortName": "Restructuring - Summary of Details of Movement in Restructuring Charges (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R53": { "role": "http://www.iconplc.com/role/OperatingleasesScheduleofLeaseCostsDetails", "longName": "9954499 - Disclosure - Operating leases - Schedule of Lease Costs (Details)", "shortName": "Operating leases - Schedule of Lease Costs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.iconplc.com/role/OperatingleasesNarrativeDetails", "longName": "9954500 - Disclosure - Operating leases - Narrative (Details)", "shortName": "Operating leases - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:LeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R55": { "role": "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails", "longName": "9954501 - Disclosure - Operating leases - Schedule of Operating Lease Maturity (Details)", "shortName": "Operating leases - Schedule of Operating Lease Maturity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails", "longName": "9954502 - Disclosure - Bank credit lines and loan facilities - Schedule of Outstanding Debt (Details)", "shortName": "Bank credit lines and loan facilities - Schedule of Outstanding Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "iclr:LongTermDebtCurrentMaturitiesGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R57": { "role": "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "longName": "9954503 - Disclosure - Bank credit lines and loan facilities - Narrative (Details)", "shortName": "Bank credit lines and loan facilities - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProceedsFromLinesOfCredit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-150", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R58": { "role": "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails", "longName": "9954504 - Disclosure - Bank credit lines and loan facilities - Schedule of Contractual Maturities of Debt (Details)", "shortName": "Bank credit lines and loan facilities - Schedule of Contractual Maturities of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.iconplc.com/role/DerivativesNarrativeDetails", "longName": "9954505 - Disclosure - Derivatives - Narrative (Details)", "shortName": "Derivatives - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R60": { "role": "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "longName": "9954506 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)", "shortName": "Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-182", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-182", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.iconplc.com/role/IncometaxesComponentsofTaxDetails", "longName": "9954507 - Disclosure - Income taxes - Components of Tax (Details)", "shortName": "Income taxes - Components of Tax (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": null }, "R62": { "role": "http://www.iconplc.com/role/IncometaxesNarrativeDetails", "longName": "9954508 - Disclosure - Income taxes - Narrative (Details)", "shortName": "Income taxes - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.iconplc.com/role/NetincomeperordinaryshareScheduleofReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails", "longName": "9954509 - Disclosure - Net income per ordinary share - Schedule of Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)", "shortName": "Net income per ordinary share - Schedule of Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R64": { "role": "http://www.iconplc.com/role/NetincomeperordinaryshareScheduleofReconciliationofNetIncomeAttributabletotheGroupDetails", "longName": "9954510 - Disclosure - Net income per ordinary share - Schedule of Reconciliation of Net Income Attributable to the Group (Details)", "shortName": "Net income per ordinary share - Schedule of Reconciliation of Net Income Attributable to the Group (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:EarningsPerShareBasic", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": null }, "R65": { "role": "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails", "longName": "9954511 - Disclosure - Share-based awards - Summary of Stock Option Activity (Details)", "shortName": "Share-based awards - Summary of Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-187", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-189", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R66": { "role": "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails", "longName": "9954512 - Disclosure - Share-based awards - Narrative (Details)", "shortName": "Share-based awards - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-190", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-193", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R67": { "role": "http://www.iconplc.com/role/SharebasedawardsScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails", "longName": "9954513 - Disclosure - Share-based awards - Schedule of Weighted Average Fair Values and Assumptions Used (Details)", "shortName": "Share-based awards - Schedule of Weighted Average Fair Values and Assumptions Used (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-189", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-189", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails", "longName": "9954514 - Disclosure - Share-based awards - Summary of RSU and PSU Activity (Details)", "shortName": "Share-based awards - Summary of RSU and PSU Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-197", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-197", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.iconplc.com/role/SharebasedawardsScheduleofNoncashStockCompensationExpenseDetails", "longName": "9954515 - Disclosure - Share-based awards - Schedule of Non-cash Stock Compensation Expense (Details)", "shortName": "Share-based awards - Schedule of Non-cash Stock Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.iconplc.com/role/SharecapitalDetails", "longName": "9954516 - Disclosure - Share capital (Details)", "shortName": "Share capital (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-52", "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-211", "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R71": { "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails", "longName": "9954517 - Disclosure - Business Segment and Geographical Information - Narrative (Details)", "shortName": "Business Segment and Geographical Information - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofRevenuebyGeographicalAreaDetails", "longName": "9954518 - Disclosure - Business Segment and Geographical Information - Schedule of Distribution of Revenue by Geographical Area (Details)", "shortName": "Business Segment and Geographical Information - Schedule of Distribution of Revenue by Geographical Area (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-212", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R73": { "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofIncomefromOperationsbyGeographicalAreaDetails", "longName": "9954519 - Disclosure - Business Segment and Geographical Information - Schedule of Distribution of Income from Operations by Geographical Area (Details)", "shortName": "Business Segment and Geographical Information - Schedule of Distribution of Income from Operations by Geographical Area (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:OperatingIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-212", "name": "us-gaap:OperatingIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "unique": true } }, "R74": { "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofDepreciationandAmortizationbyGeographicalAreaDetails", "longName": "9954520 - Disclosure - Business Segment and Geographical Information - Schedule of Distribution of Depreciation and Amortization by Geographical Area (Details)", "shortName": "Business Segment and Geographical Information - Schedule of Distribution of Depreciation and Amortization by Geographical Area (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:NoncurrentAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:NoncurrentAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } }, "R75": { "role": "http://www.iconplc.com/role/SubsequenteventsNarrativeDetails", "longName": "9954521 - Disclosure - Subsequent events - Narrative (Details)", "shortName": "Subsequent events - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-236", "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-236", "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "iclr-20230930.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, principal amount", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r98", "r100", "r311", "r481", "r651", "r652" ] }, "iclr_ContractsReceivableGross": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "ContractsReceivableGross", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable and unbilled revenue, gross", "label": "Contracts Receivable, Gross", "documentation": "Contracts Receivable" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.iconplc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "iclr_BuybackProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "BuybackProgramMember", "presentation": [ "http://www.iconplc.com/role/SharecapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Buyback Program", "label": "Buyback Program [Member]", "documentation": "Buyback Program [Member]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from exercise of equity compensation", "label": "Proceeds from Stock Options Exercised", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r6", "r20" ] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredDebtMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Secured Term Loan", "label": "Secured Debt [Member]", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit facility, interest rate at period end", "label": "Line of Credit Facility, Interest Rate at Period End", "documentation": "The effective interest rate at the end of the reporting period." } } }, "auth_ref": [ "r27" ] }, "iclr_LongTermDebtMaturityYearFourAndThereafter": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "LongTermDebtMaturityYearFourAndThereafter", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027 and thereafter", "label": "Long-Term Debt, Maturity, Year Four And Thereafter", "documentation": "Long-Term Debt, Maturity, Year Four And Thereafter" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r27" ] }, "iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent", "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage change in unearned revenue (payments on account)", "label": "Increase (Decrease) In Contract With Customer, Liability, Gross, Current, Percent", "documentation": "Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesReceivable", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes receivable", "label": "Income Taxes Receivable, Current", "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes." } } }, "auth_ref": [ "r101", "r695" ] }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Distribution of Depreciation and Amortization by Geographical Area", "label": "Long-Lived Assets by Geographic Areas [Table Text Block]", "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets." } } }, "auth_ref": [ "r23" ] }, "iclr_VariableRateComponentOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "VariableRateComponentOneMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable rate component one", "label": "Variable Rate Component One [Member]", "documentation": "Variable Rate Component One" } } }, "auth_ref": [] }, "iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior secured credit facility and senior secured notes", "label": "Senior Secured Credit Facility And Senior Secured Notes [Member]", "documentation": "Senior Secured Credit Facility And Senior Secured Notes" } } }, "auth_ref": [] }, "iclr_OncacareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "OncacareMember", "presentation": [ "http://www.iconplc.com/role/GoodwillNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Oncacare", "label": "Oncacare [Member]", "documentation": "Oncacare" } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.iconplc.com/role/Summaryofsignificantaccountingpolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of significant accounting policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r128", "r197" ] }, "iclr_SeniorSecuredRevolvingLoanFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "SeniorSecuredRevolvingLoanFacilityMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Secured Revolving Loan Facility", "label": "Senior Secured Revolving Loan Facility [Member]", "documentation": "Senior Secured Revolving Loan Facility" } } }, "auth_ref": [] }, "iclr_Clients15Member": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "Clients15Member", "presentation": [ "http://www.iconplc.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Clients 1-5", "label": "Clients 1-5 [Member]", "documentation": "Clients 2-5 [Member]" } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r32" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.iconplc.com/role/OperatingleasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Lease Costs", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r744" ] }, "iclr_PersonnelRelatedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "PersonnelRelatedLiabilitiesMember", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Personnel related liabilities", "label": "Personnel Related Liabilities [Member]", "documentation": "Personnel Related Liabilities" } } }, "auth_ref": [] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r319", "r366", "r367", "r368", "r369", "r370", "r371", "r463", "r498", "r499", "r500", "r651", "r652", "r663", "r664", "r665" ] }, "iclr_SeniorSecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "SeniorSecuredNotesMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Secured Notes", "label": "Senior Secured Notes [Member]", "documentation": "Senior Secured Notes" } } }, "auth_ref": [] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://www.iconplc.com/role/OperatingleasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Lease, Description [Line Items]", "label": "Lessee, Lease, Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r486" ] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.iconplc.com/role/Intangibleassets" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "label": "Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r279" ] }, "iclr_LongTermDebtExcludingCurrentMaturitiesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "LongTermDebtExcludingCurrentMaturitiesGross", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total long-term debt", "label": "Long-term Debt, Excluding Current Maturities, Gross", "documentation": "Long-term Debt, Excluding Current Maturities, Gross" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.iconplc.com/role/NetincomeperordinaryshareScheduleofReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.iconplc.com/role/NetincomeperordinaryshareScheduleofReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r217", "r222" ] }, "iclr_RestOfWorldMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "RestOfWorldMember", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofDepreciationandAmortizationbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofIncomefromOperationsbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofRevenuebyGeographicalAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rest of World", "label": "Rest of World [Member]", "documentation": "Rest of World [Member]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "calculation": { "http://www.iconplc.com/role/NetincomeperordinaryshareScheduleofReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/NetincomeperordinaryshareScheduleofReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of dilutive share options and other awards outstanding under share based compensation programs (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment", "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation." } } }, "auth_ref": [ "r710" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r155" ] }, "iclr_PerformanceShareUnitMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "PerformanceShareUnitMember", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Share Unit (PSUs)", "label": "Performance Share Unit [Member]", "documentation": "Performance Share Unit [Member]" } } }, "auth_ref": [] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofDepreciationandAmortizationbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofIncomefromOperationsbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofRevenuebyGeographicalAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S.", "label": "UNITED STATES" } } }, "auth_ref": [] }, "iclr_VariableRateComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "VariableRateComponentDomain", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate Component [Domain]", "label": "Variable Rate Component [Domain]", "documentation": "Variable Rate Component [Domain]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.iconplc.com/role/NetincomeperordinaryshareScheduleofReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.iconplc.com/role/NetincomeperordinaryshareScheduleofReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r216", "r222" ] }, "iclr_DerivativeVariableInterestRateReferenceRateInExcessOf": { "xbrltype": "percentItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "DerivativeVariableInterestRateReferenceRateInExcessOf", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, variable interest rate, reference rate in excess of", "label": "Derivative, Variable Interest Rate, Reference Rate In Excess Of", "documentation": "Derivative, Variable Interest Rate, Reference Rate In Excess Of" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Contractual Maturities of Debt", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r11" ] }, "us-gaap_LongTermLineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermLineOfCredit", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current bank credit lines and loan facilities", "label": "Long-Term Line of Credit, Noncurrent", "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r32", "r57", "r58" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization, Nonproduction", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r9", "r51" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.iconplc.com/role/OperatingleasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining lease term", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r491", "r673" ] }, "iclr_ShceduleOfOperatingIncomeByGeographyTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "ShceduleOfOperatingIncomeByGeographyTableTextBlock", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Distribution of Income from Operations by Geographical Area", "label": "Shcedule Of Operating Income By Geography [Table Text Block]", "documentation": "Shcedule Of Operating Income By Geography" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available for sale investments", "verboseLabel": "Available for sale securities (short-term)", "label": "Debt Securities, Available-for-Sale, Current", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current." } } }, "auth_ref": [ "r261", "r270" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Axis]", "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r462", "r463", "r464", "r465", "r468" ] }, "iclr_ContractAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "ContractAssetsAbstract", "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract Assets [Abstract]", "label": "Contract Assets [Abstract]", "documentation": "Contract Assets" } } }, "auth_ref": [] }, "iclr_NonExecutiveDirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "NonExecutiveDirectorMember", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-executive directors", "label": "Non-Executive Director [Member]", "documentation": "Non-executive Director [Member]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Outstanding Debt", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "iclr_InterestRateCapAndInterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "InterestRateCapAndInterestRateSwapMember", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate cap and interest rate swap", "label": "Interest Rate Cap And Interest Rate Swap [Member]", "documentation": "Interest Rate Cap And Interest Rate Swap" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.iconplc.com/role/NetincomeperordinaryshareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of reconciliation of number of shares used in computation of basic and diluted net income per ordinary share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r710" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.iconplc.com/role/Sharebasedawards" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based awards", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r373", "r377", "r405", "r406", "r407", "r669" ] }, "iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "IncreaseDecreaseInContractWithCustomerAssetGrossCurrent", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails": { "parentTag": "iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails", "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in unbilled services (unbilled revenue)", "verboseLabel": "Increase in unbilled services (unbilled revenue)", "label": "Increase (Decrease) In Contract With Customer, Asset, Gross, Current", "documentation": "Increase (Decrease) In Contract With Customer, Asset, Gross, Current" } } }, "auth_ref": [] }, "iclr_Clients610Member": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "Clients610Member", "presentation": [ "http://www.iconplc.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Clients 6-10", "label": "Clients 6-10 [Member]", "documentation": "Clients 6-10 [Member]" } } }, "auth_ref": [] }, "iclr_SummaryOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "SummaryOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of RSU and PSU activity", "label": "Summary Of Share Based Compensation Restricted Stock Units Performance Stock Units, Award, Activity [Table Text Block]", "documentation": "Summary Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDeferredHedgeGains": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfDeferredHedgeGains", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Charge on cash flow hedge", "label": "Amortization of Deferred Hedge Gains", "documentation": "The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth." } } }, "auth_ref": [ "r703" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Secured Revolving Loan Facility", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "iclr_PerformanceBasedGrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "PerformanceBasedGrantsMember", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "PSUs based on service and EPS targets", "label": "Performance Based Grants [Member]", "documentation": "Performance Based Grants [Member]" } } }, "auth_ref": [] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r287", "r288", "r294", "r295" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://www.iconplc.com/role/OperatingleasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Lease, Description [Table]", "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r486" ] }, "iclr_RestrictedStockUnitsTwentyThirteenMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "RestrictedStockUnitsTwentyThirteenMember", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted stock units 2013", "label": "Restricted Stock Units Twenty Thirteen [Member]", "documentation": "Restricted Stock Units Twenty Thirteen [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, interest rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r31", "r312" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails", "http://www.iconplc.com/role/SharecapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r298", "r299", "r300", "r301", "r365", "r372", "r400", "r401", "r402", "r501", "r502", "r528", "r553", "r554", "r607", "r609", "r611", "r612", "r625", "r638", "r639", "r648", "r655", "r668", "r675", "r678", "r725", "r729", "r750", "r751", "r752", "r753", "r754" ] }, "us-gaap_PaymentsToAcquireLongtermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireLongtermInvestments", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchase of investments in equity - long term", "label": "Payments to Acquire Long-Term Investments", "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term." } } }, "auth_ref": [ "r700" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r123", "r235" ] }, "iclr_TermLoanFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "TermLoanFacilityMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Secured Term Loan", "label": "Term Loan Facility [Member]", "documentation": "Term Loan Facility" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.iconplc.com/role/IncometaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Components of Income Tax Expense", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r140" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r319", "r366", "r371", "r463", "r499", "r651", "r652", "r663", "r664", "r665" ] }, "iclr_VariableRateComponentAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "VariableRateComponentAxis", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate Component [Axis]", "label": "Variable Rate Component [Axis]", "documentation": "Variable Rate Component" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "presentation": [ "http://www.iconplc.com/role/RestructuringTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Restructuring Charges", "label": "Restructuring and Related Costs [Table Text Block]", "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [ "r52", "r54", "r55" ] }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Distribution of Revenue by Geographical Area", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue." } } }, "auth_ref": [ "r22" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r319", "r366", "r371", "r463", "r498", "r663", "r664", "r665" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r17" ] }, "iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "ScheduleOfNonCashStockCompensationExpenseTableTextBlock", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of non-cash stock compensation expense", "label": "Schedule of Non Cash Stock Compensation Expense [Table Text Block]", "documentation": "Schedule of Non Cash Stock Compensation Expense." } } }, "auth_ref": [] }, "iclr_OtherCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "OtherCustomersMember", "presentation": [ "http://www.iconplc.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Customers [Member]", "documentation": "Other Customers [Member]" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails", "http://www.iconplc.com/role/SharecapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r298", "r299", "r300", "r301", "r372", "r502", "r528", "r553", "r554", "r607", "r609", "r611", "r612", "r625", "r638", "r639", "r648", "r655", "r668", "r675", "r729", "r749", "r750", "r751", "r752", "r753", "r754" ] }, "iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Remaining Contractual Life", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeAssetNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetNotionalAmount", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional", "label": "Derivative Asset, Notional Amount", "documentation": "Nominal or face amount used to calculate payments on the derivative asset." } } }, "auth_ref": [ "r614", "r617", "r619", "r622", "r736", "r737", "r738" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails", "http://www.iconplc.com/role/SharecapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r298", "r299", "r300", "r301", "r365", "r372", "r400", "r401", "r402", "r501", "r502", "r528", "r553", "r554", "r607", "r609", "r611", "r612", "r625", "r638", "r639", "r648", "r655", "r668", "r675", "r678", "r725", "r729", "r750", "r751", "r752", "r753", "r754" ] }, "iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Related Costs Share Based Payments Disclosure [Line Items]", "label": "Compensation Related Costs Share Based Payments Disclosure [Line Items]", "documentation": "Compensation Related Costs Share Based Payments Disclosure [Line Items]" } } }, "auth_ref": [] }, "iclr_VariableRateComponentTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "VariableRateComponentTwoMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable rate component two", "label": "Variable Rate Component Two [Member]", "documentation": "Variable Rate Component Two" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r319", "r366", "r367", "r368", "r369", "r370", "r371", "r463", "r500", "r651", "r652", "r663", "r664", "r665" ] }, "iclr_OtherReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "OtherReceivablesMember", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables", "label": "Other Receivables [Member]", "documentation": "Other Receivables" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r298", "r299", "r300", "r301", "r372", "r502", "r528", "r553", "r554", "r607", "r609", "r611", "r612", "r625", "r638", "r639", "r648", "r655", "r668", "r675", "r729", "r749", "r750", "r751", "r752", "r753", "r754" ] }, "iclr_UnrecognizedTaxBenefitsCurrentYearTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "UnrecognizedTaxBenefitsCurrentYearTaxPositions", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/IncometaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Items generating unrecognized tax benefits", "label": "Unrecognized Tax Benefits, Current Year Tax Positions", "documentation": "Unrecognized Tax Benefits, Current Year Tax Positions" } } }, "auth_ref": [] }, "iclr_Clients1125Member": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "Clients1125Member", "presentation": [ "http://www.iconplc.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Clients 11-25", "label": "Clients 11-25 [Member]", "documentation": "Clients 11-25 [Member]" } } }, "auth_ref": [] }, "iclr_OtherUndenominatedCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "OtherUndenominatedCapital", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other undenominated capital", "label": "Other Undenominated Capital", "documentation": "Other undenominated capital." } } }, "auth_ref": [] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units (RSUs)", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r110" ] }, "iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails", "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Change in net balance", "terseLabel": "Increase in net balance", "label": "Change In Advance Payments Netted Against Unbilled Contracts Receivable", "documentation": "Change In Advance Payments Netted Against Unbilled Contracts Receivable" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r32", "r201", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r481", "r650", "r651", "r652", "r653", "r654", "r704" ] }, "iclr_ContractsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "ContractsReceivableNet", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Accounts receivable and unbilled revenue, net", "label": "Contracts Receivable, Net", "documentation": "Contracts Receivable, Net" } } }, "auth_ref": [] }, "iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable": { "xbrltype": "stringItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "CompensationRelatedCostsShareBasedPaymentsDisclosureTable", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Related Costs Share Based Payments Disclosure [Table]", "label": "Compensation Related Costs Share Based Payments Disclosure [Table]", "documentation": "Compensation Related Costs Share Based Payments Disclosure [Table]" } } }, "auth_ref": [] }, "us-gaap_RestructuringCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCosts", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.iconplc.com/role/RestructuringNarrativeDetails", "http://www.iconplc.com/role/RestructuringSummaryofRestructuringChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring", "label": "Restructuring Costs", "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r9" ] }, "iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "ConsultantsRestrictedStockUnitsTwentyNineteenMember", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consultants Restricted Stock Units 2019", "label": "Consultants Restricted Stock Units Twenty Nineteen [Member]", "documentation": "Consultants Restricted Stock Units Twenty Nineteen [Member]" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r99", "r152", "r187", "r236", "r479", "r587", "r686", "r760" ] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r17", "r446" ] }, "iclr_FacilityLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "FacilityLiabilityMember", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Facility liability", "label": "Facility Liability [Member]", "documentation": "Facility Liability" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Schedule of Restructuring and Related Costs [Table]", "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring." } } }, "auth_ref": [ "r287", "r288", "r289", "r290", "r294", "r295", "r296" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Secured Revolving Loan Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "us-gaap_BaseRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BaseRateMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Base rate", "label": "Base Rate [Member]", "documentation": "Minimum rate investor will accept." } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Activities [Abstract]", "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetsCurrent", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative asset, current", "label": "Derivative Asset, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r173" ] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.iconplc.com/role/OperatingleasesNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsScheduleofNoncashStockCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Selling, general and administration costs", "terseLabel": "Selling, general and administrative", "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r711" ] }, "us-gaap_RestructuringPlanAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringPlanAxis", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Axis]", "label": "Restructuring Plan [Axis]", "documentation": "Information by individual restructuring plan." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Domain]", "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_RestructuringPlanDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringPlanDomain", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Domain]", "label": "Restructuring Plan [Domain]", "documentation": "Identification of the individual restructuring plans." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Axis]", "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt discount paid", "label": "Debt Instrument, Unamortized Discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r97", "r100", "r730" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise of share options", "label": "Stock Issued During Period, Value, Stock Options Exercised", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r16", "r35", "r137" ] }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED", "http://www.iconplc.com/role/SharecapitalDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Share repurchase program", "terseLabel": "Share repurchase program, value of shares repurchased", "label": "Stock Repurchased and Retired During Period, Value", "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)." } } }, "auth_ref": [ "r16", "r108", "r109", "r137" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative instruments", "verboseLabel": "Derivative assets", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r173", "r174", "r469", "r544", "r545", "r546", "r547", "r548", "r550", "r551", "r552", "r553", "r554", "r569", "r570", "r614", "r618", "r620", "r621", "r623", "r624", "r644", "r678", "r759" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.iconplc.com/role/IntangibleassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r48", "r49", "r506" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r201", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r481", "r650", "r651", "r652", "r653", "r654", "r704" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Issue of restricted share units / performance share units (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r16", "r108", "r109", "r137" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r25", "r105", "r106", "r146", "r148", "r201", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r481", "r650", "r651", "r652", "r653", "r654", "r704" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://www.iconplc.com/role/FairValueMeasuresandDisclosuresTables" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets Measured on Recurring Basis", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r96", "r144" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.iconplc.com/role/IntangibleassetsTables", "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r48", "r49" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://www.iconplc.com/role/FairValueMeasuresandDisclosuresTables" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset." } } }, "auth_ref": [ "r96", "r144" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r32", "r60", "r61", "r97", "r98", "r100", "r103", "r135", "r136", "r201", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r481", "r650", "r651", "r652", "r653", "r654", "r704" ] }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/GoodwillNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated impairment loss", "label": "Goodwill, Impaired, Accumulated Impairment Loss", "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r274", "r277", "r649" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity." } } }, "auth_ref": [ "r21", "r131" ] }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchase of available for sale investments", "label": "Payments to Acquire Debt Securities, Available-for-Sale", "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r40", "r190", "r260" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/OperatingleasesNarrativeDetails", "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_LinesOfCreditCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LinesOfCreditCurrent", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current bank credit lines and loan facilities", "label": "Line of Credit, Current", "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r105", "r146" ] }, "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of available for sale investments", "label": "Proceeds from Sale of Debt Securities, Available-for-Sale", "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r39", "r190", "r260", "r262" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetsNoncurrent", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative asset, noncurrent", "label": "Derivative Asset, Noncurrent", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r173" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r193" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r167" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Net income per Ordinary Share attributable to the Group (note 13):", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.iconplc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r193" ] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Business Segment and Geographical Information", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r228", "r229", "r230", "r231", "r232", "r240", "r244", "r248", "r249", "r250", "r251", "r252", "r253", "r256" ] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability, current", "label": "Derivative Liability, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r173" ] }, "us-gaap_PaymentsOfDebtRestructuringCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtRestructuringCosts", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments of debt restructuring costs", "label": "Payments of Debt Restructuring Costs", "documentation": "The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage." } } }, "auth_ref": [ "r43" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED", "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise of share options (in shares)", "negatedLabel": "Exercised (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r16", "r108", "r109", "r137", "r386" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r125", "r126", "r127" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.iconplc.com/role/Derivatives" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r143", "r447", "r455" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofIncomefromOperationsbyGeographicalAreaDetails", "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Income from operations", "terseLabel": "Income from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r232", "r242", "r247", "r250", "r647" ] }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED", "http://www.iconplc.com/role/SharecapitalDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Share repurchase program (in shares)", "terseLabel": "Share repurchase program, number of shares repurchased (in shares)", "label": "Stock Repurchased and Retired During Period, Shares", "documentation": "Number of shares that have been repurchased and retired during the period." } } }, "auth_ref": [ "r16", "r108", "r109", "r137" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofDepreciationandAmortizationbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofIncomefromOperationsbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofRevenuebyGeographicalAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://www.iconplc.com/role/GoodwillNarrativeDetails", "http://www.iconplc.com/role/SubsequenteventsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of share capital acquired", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r74" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillRollForward", "presentation": [ "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.iconplc.com/role/GoodwillNarrativeDetails", "http://www.iconplc.com/role/SubsequenteventsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r73", "r75", "r434", "r666", "r667" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.iconplc.com/role/SubsequenteventsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r434" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.iconplc.com/role/GoodwillNarrativeDetails", "http://www.iconplc.com/role/SubsequenteventsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r434", "r666", "r667" ] }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesNoncurrent", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability, noncurrent", "label": "Derivative Liability, Noncurrent", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r173" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property, plant and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r124" ] }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentLiabilitiesMember", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current other liabilities", "label": "Other Noncurrent Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r462", "r463", "r467" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of stock option activity", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r18", "r19", "r67" ] }, "us-gaap_OtherCurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentLiabilitiesMember", "presentation": [ "http://www.iconplc.com/role/OperatingleasesNarrativeDetails", "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Current Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other current liabilities." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis spread on variable rate (in percent)", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r408", "r409", "r410", "r542", "r707", "r708", "r709", "r740", "r761" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of weighted average fair values and assumptions used", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r139" ] }, "us-gaap_NontradeReceivablesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NontradeReceivablesCurrent", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables", "label": "Nontrade Receivables, Current", "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r695" ] }, "us-gaap_DerivativeFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFixedInterestRate", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, fixed interest rate", "label": "Derivative, Fixed Interest Rate", "documentation": "Fixed interest rate related to the interest rate derivative." } } }, "auth_ref": [] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange movement", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r276" ] }, "us-gaap_IncomeTaxesReceivableNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesReceivableNoncurrent", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes receivable", "label": "Income Taxes Receivable, Noncurrent", "documentation": "Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes." } } }, "auth_ref": [ "r694" ] }, "country_IE": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "IE", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofDepreciationandAmortizationbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofIncomefromOperationsbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofRevenuebyGeographicalAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ireland", "label": "IRELAND" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxesAndTaxCredits", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred taxes", "label": "Deferred Income Taxes and Tax Credits", "documentation": "Amount of deferred income tax expense (benefit) and income tax credits." } } }, "auth_ref": [ "r127" ] }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityClassOfTreasuryStockLineItems", "presentation": [ "http://www.iconplc.com/role/SharecapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity, Class of Treasury Stock [Line Items]", "label": "Equity, Class of Treasury Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt at fair value", "label": "Long-Term Debt, Fair Value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r16", "r35", "r159", "r184", "r185", "r186", "r202", "r203", "r204", "r206", "r212", "r214", "r227", "r265", "r266", "r342", "r408", "r409", "r410", "r427", "r428", "r449", "r450", "r451", "r452", "r453", "r454", "r457", "r472", "r473", "r474", "r475", "r476", "r477", "r494", "r529", "r530", "r531", "r542", "r602" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r159", "r202", "r203", "r204", "r206", "r212", "r214", "r265", "r266", "r408", "r409", "r410", "r427", "r428", "r449", "r451", "r452", "r454", "r457", "r529", "r531", "r542", "r761" ] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current liabilities:", "label": "Liabilities, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.iconplc.com/role/Fairvaluemeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value measurements", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r461" ] }, "us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Foreign exchange movements", "label": "Translation Adjustment Functional to Reporting Currency, Increase (Decrease), Gross of Tax", "documentation": "Amount of cumulative translation gain (loss), before tax, from translating foreign currency financial statements into the reporting currency." } } }, "auth_ref": [ "r115", "r743" ] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current assets:", "label": "Assets, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r28", "r199", "r264", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r438", "r441", "r442", "r470", "r561", "r646", "r688", "r727", "r747", "r748" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails": { "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less debt issuance costs and debt discount", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r99", "r317", "r329", "r651", "r652" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r89", "r91", "r93", "r94", "r552", "r554", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r576", "r577", "r578", "r579", "r590", "r591", "r592", "r593", "r596", "r597", "r598", "r599", "r614", "r615", "r620", "r623", "r644", "r676", "r678" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Canceled/expired (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r735" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Canceled/expired (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r735" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r16", "r159", "r184", "r185", "r186", "r202", "r203", "r204", "r206", "r212", "r214", "r227", "r265", "r266", "r342", "r408", "r409", "r410", "r427", "r428", "r449", "r450", "r451", "r452", "r453", "r454", "r457", "r472", "r473", "r474", "r475", "r476", "r477", "r494", "r529", "r530", "r531", "r542", "r602" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r29", "r674" ] }, "iclr_StockRepurchaseProgramAuthorizedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "StockRepurchaseProgramAuthorizedPercentage", "presentation": [ "http://www.iconplc.com/role/SharecapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share repurchase program, authorized percentage", "label": "Stock Repurchase Program, Authorized Percentage", "documentation": "Stock Repurchase Program, Authorized Percentage" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r15", "r37", "r450", "r453", "r494", "r529", "r530", "r697", "r698", "r699", "r707", "r708", "r709" ] }, "iclr_A2021RestructuringPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "A2021RestructuringPlanMember", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2021 restructuring plan", "label": "2021 Restructuring Plan [Member]", "documentation": "2021 Restructuring Plan" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r462", "r463", "r467" ] }, "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Income before provision for income taxes", "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax", "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments." } } }, "auth_ref": [ "r121", "r699" ] }, "us-gaap_ClassOfTreasuryStockTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfTreasuryStockTable", "presentation": [ "http://www.iconplc.com/role/SharecapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Treasury Stock [Table]", "label": "Class of Treasury Stock [Table]", "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock." } } }, "auth_ref": [ "r62", "r63", "r64", "r65" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current other liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r33" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, notional amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r737", "r738" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 }, "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Share of losses in equity method investments", "negatedTerseLabel": "Loss on equity method investments", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r9", "r117", "r150", "r238", "r263", "r522" ] }, "iclr_AdjustmentToRetainedEarningShareRepurchaseCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "AdjustmentToRetainedEarningShareRepurchaseCosts", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Share repurchase costs", "label": "Adjustment to Retained Earning Share Repurchase costs", "documentation": "Adjustment to Retained Earning Share Repurchase costs" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.iconplc.com/role/IncometaxesComponentsofTaxDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Provision for income taxes", "terseLabel": "Provision for income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r153", "r157", "r213", "r214", "r239", "r418", "r430", "r527" ] }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillPurchaseAccountingAdjustments", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior period acquisition", "label": "Goodwill, Purchase Accounting Adjustments", "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r0", "r721" ] }, "iclr_PhilipsPharmaSolutionsFormerlyBioTelResearchLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "PhilipsPharmaSolutionsFormerlyBioTelResearchLLCMember", "presentation": [ "http://www.iconplc.com/role/SubsequenteventsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Philips Pharma Solutions (formerly BioTel Research, LLC)", "label": "Philips Pharma Solutions (Formerly BioTel Research, LLC) [Member]", "documentation": "Philips Pharma Solutions (Formerly BioTel Research, LLC)" } } }, "auth_ref": [] }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TechnologyBasedIntangibleAssetsMember", "presentation": [ "http://www.iconplc.com/role/IntangibleassetsDetails", "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Technology assets", "label": "Technology-Based Intangible Assets [Member]", "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights." } } }, "auth_ref": [ "r24" ] }, "iclr_EarningsPerShareBasicAndDilutedEPSAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "EarningsPerShareBasicAndDilutedEPSAbstract", "presentation": [ "http://www.iconplc.com/role/NetincomeperordinaryshareScheduleofReconciliationofNetIncomeAttributabletotheGroupDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net income per Ordinary Share attributable to the Group:", "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]", "documentation": "Earnings Per Share, Basic and Diluted EPS" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r287", "r288", "r289", "r290", "r294", "r295", "r296" ] }, "iclr_RestOfEuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "RestOfEuropeMember", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofDepreciationandAmortizationbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofIncomefromOperationsbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofRevenuebyGeographicalAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rest of Europe", "label": "Rest Of Europe [Member]", "documentation": "Rest Of Europe [Member]" } } }, "auth_ref": [] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Type [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r287", "r288", "r294", "r295" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities:", "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtTextBlock", "presentation": [ "http://www.iconplc.com/role/Bankcreditlinesandloanfacilities" ], "lang": { "en-us": { "role": { "terseLabel": "Bank credit lines and loan facilities", "label": "Long-Term Debt [Text Block]", "documentation": "The entire disclosure for long-term debt." } } }, "auth_ref": [ "r133" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities and Shareholders' Equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r114", "r149", "r520", "r674", "r705", "r713", "r742" ] }, "iclr_OtherLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "OtherLiabilityMember", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other liability", "label": "Other Liability [Member]", "documentation": "Other Liability" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.iconplc.com/role/OperatingleasesNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsScheduleofNoncashStockCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r289", "r586" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Number of Shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.iconplc.com/role/GoodwillNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r46", "r163", "r643" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares vesting period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r669" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares which have been reserved for issuance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Comprehensive income (net of tax):", "label": "Net Income (Loss) Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Drawdown of bank credit lines and loan facilities", "label": "Proceeds from Lines of Credit", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r42", "r704" ] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.iconplc.com/role/Operatingleases" ], "lang": { "en-us": { "role": { "terseLabel": "Operating leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r482" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.iconplc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r689" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r161", "r172", "r199", "r264", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r437", "r441", "r470", "r674", "r727", "r728", "r747" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Lease imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r493" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.iconplc.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]" } } }, "auth_ref": [ "r256", "r658", "r734", "r756", "r757" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/SubsequenteventsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business combination, consideration transferred", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r1", "r2", "r13" ] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated Useful Life", "label": "Finite-Lived Intangible Asset, Useful Life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r484" ] }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of accounts receivables and unbilled revenue, and unbilled services and unearned revenue", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability." } } }, "auth_ref": [ "r733" ] }, "us-gaap_TradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeNamesMember", "presentation": [ "http://www.iconplc.com/role/IntangibleassetsDetails", "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade names", "terseLabel": "Trade names & brands", "label": "Trade Names [Member]", "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r76" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assumptions:", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/OperatingleasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r484" ] }, "us-gaap_GoodwillDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillDisclosureTextBlock", "presentation": [ "http://www.iconplc.com/role/Goodwill" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill." } } }, "auth_ref": [ "r271", "r273", "r278", "r649" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.iconplc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r689" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.iconplc.com/role/IntangibleassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r506" ] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/OperatingleasesNarrativeDetails", "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Domain]", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r88", "r92" ] }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset." } } }, "auth_ref": [ "r443" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r202", "r203", "r204", "r227", "r505", "r537", "r543", "r555", "r556", "r557", "r558", "r559", "r560", "r563", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r576", "r577", "r578", "r579", "r580", "r582", "r584", "r585", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r602", "r679" ] }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable", "presentation": [ "http://www.iconplc.com/role/GoodwillNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]", "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]", "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company." } } }, "auth_ref": [ "r48" ] }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability." } } }, "auth_ref": [ "r443" ] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.iconplc.com/role/IntangibleassetsDetails", "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r280", "r281", "r282", "r283", "r506", "r507" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r484" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.iconplc.com/role/IntangibleassetsDetails", "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r48", "r49" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofDepreciationandAmortizationbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofIncomefromOperationsbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofRevenuebyGeographicalAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r254", "r255", "r546", "r549", "r551", "r608", "r610", "r613", "r626", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r642", "r657", "r678", "r734", "r756" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r10", "r512", "r521", "r674" ] }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsNonrecurringMember", "presentation": [ "http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value, nonrecurring", "label": "Fair Value, Nonrecurring [Member]", "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value." } } }, "auth_ref": [ "r462", "r463", "r464", "r465", "r466", "r468" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2023 (remaining)", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year." } } }, "auth_ref": [ "r706" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails": { "parentTag": "iclr_ContractsReceivableNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Allowance for credit losses", "label": "Accounts Receivable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r171", "r259", "r267", "r268", "r269", "r755" ] }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of long lived assets", "label": "Impairment, Long-Lived Asset, Held-for-Use", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)." } } }, "auth_ref": [ "r9", "r50", "r132" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.iconplc.com/role/IntangibleassetsDetails", "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer relationships", "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r78" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r393" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails": { "parentTag": "iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails", "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Unearned revenue", "negatedLabel": "Unearned revenue (payments on account)", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r343", "r344", "r363" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerAsset", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedLabel": "Unbilled revenue", "label": "Increase (Decrease) in Contract with Customer, Asset", "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r702" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate movements on cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r471" ] }, "us-gaap_DatabasesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DatabasesMember", "presentation": [ "http://www.iconplc.com/role/IntangibleassetsDetails", "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Patient database", "label": "Database Rights [Member]", "documentation": "Exclusive legal rights granted to the owner or licensee of collections of information stored in electronic form (such as on computer disks or files)." } } }, "auth_ref": [ "r79" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofDepreciationandAmortizationbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofIncomefromOperationsbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofRevenuebyGeographicalAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r254", "r255", "r546", "r549", "r551", "r608", "r610", "r613", "r626", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r642", "r657", "r678", "r734", "r756" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r125" ] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/IncometaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability for unrecognized tax benefit", "label": "Unrecognized Tax Benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r413", "r421" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "verboseLabel": "Unearned revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r503", "r702" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r46", "r125", "r196" ] }, "us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedLabel": "Other net assets", "label": "Increase (Decrease) in Other Current Assets and Liabilities, Net", "documentation": "Amount of increase (decrease) in current operating assets after deduction of current operating liabilities classified as other." } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/OperatingleasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets obtained in exchange for lease obligations", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r490", "r673" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r202", "r203", "r204", "r227", "r505", "r537", "r543", "r555", "r556", "r557", "r558", "r559", "r560", "r563", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r576", "r577", "r578", "r579", "r580", "r582", "r584", "r585", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r602", "r679" ] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.iconplc.com/role/Incometaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r200", "r412", "r419", "r422", "r425", "r429", "r431", "r432", "r433", "r540" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "negatedLabel": "Share issuance costs", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration." } } }, "auth_ref": [ "r16", "r137" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/IncometaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest and related penalties", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r420" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Total costs and expenses", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r120" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r183", "r414", "r415", "r422", "r423", "r424", "r426", "r538" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r385" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Forfeited (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r394" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r392" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r392" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at beginning of period (in shares)", "periodEndLabel": "Outstanding at end of period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r389", "r390" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at beginning of period (in USD per share)", "periodEndLabel": "Outstanding at end of period (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r389", "r390" ] }, "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.iconplc.com/role/OperatingleasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "label": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes operating lease liability." } } }, "auth_ref": [ "r485" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r8" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive income attributable to the Group", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r38", "r180", "r182", "r188", "r509", "r525" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of stock units vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash." } } }, "auth_ref": [ "r396" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format." } } }, "auth_ref": [ "r155" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares vested (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r393" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.iconplc.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]" } } }, "auth_ref": [ "r256", "r658", "r734", "r756", "r757" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r26", "r674" ] }, "us-gaap_ShareRepurchaseProgramAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareRepurchaseProgramAxis", "presentation": [ "http://www.iconplc.com/role/SharecapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Repurchase Program", "label": "Share Repurchase Program [Axis]", "documentation": "Information by share repurchase program." } } }, "auth_ref": [] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other non-cash items", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r127" ] }, "us-gaap_SubleaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubleaseIncome", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/OperatingleasesScheduleofLeaseCostsDetails": { "parentTag": "us-gaap_LeaseCost", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/OperatingleasesScheduleofLeaseCostsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Income from sub-leases", "label": "Sublease Income", "documentation": "Amount of sublease income excluding finance and operating lease expense." } } }, "auth_ref": [ "r489", "r673" ] }, "us-gaap_GoodwillFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill at fair value", "label": "Goodwill, Fair Value Disclosure", "documentation": "Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r741" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.iconplc.com/role/SubsequenteventsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent event type [Domain]", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r478", "r496" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expense", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r122" ] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/OperatingleasesScheduleofLeaseCostsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/OperatingleasesNarrativeDetails", "http://www.iconplc.com/role/OperatingleasesScheduleofLeaseCostsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net operating lease costs", "terseLabel": "Total lease cost", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r487", "r673" ] }, "us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net intangible assets at fair value", "label": "Finite-Lived Intangible Assets, Fair Value Disclosure", "documentation": "Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life." } } }, "auth_ref": [ "r741" ] }, "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasuredAtNetAssetValuePerShareMember", "presentation": [ "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments Measured at Net Asset Value", "label": "Fair Value Measured at Net Asset Value Per Share [Member]", "documentation": "Fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r366", "r460", "r468" ] }, "us-gaap_ShareRepurchaseProgramDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareRepurchaseProgramDomain", "presentation": [ "http://www.iconplc.com/role/SharecapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Repurchase Program [Domain]", "label": "Share Repurchase Program [Domain]", "documentation": "Name of the share repurchase program." } } }, "auth_ref": [] }, "us-gaap_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncurrentAssets", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofDepreciationandAmortizationbyGeographicalAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-lived assets", "label": "Long-Lived Assets", "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets." } } }, "auth_ref": [ "r255" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/OperatingleasesScheduleofLeaseCostsDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/OperatingleasesScheduleofLeaseCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease costs", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r488", "r673" ] }, "us-gaap_RepaymentsOfSeniorDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfSeniorDebt", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of senior debt", "label": "Repayments of Senior Debt", "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period." } } }, "auth_ref": [ "r45" ] }, "us-gaap_OtherRestructuringCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherRestructuringCosts", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other restructuring costs", "label": "Other Restructuring Costs", "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofDepreciationandAmortizationbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofIncomefromOperationsbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofRevenuebyGeographicalAreaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r47", "r116" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 9.0 }, "http://www.iconplc.com/role/IntangibleassetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/IntangibleassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "totalLabel": "Net book value", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r130", "r506" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "periodStartLabel": "Opening balance", "periodEndLabel": "Closing balance", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r165", "r272", "r508", "r649", "r674", "r715", "r722" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/IntangibleassetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/IntangibleassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total cost", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r130", "r507" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.iconplc.com/role/RevenueTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Disaggregation of Revenue", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r734" ] }, "us-gaap_SeniorSubordinatedNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeniorSubordinatedNotesMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Secured Notes", "label": "Senior Subordinated Notes [Member]", "documentation": "A senior subordinated note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior subordinated debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors. However senior subordinated notes are junior to Senior Notes and Senior bond holders." } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 }, "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED", "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Net income attributable to the Group", "verboseLabel": "Net income attributable to the Group", "terseLabel": "Net income", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r160", "r178", "r181", "r192", "r199", "r205", "r213", "r214", "r232", "r242", "r247", "r250", "r264", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r436", "r439", "r440", "r459", "r470", "r511", "r523", "r541", "r583", "r600", "r601", "r647", "r671", "r672", "r687", "r699", "r727" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "verboseLabel": "Net income", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r118", "r127", "r151", "r160", "r178", "r181", "r186", "r199", "r205", "r207", "r208", "r209", "r210", "r213", "r214", "r219", "r232", "r242", "r247", "r250", "r264", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r459", "r470", "r524", "r583", "r600", "r601", "r647", "r686", "r727" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.iconplc.com/role/Netincomeperordinaryshare" ], "lang": { "en-us": { "role": { "terseLabel": "Net income per ordinary share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r215", "r223", "r224", "r225" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.iconplc.com/role/GoodwillTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r649", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "presentation": [ "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-Lived Intangible Assets [Line Items]", "label": "Indefinite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLinesOfCredit", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repayment of bank credit lines and loan facilities", "label": "Repayments of Lines of Credit", "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r45", "r704" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403" ] }, "us-gaap_OtherLongTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLongTermInvestments", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in equity- long term", "label": "Other Long-Term Investments", "documentation": "Amount of long-term investments classified as other." } } }, "auth_ref": [ "r513", "r693" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedLabel": "Repurchase of ordinary shares", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r44" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Leases [Abstract]", "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.iconplc.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r362", "r656", "r657", "r658", "r659", "r660", "r661", "r662" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsScheduleofNoncashStockCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r404", "r411" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes payable", "label": "Accrued Income Taxes, Current", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r106", "r147" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction and integration-related expenses", "label": "Business Combination, Acquisition Related Costs", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r72" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.iconplc.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r362", "r656", "r657", "r658", "r659", "r660", "r661", "r662" ] }, "us-gaap_AccruedIncomeTaxesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesNoncurrent", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current income taxes payable", "label": "Accrued Income Taxes, Noncurrent", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent." } } }, "auth_ref": [ "r107", "r147" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r34", "r102", "r516", "r562" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average number of Ordinary Shares outstanding (note 13):", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Stock compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r8" ] }, "us-gaap_RevenueRemainingPerformanceObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligation", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, remaining performance obligation", "label": "Revenue, Remaining Performance Obligation, Amount", "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue." } } }, "auth_ref": [ "r154" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.iconplc.com/role/OperatingleasesNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsScheduleofNoncashStockCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "verboseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r284", "r289", "r586" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.iconplc.com/role/SubsequenteventsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r478", "r496" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.iconplc.com/role/SubsequenteventsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r73", "r75", "r434" ] }, "iclr_LongTermDebtCurrentMaturitiesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "LongTermDebtCurrentMaturitiesGross", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less current portion of long-term debt", "label": "Long-term Debt, Current Maturities, Gross", "documentation": "Long-term Debt, Current Maturities, Gross" } } }, "auth_ref": [] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r552", "r554", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r576", "r577", "r578", "r579", "r590", "r591", "r592", "r593", "r596", "r597", "r598", "r599", "r614", "r615", "r620", "r623", "r676", "r678" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative instruments", "verboseLabel": "Derivative liability", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r173", "r174", "r469", "r544", "r545", "r546", "r547", "r550", "r551", "r552", "r553", "r554", "r576", "r578", "r579", "r615", "r616", "r618", "r620", "r621", "r623", "r624", "r644", "r759" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r175", "r176", "r444", "r445", "r448" ] }, "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Income before share of earnings from equity method investments", "label": "Income (Loss) From Continuing Operations Before Equity Method Investments, Noncontrolling Interest", "documentation": "Income (Loss) From Continuing Operations Before Equity Method Investments, Noncontrolling Interest" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchase of subsidiary undertakings", "label": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r41", "r435" ] }, "iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent", "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage change in unbilled services (unbilled revenue)", "label": "Increase (Decrease) In Contract With Customer, Asset, Gross, Current, Percent", "documentation": "Increase (Decrease) In Contract With Customer, Asset, Gross, Current, Percent" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r676", "r677", "r678", "r680", "r681", "r682", "r685", "r707", "r708", "r740", "r758", "r761" ] }, "iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrent", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails": { "parentTag": "iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails", "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Change in unearned revenue (payments on account)", "terseLabel": "Decrease in unearned revenue (payments on account)", "label": "Increase (Decrease) In Contract With Customer, Liability, Gross, Current", "documentation": "Increase (Decrease) In Contract With Customer, Liability, Gross, Current" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED", "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on cash flow hedge", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax", "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r175", "r176" ] }, "iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent": { "xbrltype": "percentItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent", "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage change in net balance", "label": "Change In Advance Payments Netted Against Unbilled Contracts Receivable, Percent", "documentation": "Change In Advance Payments Netted Against Unbilled Contracts Receivable, Percent" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r483" ] }, "iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "AdvancePaymentsNettedAgainstUnbilledContractsReceivable", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net balance", "label": "Advance Payments Netted Against Unbilled Contracts Receivable", "documentation": "Advance Payments Netted Against Unbilled Contracts Receivable" } } }, "auth_ref": [] }, "iclr_PaymentsForShareRepurchaseCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "PaymentsForShareRepurchaseCosts", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedLabel": "Share repurchase costs", "label": "Payments For Share Repurchase Costs", "documentation": "Payments For Share Repurchase Costs" } } }, "auth_ref": [] }, "us-gaap_GoodwillAcquiredDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAcquiredDuringPeriod", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/GoodwillNarrativeDetails", "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current period acquisition", "label": "Goodwill, Acquired During Period", "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination." } } }, "auth_ref": [ "r275", "r649" ] }, "us-gaap_AmortizationOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCosts", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of financing costs and debt discount", "label": "Amortization of Debt Issuance Costs", "documentation": "Amount of amortization expense attributable to debt issuance costs." } } }, "auth_ref": [ "r119", "r326", "r480", "r703" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.iconplc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares which have been reserved for issuance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r670" ] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Reduction in carrying value of operating right-of-use assets", "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r703" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r156", "r176", "r177" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/RestructuringSummaryofDetailsofMovementinRestructuringChargesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Utilization", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r288", "r701" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock units to be granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r66" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r111", "r137", "r519", "r532", "r534", "r539", "r564", "r674" ] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total derivatives designated as hedging instruments", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r17" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combinations", "label": "Business Combinations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy." } } }, "auth_ref": [ "r71" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average grant date fair value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r395" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "documentation": "Disclosure of information about derivatives and hedging activities." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at beginning of period (in shares)", "periodEndLabel": "Outstanding at end of period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r381", "r382" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.iconplc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at beginning of period (in USD per share)", "periodEndLabel": "Outstanding at end of period (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r381", "r382" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercisable at end of period (in shares)", "terseLabel": "Number of shares exercisable (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r383" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationScheduleofDistributionofRevenuebyGeographicalAreaDetails", "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.iconplc.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r233", "r234", "r241", "r245", "r246", "r252", "r254", "r256", "r361", "r362", "r505" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercisable at end of period (in USD per share)", "terseLabel": "Weighted average exercise price of options exercisble (USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r383" ] }, "us-gaap_ContractWithCustomerAssetGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetGrossCurrent", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails": { "parentTag": "iclr_ContractsReceivableNet", "weight": 1.0, "order": 1.0 }, "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails": { "parentTag": "iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails", "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails", "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Unbilled revenue", "terseLabel": "Unbilled services (unbilled revenue)", "label": "Contract with Customer, Asset, before Allowance for Credit Loss, Current", "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current." } } }, "auth_ref": [ "r731", "r732" ] }, "us-gaap_SeveranceCosts1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeveranceCosts1", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Severance costs", "label": "Severance Costs", "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r9" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.iconplc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "presentation": [ "http://www.iconplc.com/role/DerivativesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r90" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, par value (in EUR cents per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r109" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liability", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r416", "r417", "r515" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "verboseLabel": "Ordinary shares, shares issued (in shares)", "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r109" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r401" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r400" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.iconplc.com/role/NetincomeperordinaryshareScheduleofReconciliationofNetIncomeAttributabletotheGroupDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in USD per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r189", "r207", "r208", "r209", "r210", "r211", "r218", "r220", "r221", "r222", "r226", "r458", "r459", "r510", "r526", "r645" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r402" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://www.iconplc.com/role/OperatingleasesNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsScheduleofNoncashStockCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Direct costs", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Ordinary shares, par value 6 euro cents per share; 100,000,000 shares authorized, 82,326,976 shares issued and outstanding at September 30, 2023 and 81,723,555 shares issued and outstanding at December\u00a031, 2022", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r109", "r517", "r674" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "terseLabel": "Revenue from Contract with Customer [Abstract]", "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsScheduleofNoncashStockCompensationExpenseDetails", "http://www.iconplc.com/role/SharebasedawardsScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r374", "r376", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r109", "r563" ] }, "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate cash flow hedge gain (loss) to be reclassified during next 12 months, net", "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net", "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months." } } }, "auth_ref": [ "r95" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Prepayments and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r696" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, shares outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r16", "r109", "r563", "r581", "r761", "r762" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsScheduleofNoncashStockCompensationExpenseDetails", "http://www.iconplc.com/role/SharebasedawardsScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r374", "r376", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Title of Individual [Domain]", "label": "Title of Individual [Domain]" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.iconplc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options Outstanding Number of Shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest paid", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r191", "r194", "r195" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Title of Individual [Axis]", "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r712", "r746" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities", "http://www.iconplc.com/role/Revenue" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "verboseLabel": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r158", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r364" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash stock compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r69", "r70", "r375" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r394" ] }, "us-gaap_NumberOfInterestRateDerivativesHeld": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfInterestRateDerivativesHeld", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of interest rate derivatives held", "label": "Number of Interest Rate Derivatives Held", "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date." } } }, "auth_ref": [ "r86", "r87" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Domain]", "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average contractual term of options outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r138" ] }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SOFR", "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg." } } }, "auth_ref": [ "r739" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognition", "label": "Revenue from Contract with Customer [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r158", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r640" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Direct costs (excluding depreciation and amortization)", "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization", "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization." } } }, "auth_ref": [ "r691", "r692" ] }, "us-gaap_CostOfRevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenueAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Costs and expenses:", "label": "Cost of Revenue [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Grant Date Fair Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r319", "r366", "r367", "r368", "r369", "r370", "r371", "r498", "r499", "r500", "r651", "r652", "r663", "r664", "r665" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.iconplc.com/role/OperatingleasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average discount rate", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r492", "r673" ] }, "us-gaap_BilledContractReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BilledContractReceivables", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails": { "parentTag": "iclr_ContractsReceivableNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Billed services (accounts receivable)", "label": "Billed Contracts Receivable", "documentation": "Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date." } } }, "auth_ref": [ "r504" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.iconplc.com/role/Basisofpresentation" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of presentation", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r104", "r141", "r535", "r536" ] }, "us-gaap_PaymentsOfStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfStockIssuanceCosts", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "negatedLabel": "Share issue costs", "label": "Payments of Stock Issuance Costs", "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security." } } }, "auth_ref": [ "r43" ] }, "us-gaap_InterestRateCapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateCapMember", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Caps", "label": "Interest Rate Cap [Member]", "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount." } } }, "auth_ref": [ "r641" ] }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "presentation": [ "http://www.iconplc.com/role/RestructuringTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of details of movement in restructuring charges", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period." } } }, "auth_ref": [ "r53", "r56" ] }, "us-gaap_OrderOrProductionBacklogMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrderOrProductionBacklogMember", "presentation": [ "http://www.iconplc.com/role/IntangibleassetsDetails", "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Order backlog", "label": "Order or Production Backlog [Member]", "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination." } } }, "auth_ref": [ "r77" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r493" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in USD per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r385" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.iconplc.com/role/NetincomeperordinaryshareScheduleofReconciliationofNetIncomeAttributabletotheGroupDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in USD per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r189", "r207", "r208", "r209", "r210", "r211", "r216", "r218", "r220", "r221", "r222", "r226", "r458", "r459", "r510", "r526", "r645" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive loss, net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r7", "r14", "r142", "r179", "r182" ] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total liabilities", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r96" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised (in USD per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r386" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total future minimum lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r493" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r30", "r162", "r199", "r264", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r438", "r441", "r442", "r470", "r674", "r727", "r747", "r748" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total debt", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r25", "r148", "r328" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "http://www.iconplc.com/role/FairvaluemeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total assets", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r96" ] }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/FairvaluemeasurementsMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available for sale investments (long-term)", "label": "Debt Securities, Available-for-Sale, Noncurrent", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent." } } }, "auth_ref": [ "r164", "r261", "r270" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 1", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r493" ] }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "presentation": [ "http://www.iconplc.com/role/SummaryofsignificantaccountingpoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets", "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined." } } }, "auth_ref": [ "r12" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 5", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r493" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Shareholders' Equity:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationBargainPurchaseGainRecognizedAmount", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "http://www.iconplc.com/role/GoodwillNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Acquisition-related gain", "terseLabel": "Acquisition-related gain", "label": "Business Combination, Bargain Purchase, Gain Recognized, Amount", "documentation": "In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity." } } }, "auth_ref": [ "r80", "r81", "r82", "r83", "r84", "r85" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 4", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r493" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 3", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r493" ] }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationPercentage", "presentation": [ "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, remaining performance obligation percentage", "label": "Revenue, Remaining Performance Obligation, Percentage", "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue." } } }, "auth_ref": [ "r690" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/OperatingleasesScheduleofOperatingLeaseMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 2", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r493" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current Liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesNarrativeDetails", "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r32", "r59" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "totalLabel": "Total Shareholders' Equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r109", "r112", "r113", "r129", "r565", "r581", "r603", "r604", "r674", "r688", "r705", "r713", "r742", "r761" ] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.iconplc.com/role/Subsequentevents" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r495", "r497" ] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.iconplc.com/role/Restructuring" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r285", "r286", "r288", "r291", "r297" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.iconplc.com/role/Sharecapital" ], "lang": { "en-us": { "role": { "terseLabel": "Share capital", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r134", "r198", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r456", "r605", "r606", "r627" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net of allowance for credit losses", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r257", "r258" ] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCharges", "crdr": "debit", "presentation": [ "http://www.iconplc.com/role/RestructuringSummaryofDetailsofMovementinRestructuringChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional provisions", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r9", "r292", "r294", "r726" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.iconplc.com/role/OperatingleasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Operating Lease Maturity", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r745" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r145", "r168", "r199", "r232", "r243", "r248", "r264", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r437", "r441", "r470", "r514", "r575", "r674", "r688", "r727", "r728", "r747" ] }, "iclr_OtherUndenominatedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://www.iconplc.com/20230930", "localname": "OtherUndenominatedCapitalMember", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Other Undenominated Capital", "label": "Other Undenominated Capital [Member]", "documentation": "Other undenominated capital." } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax asset", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r416", "r417" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Issue of restricted share units / performance share units", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r68", "r108", "r109", "r137" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r11", "r201", "r322" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateSwapMember", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap", "label": "Interest Rate Swap [Member]", "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period." } } }, "auth_ref": [ "r641", "r683", "r684" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Long-Term Debt, Maturity, Year Three", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r11", "r201", "r322" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofContractualMaturitiesofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Long-Term Debt, Maturity, Year Two", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r11", "r201", "r322" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization expense", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r9", "r237" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.iconplc.com/role/SubsequenteventsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent event type [Axis]", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r478", "r496" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.iconplc.com/role/BankcreditlinesandloanfacilitiesScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total long-term debt, net", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r169" ] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.iconplc.com/role/RestructuringNarrativeDetails", "http://www.iconplc.com/role/RestructuringSummaryofDetailsofMovementinRestructuringChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Opening provision", "periodStartLabel": "Ending provision", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r288", "r293" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.iconplc.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r36", "r37", "r115", "r170", "r518", "r533", "r534" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsNarrativeDetails", "http://www.iconplc.com/role/SharebasedawardsSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average contractual term of options exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r66" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.iconplc.com/role/SharebasedawardsScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected life", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r399" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.iconplc.com/role/IntangibleassetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.iconplc.com/role/IntangibleassetsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accumulated amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r166", "r282" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "16", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b),(d)", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "a", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "b", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-13" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-14" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "05", "Paragraph": "4", "Subparagraph": "(a)-(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "38", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-3" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-4" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "30", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-5" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "30", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-6" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.18)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(1)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-2" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-20/tableOfContent" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-30/tableOfContent" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//420/tableOfContent" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r641": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r642": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r643": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r645": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r646": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r647": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r648": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r649": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r650": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r651": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r652": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r653": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r654": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r655": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r656": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r657": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r658": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r659": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r660": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r661": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r662": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r663": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r666": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r667": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r668": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r669": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r670": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r671": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r672": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r673": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r674": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r675": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r676": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r678": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r682": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r683": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r684": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r685": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r686": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r687": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r688": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r689": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r690": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(1)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r691": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r692": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r693": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r694": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r695": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r696": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r697": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r698": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r699": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r700": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r701": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r702": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r703": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r704": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r705": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r706": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r707": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r708": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r709": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r710": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r711": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r712": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r713": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r714": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r715": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r716": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r717": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r718": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r719": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r720": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r721": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r722": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r723": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r724": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r725": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r726": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3" }, "r727": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r728": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r729": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r730": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r731": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r732": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3" }, "r733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r753": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r754": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r755": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r756": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r757": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r758": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r759": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r760": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r761": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r762": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 89 0001060955-23-000033-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001060955-23-000033-xbrl.zip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end

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